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Abstract 
Although the latest advancements in lipid analysis technology provide an excellent 
opportunity for the comprehensive study of lipidome, fulfilling the analytical requirements at 
the desired quality is still a major challenge. In lipidomic workflow, sample treatment and 
extraction for simultaneous analysis of endogenous lipids is of a great interest, especially 
when a number of undesirable circumstances such as ionization suppression are the matter of 
concern. In this thesis, I describe several approaches for both in vivo and high throughput in 
vitro sample preparation for molecular lipidomics based on solid phase microextraction 
(SPME) in the direct extraction mode.  
The initial research presented in this thesis focused on the analysis of fatty acids (FA) as the 
major building block and most fundamental category of entire lipid family. In this study, we 
present a direct immersion solid phase microextraction method coupled to a liquid 
chromatography-mass spectrometry platform (DI-SPME- HPLC-ESI-MS) for determination 
of unconjugated fatty acids (FA) in fish and human plasma. The proposed method was fully 
validated according to bioanalytical method validation guidelines. The affinity constant (Ka) 
of individual FAs to protein albumin was determined to be 9.2 × 10
4
 to 4.3 × 10
5
 M
−1
. The 
plasma protein binding (PPB%) was calculated and found to be in the range of 98.0−99.7% 
for different polyunsaturated fatty acids (PUFAs). The PUFAs under study were found at a 
high concentration range in fish plasma, whereas only a few were within quantification range 
in control human plasma. The method was successfully applied for monitoring PUFA 
changes in plasma samples obtained during operation of a group of patients undergoing 
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cardiac surgery with the use of cardiopulmonary bypass (CPB). The most significant 
alteration induced by surgery was noticed in the concentration level of α-linolenic acid (18:3, 
ALA), arachidonic acid (20:4, AA), and docosahexanoic acid (22:6, DHA) soon after 
inception of CPB in all cases. 
The quantitative results obtained for fatty acid measurement have encouraged me to expand 
my study for analyzing a broad spectrum of complex lipids as the next step. Therefore, in 
 Chapter 3 biocompatible thin film SPME technique is introduced for quantitative analysis of 
lipids from human plasma in a high throughput manner. Robotic assisted 96-blade thin-film 
SPME was employed for the extraction of a group of non-endogenous lipids from plasma, 
and satisfactory results for recovery and reproducibility were achieved. In addition, the new 
extraction method eliminated the need for multi-step sample handling including 
centrifugation, filtering, solvent evaporation, and reconstitution. The total preparation time 
was reduced to less than 2 min per sample, while artifacts and sample loss were minimized 
due to the simplified method. Absolute recoveries were typically 1-2%, thereby avoiding 
sample disturbance while providing proper sensitivity. Furthermore, endogenous and non-
endogenous groups of target lipids were quantified, and excellent linearity and method 
precision were obtained. The regression calibrations obtained from five different plasma 
batches represents RSD less than 5% in all cases, clearly indicating the absence of matrix 
effects and lot-to-lot variations of the proposed method. The linearity (R2 > 0.99), inter and 
intra-day reproducibility (2-7%), and precision (1-12%) provided verification of method 
validity.   
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Finally, the evaluated SPME method was compared to the conventional Bligh & Dyer 
technique for the untargeted lipidomic study of human hepatocellular carcinoma (HCC) cell 
lines. Cells were cultured under standard conditions in two individual groups; one cultivated 
normally as a control group and another supplemented by eicosapantanoic acid (20:5), as a 
highly polyunsaturated fatty acid, to study the effect of treatment on the lipidome pattern of 
cancerous cells. The obtained results provided a list of up-regulated and down-regulated 
lipids through a comparison between control versus treated cells. Method precision for the 
SPME approach was excellent (5-18% RSD) for all detected lipids. The relative LOD range 
was 0.5-1 ng/ml for the proposed SPME method, while for Bligh & Dyer, it was found to 
range between 0.05-0.1 ng/ml. Automated 96-blade sample handling enhanced extraction 
rates by approximately 2 min per sample, while generating comparable or enhanced product 
yields in comparison to conventional methods 
This study highlights important advantages of both SPME approaches using the rod fiber and 
thin-film geometries to capture fatty acids and lipids from different biological media 
including human and fish plasma as well as cell culture. The experimental results confirm the 
suitability of SPME for both in vitro and in vivo study in clinical samples as a new tool for 
lipidomic analysis. 
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Chapter 1 
Introduction 
1.1 Lipid chemistry and general classification 
A variety of definitions exist for the term “lipid”; some describe its molecular structure, 
while others designate shared physical properties. As an extensive definition, “lipids” are 
said to be a set of naturally occurring molecules that mainly contain fatty acids (FAs) in their 
structure, and come in a diversity of structures and functionalities. Based on their molecular 
structure similarities, they can be further categorized into a range of substituent classes and 
sub-classes. All lipids within a category contain the same functional head group, but differ in 
the number of carbon atoms (usually C
14
), and double bonds incorporated into their aliphatic 
chains. Based on their functional backbone and associated physicochemical properties, lipids 
are generally classified into eight categories, each with its own sub-classification hierarchy. 
This grouping scheme is driven by the discernible hydrophobic and hydrophilic elements that 
compose the chemical structure of lipids. The main lipid classes are comprised of fatty acyls, 
glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, 
and polyketides.
1,2
 This global classification is fairly comprehensive and referred to as a 
guide. In the following sections, the abovementioned lipid classes and their subclasses, which 
have been studied in the current thesis, are introduced and described in detail. 
Comprehensive information about lipids, including their systematic cataloguing and related 
nomenclature is provided in online databases such as LIPID MAPS 
(http://www.lipidmaps.org/), Lipid Library ((http://lipidlibrary.aocs.org), Lipid Bank 
((http://www.lipidbank.jp) and Cyberlipids ((http://www.cyberlipid.org).
3–5
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1.1.1  Fatty Acid  
Fatty acids are a diverse group of molecules composed of a carboxylic acid head group 
attached to a long linear or branched aliphatic chain, which can vary in regards to the number 
of carbon atoms it carries, as well as its level of saturation. The chain length usually ranges 
from 4 to 28 carbons. Fatty acids are synthesized by chain elongation of an acetyl-CoA 
primer with malonyl-CoA (or methylmalonyl-CoA) groups. The "free fatty acids", i.e. not 
attached to other molecules, are mainly produced from hydrolysis of other major groups of 
lipids, such as triglycerides or phospholipids. FFA in the blood plasma arises mainly from 
lipolysis (TG hydrolysis) while the intracellular FFA may have been taken up from the 
blood, or they may have been synthesized in the cell; this varies with cell type. They serve as 
a source of fuel by producing adenosine triphosphate (ATP) through beta oxidation, 
particularly for heart and skeletal muscle. Saturated fatty acids have no double bonds, while 
unsaturated fatty acids have one (monounsaturated) or more double bonds (polyunsaturated); 
and the most naturally occurring unsaturated fatty acids are in the cis configuration. 
Polyunsaturated fatty acids (PUFA) can be classified into two groups, n-6 or n-3, depending 
on the position (n) of the double bond that is nearest to the methyl end of the fatty acid. 
Polyunsaturated fatty acids can be defined as fatty acids with 18 carbons or more in length 
that contain two or more double bonds. Typically, a mammalian diet requires a large intake 
of PUFA; this is due to the fact that although primary linoleic acid (18:2, n-6) is required for 
normal development, most mammalians, including humans lack the desaturase enzymes 
needed for their production.
6–8
 Due to the great importance of this group of lipids, the 
development of a new analytical technique for their quantification is the subject of focus in 
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 Chapter 2 of the currently presented thesis. Table  1-1 illustrates the example structure of 
different fatty acids. 
Table  1-1 Representative chemical structures of saturated and polyunsaturated fatty acids 
Name Feature Abbreviation Chemical structure 
Stearic acid  (18:0) Saturated 
 
Oleic acid  (18:1) Monounsaturated 
 
α-Linolenic acid  (18:3) 
Polyunsaturated 
Essential 
 
Eicosapentaenoic 
acid  
(20:5) 
Polyunsaturated 
Essential 
 
Docosahexaenoic 
Acid  
(22:6) 
Polyunsaturated 
Essential    
 
 
1.1.2 Glycerophospholipids  
A large majority of membrane lipid content consists of glycerophospholipids. This varies 
with cell type and cell organelle. A molecular species of a glycerophospholipid is 
characterized by its phospholipid class, subclass, and its fatty acyl content. The molecular 
structure of this group of lipids is composed of a glycerol backbone linked to a phosphate 
moiety in the sn3 position, and hydrocarbon chains esterified to the sn1 and sn2 positions. 
Modification of the glycerol backbone, head group, or stereospecificity of the aliphatic chain 
substantially alters the biological activity of the molecule. Based on the nature of the polar 
head group at the sn3 position of the glycerol backbone, glycerophospholipids are subdivided 
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into individual sub-categories. Due to variations in head group as well as diversity in the 
length and number of double bonds, glycerophospholipids are comprised of a great number 
of molecular species. 
9,10
 The most abundant sub-categories of phospholipids includes 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE), which together with other 
lipids construct the biomembrane structures.
11
 Chemical structures of various phospholipid 
classes and sub-classes are shown in Table  1-2. 
Table  1-2 Representative chemical structures of glycerophospholipids and lysophospholipids 
Name Abbreviation Chemical structure 
Lysophosphatidylcholine LPC 
 
Phosphatidylcholine PC 
 
Phosphatidylethanolamine PE 
 
Phosphatidylglycerol PG 
 
Phosphatidylinositol PI 
 
Phosphatidylserine PS 
 
Cardiolipin  CL 
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1.1.3 Sphingolipids 
Sphingolipids (SM) are a complex family of compounds that share a sphingosine base 
backbone and a long chain fatty acid; they are considered the second largest category of polar 
lipids. Major subdivisions of sphingolipids include sphingomyelins and ceramides, as well as 
other glycosphingolipids that contain multiple sugar rings. Similarly to PCs, sphingomyelins 
consist of a choline head group, and as a result, these two groups share many physical 
properties. Both PC and SM are located in the outer leaflet of plasma membranes, although 
they are also found in various other biological structures such as lipoproteins. 
12,13
 
Sphingolipids are particularly abundant in the central nervous system, representing 
approximately 5-10% of total lipid mass in most brain cells. 
14,15
 In addition to playing 
structural roles in cellular membranes, sphingolipid metabolites act as bioactive signaling 
molecules involved in the regulation of cell growth, differentiation, senescence, and 
apoptosis. The main sphingolipids relevant to this study are shown in Table ‎1-3. 
 
Table  1-3 Representative chemical structures of sphingolipid family sub-classes 
Name Abbreviation Chemical structure 
Ceramide   CE 
 
Sphingomyelin SM 
 
Sphingosine SP 
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1.1.4 Glycerolipids 
The glycerolipid category (Table  1-4) is dominated by a category of lipids having a glycerol 
scaffold in which one, two, or three substituted fatty acids are esterified, with fatty acids 
differing in chain length and number of double bonds. Accordingly, the most prominent 
glycerolipids include monoglycerides (MGs), diacylglycerols (DGs) and triacylglycerols 
(TGs), among which TGs account for the highest proportion of total lipids in plasma, being 
the most abundant dietary lipids. They are distributed between lipoproteins for transportation 
in the blood stream, and their concentration is dependent on food intake.
16–18
 Blood-plasma 
triglycerides provide a major source of energy, and are secreted from liver. Conversely, 
adipose tissue has a primary role in the synthesis and storage of triacylglycerol (TG) in 
periods of energy excess. During periods of energy demand, TG are rapidly hydrolyzed to 
release free fatty acids, which are then taken up by other organs to meet the energy 
requirements of the organism.
19,20
  
 
Table  1-4 Representative chemical structures of glycerolipid family sub-classes 
Name Abbreviation Chemical structure 
Monoglyceride MG 
 
Diglyceride DG 
 
Triglyceride TG 
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1.2 Lipid Distribution and interaction with proteins  
As an insoluble compound, the transportation and delivery of lipids in the blood stream are 
enforced by complex lipoproteins composed of lipids and proteins that ultimately render the 
particles soluble in aqueous environments (FFAs bind to albumin and lipoproteins have at 
most a minor role in their transport). Plasma lipoproteins are spherical particles consisting of 
a lipophilic core surrounded by an amphipathic monolayer of phospholipids with their 
hydrophobic tails facing the central core, while their hydrophilic regions face the surrounding 
aqueous environment. The core of all lipoproteins contains triglycerides (TG) and cholesterol 
esters, also have small amounts of sphingolipids. The external layer is made of phospholipids 
and specialized protein components called apolipoproteins or apoproteins. These proteins 
help to maintain the structural integrity of particles, facilitate lipid solubilisation, and serve as 
ligands for lipoprotein receptors, while also regulating the activity of their metabolic 
enzymes. Lipoproteins not only differ in the ratio of protein to lipids; they also vary in terms 
of type of apoproteins involved. Hence, they are comprised of various attribute densities, 
sizes, and compositions, ranging from very low-density lipoproteins (VLDL; 2nd highest in 
triacylglycerols); low density lipoproteins (LDL; highest in cholesteryl esters); and high 
density lipoproteins (HDL; premier in density due to the high protein to lipid ratio). 
Chylomicrons are also lipoprotein particles that consist of triglycerides (85–92%), 
phospholipids (6–12%), cholesterol (1–3%), and proteins (1–2%). They transport dietary 
lipids from the intestines to other locations in the body. All these plasma lipoproteins 
encompass low energy of stabilization and constantly lose, acquire, and exchange their lipid 
and protein constituents during ordinary metabolism.
13,17,21,22
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1.3  Necessity of lipid analysis and lipidomics  
In view of their importance to biologic and pathophysiological processes, lipids share a wide 
variety of key cellular functions, including compartmentalization, energy storage, cell-
signaling, protein trafficking, and membrane anchoring. Such functional diversity is 
evidently important in maintaining the cellular homeostasis of living organisms; accordingly, 
any alteration in their critical functionality can induce severe pathophysiological 
consequences associated to chronic diseases such as diabetes, cancer, arthritis, obesity, as 
well as neurodegenerative and infectious diseases.
7,23–30
 In order to reveal lipid-related 
dysfunctions, the biological role of each individual molecular lipid species needs to be 
identified. Therefore, precise quantification of lipid constituents and apprehension of the 
origins of their chemical distortion provide important insights to developmental biology, 
diagnostics, and potential treatments. To this end, lipid analysis will embraces a conclusive 
explanation of the biochemical mechanism through which lipids interacts with each other and 
with fundamental proteins, and also assist with characterization of their dynamics, kinetics, 
and alterations. During systematic investigations of entire lipids, it is crucial that their 
functionality in the physiological and metabolic levels, their signaling pathways and 
regulation, as well as their correlation with other metabolites be well-understood. Lipidomics 
is a branch of study that seeks to map the entire spectrum of cellular lipids in any biological 
system (cell, tissue, organ, or organism). It is an “omics” subdivision that complements 
proteomics, genomics, and metabolomics so as to provide a more comprehensive perception 
of system biology in health and disease. Although recent scientific endeavors have been 
focused on the true power and promises of lipidomics, the true potential of this field is only 
beginning to be realized. 
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1.3.1 Trends in lipid analysis  
In biological and clinical studies, the development of comprehensive analytical platforms that 
is capable of providing coverage for a wide variety of lipids continues to be a primary 
challenge for analytical chemistry. In addition, the diverse chemical structures and large 
dynamic range of concentrations of lipids complicate their analysis condition. Any successful 
lipid analysis method is intended to be a flawless workflow of sample preparation and 
extraction, separation, detection, and straightforward data processing. However, no single 
methodology or technique is yet in widespread use to screen all lipids. Traditional 
approaches for determination and quantification of all lipid classes are either not sensitive 
enough and lack accuracy, or do not provide enough throughput; as such, these methods are 
inadequate for practical analysis of clinical samples. For the most part, these methods were 
developed for analyses of specific categories of compounds such as membrane phospholipids 
or the mitochondrial lipids, and consequently, are unable to cover the whole lipid array.
31–40
 
Although these conventional methods may offer the advantage of simplicity, for instance, by 
commercializing assay kits for enzymatic methodologies
41–44
 or provide relatively 
inexpensive approaches, such as thin-layer chromatography (TLC),
45,46
 neither do they 
provide a full profile of all lipid classes, nor do they evade the necessity of multiple 
preparative steps, which makes them susceptible to interferences. In this regard, the lipid 
biology research field is undergoing a cutting-edge technological transformation that 
involves lipid separation and determination approaches, as well as their further identification 
and characterization steps. This includes the use of more advanced chromatography 
techniques, as well as state-of-the-art mass spectrometry (MS), most notably centered on 
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electrospray ionization (ESI),  high-resolution mass analyzer using multiple reaction 
monitoring (MRM), or selected ion monitoring (SIM).
47,48
 
1.4 Lipid analysis and lipidomics: miscellaneous platforms  
In a biological practice, the full lipid content is elucidated by performing high throughput 
molecular lipidomics on cells or biofluids. Generally, such investigations are conducted with 
aims to classify and quantify the utmost number of molecular lipids and their feasible 
systemic interactions, and also to demystify any possible genetic or external perturbations. In 
this workflow, nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry 
techniques are most commonly used as analytical tools for detection and determination of 
lipids. The evolution of lipid analysis and lipidomics has accelerated advancements in new 
analytic platforms particularly in the area of mass spectrometry. Utilization of this technique 
allows for streamlining of required procedures, analyses of larger groups of lipid molecules, 
and collection of more detailed structural information. In this section, the major MS-based 
platforms used in clinical lipidomics are introduced, and their recent technological 
developments are reviewed. 
1.4.1 Direct infusion and shotgun lipidomics 
For lipidomics studies, the MS platform is either supported by separation (chromatographic 
or electrophoretic) techniques, or alternatively performed solely through direct introduction 
of lipid extracts to the MS instrument. The latter approach is recognized as direct infusion or 
shotgun lipidomics, which allows for sample introduction and processing in a high-
throughput manner.
39,49,50
 The feasibility of shotgun lipidomics approaches is based on the 
use of electrospray ionization as an inherent soft-ionization technique. This approach is 
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mainly practical for lipids with polar head groups (e.g., glycerophospholipids) as readily 
ionized species with respect to their molecular structure,
51–53
 although it has also been 
applied for the characterization of sphingomyelins and ceramides,
36,54
 as well as 
glycerolipids.
55
 Shotgun lipidomics is typically achievable in MS-only or MS/MS platforms  
by utilizing high mass accuracy/resolution hybrid instrumentation such as the quadruple time 
of flight (Q-TOF), or the linear ion-trap (LTQ) Orbitrap mass spectrometer with an enhanced 
duty cycle.
39,49,56–58
 The most important advantage of shotgun lipidomics is its ability to 
provide direct identification and quantification of several hundreds of lipids at the molecular 
level from total lipid extracts in a relatively short analysis time. On the other hand, a major 
concern with this approach is the risk of ion suppression encounters, particularly when the 
sample preparation method generates a crude lipid extract that becomes diluted and infuses 
directly into the mass spectrometer. However, if accurate measurment of target lipid is 
prevented by ion suppression, there are a few strategies that may be implemented, one of 
which is a method proposed and discussed later in this thesis.
59
  
1.4.2 GC and GC-MS 
Gas chromatography (GC) is often used as a separation technique for volatile and thermally 
stable analytes where the retention is influenced by the molecular boiling point. Because 
most lipids are not volatile and some of them are easily degraded in high temperature, GC is 
not a widely employed technique in lipidomics because analytes must be thermally stable 
with high vapor pressure to volatilize during injection. Although derivatization can overcome 
the problems of the analyte in terms of volatility and lability, derivatization may be difficult 
for the complex biomolecules. Analysis of different categories of lipids by GC involves 
complex pre-separation steps, due to the complexity of derivatization reagents required for 
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each lipid class/subclass. These altogether leads to the less frequent application of GC 
techniques in lipidomics studies.
60
 In fact, gas chromatographic (GC) separation with flame-
ionization detection (FID) is suitable for the analysis of fatty acids.
61
 Separation of cis/trans 
isomers of various fatty acid species can be achieved by using conventional GC-FID. The 
fatty-acid composition of fats and oils is easy to analyze by GC-FID after derivatization to 
methyl ester fatty acid (FAME) derivatives.
62
 
In lipidomics studies, GC-MS techniques using the electron ionization (EI) or chemical 
ionization (CI) are most commonly employed for low molecular weight lipids such as fatty 
acids. A large number of GC-MS studies are focused on free fatty-acid profiling or fatty acyl 
characterization of phospholipids and TGs. However, while the abovementioned methods 
provide detailed information about the R-group, they fail to provide lipid-class information 
because of the need for saponification in the sample preparation step.
33,62–65
 Recent 
advancements in time-of-flight (TOF) mass analyzer technology, which allows higher 
scanning speeds (but lower mass resolution), have encouraged wider adoption of EI in 
comprehensive two-dimensional GC (GC × GC).
66–68
 These advancements have brought 
several advantages to the methodology, such as increased separation, higher peak capacity, 
better reproducibility, and the use of available libraries for matching and compound 
identification, particularly for EI-based GC/ MS analysis. However, several major drawbacks 
of GC/MS for lipid analysis are related to the critical need of chemical derivatization of 
lipids in order to reduce their polarity and increase their volatility, which in turn facilitates 
their separation and ionization in the EI/CI GCMS-based method. While boasting certain 
advantages, these techniques are restrictive due to the unpleasant derivative steps and their 
low sensitivity, which have restrained their further application in lipid analysis. Chemical 
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derivatization may cause molecular decomposition, resulting in complex chromatograms that 
are hard to interpret.
69
 As a consequence of these challenges, and due to the expansion of soft 
ionization techniques such as electrospray ionization (ESI), a large majority of lipidomics 
studies are performed based on LC/ESI-MS, with GC-based techniques being less frequently 
applied in this area. 
1.4.3 LC and LC-MS 
The structural diversity of lipids demands for efficient separation approaches that can cover 
all classes and sub-classes of lipids. As a technique that requires no derivatization, preserves 
important lipid-class information, and interfaces easily to the soft-ionization techniques of 
atmospheric pressure mass spectrometers, the liquid chromatography (LC) is the most 
broadly applicable among all currently available methods. By coupling liquid 
chromatography to MS, the limitations of direct infusion such as suppression by competing 
ions, limited sensitivity of detection for low abundant lipid species, and difficulties of 
detecting isobaric and isomeric lipids could be substantially eliminated. Several LC 
configurations have been reported for the analysis of complex lipid mixtures, from which 
reverse phase (RPLC), normal phase (NPLC) and hydrophilic interaction liquid 
chromatography (HILIC) are the ones which have shown the most potential. Separation of 
lipids in RPLC (C18 or C8 columns) is based on lipophilicity, where lipid species are 
retained based on their carbon-chain length and the number of double bonds; as such, this 
approach provides separation of lipids of a class with excellent retention time reproducibility. 
On the other hands, NPLC and HILIC typically differentiate lipid species according to their 
functional group, so that lipids are separated with respect to the polarity of their head group. 
Depending on the application, RPLC, NPLC, and HILIC offer different advantages for 
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separation of various lipid categories, where the choice of LC method affects the resolved 
group of lipids. For comprehensive lipid analysis, normal phase LC can only be used for 
quick assessments of class-based lipid fractionation, while the use of reversed-phase LC 
allows for individual lipid fractions to be resolved within a specific class; thus, another layer 
of molecular information detail can be achieved.
70–74
 Additionally, off-line and on-line two-
dimensional LC-MS approaches have been used for separation of a wide range of complex 
lipids.
66
 Furthermore, electrospray ionization (ESI), is the most popular interface for coupling 
LC stream to the mass analyzers and detectors in lipidomics analysis; it can be easily 
integrated with online databases due to its powerful ability for efficient ionization of 
compound with different polarities.
75
 The HPLC-ESI-MS is a very appropriate method for 
targeted and untargeted lipid profiling in biological samples such as blood, plasma, and 
tissue. 
70,74,76–81
 However, one of the restrictions of LC-ESI-MS is that it provides limited 
information about the fatty acyl constituents of individual lipids; for instance it cannot 
distinguish the differentiating double-bound positional isomers, cis-/trans-isomers, or 
regioisomers. For such specific studies, other LC techniques have been used, including 
silver-ion RPLC, chiral LC, and supercritical fluid chromatography (SFC). In such cases a 
long chromatographic run of about 1.5–2.5 h is required to determine exact stereo-chemical 
configurations of lipids, which is a major drawback of these separation approaches.
60,72,82,83
 
Conversely, for structure analysis of lipids, more powerful mass analyzers with higher 
resolving power such as ion mobility,
84,85
 or other soft ionization techniques, such as matrix-
assisted laser desorption/ionization (MALDI) combined to Q-TOF, have been reported 
previously.
86–88
 MALDI-TOF is a popular technique for lipid analysis, since it can be used to 
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determine head groups and structural compositions of individual fatty acyl chains when 
coupled to post-source decay fragmentation.
47
 
1.5 Sample preparation and extraction for lipidomics 
As a multidisciplinary field, lipidomics necessitates the collaboration of a team of scientists, 
which may include biologists, analytical chemists, physicians, bioinformaticians, 
statisticians, etc. The workflow of lipidomics starts with the active contribution of analytical 
chemists for purification and extraction of lipids from biological samples such as blood, 
cells, tissues, and subcellular organelles. In addition, choices regarding method development, 
sample introduction and data acquisition need to be carefully made for optimum results.  
Different analytical separation techniques and extraction strategies can be designed and 
developed in accordance with specific lipid components and analyte targets. If the purpose is 
global lipidomics, the choice of extraction protocol is of great importance, and considerable 
effort must be put into selecting an approach capable of improving overall lipid coverage. In 
lipidomics, the lipid extraction procedure must be able to quantitatively extract lipids while 
avoiding any degradation and possible interferences of non-lipid constituents such as sugars, 
peptides, and amino acids, which may distress the ionization efficiency. In this section, a 
detailed critical summary of the most commonly used methods for clinical sample 
preparation is provided; arguing the pros and cons in detail. This includes various liquid-
liquid extraction (LLE) and solid-phase extraction (SPE) protocols that have been previously 
reported in the literature. 
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1.5.1 Liquid-Liquid Extraction 
Liquid-liquid extraction has been regarded as the technique of choice for lipid extraction; and 
since its initial debut, many modifications have been applied to this method for different 
analytical purposes. Due to its relative simplicity, the single organic solvent approach, often 
using methanol or acetonitrile, has been conventionally applied towards the extraction of 
polar lipids. This method has in the past been applied to extract glycerophospholipids, 
lysophospholipids, and other phospholipids from human plasma by adding an excess volume 
of neat methanol to human plasma or blood, followed by agitation.
89,90
 As the most 
conventional approach, Folch method,
91
 introduced the use of two organic solvents, methanol 
and choloroform. The ratio of solvents was subsequently modified by Bligh and Dyer
92
 to 
improve lipid recovery. These methods are based on phase partitioning of lipids into organic 
and aqueous layers due to their polarity, and have been successfully applied to achieve 
exhaustive extraction of key lipid classes, ranging from (lyso) phospholipids and 
glycerolipids, DGs and TGs, to a wide range of bioactive fatty acids.
47,76,93–100
 More recently, 
alterations in extraction procedures were proposed that use a variety of 
chloroform/methanol/water ratios, as well as additives such as hydrochloric acid and acetic 
acid. However, the use of such additives in LLE methods is a matter of concern, since acidic 
or alkaline conditions induce hydrolysis of endogenous lipids, resulting in artificial 
generation, and consequently, biased quantification of lipids.
101
 Other LLE approaches have 
also been reported with aims to use less toxic organic solvents, such as dichloromethane, 
butanol, methyl tert-butyl ether, hexane/isopropanol, or ethyl acetate/ethanol mixtures.
102–104
 
The Matyash method,
105
 uses methyl tert-butyl ether (MTBE), which due to its lower density 
forms the upper layer during phase separation as the lipid containing organic phase. This 
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simplifies the final lipid extract collection, and minimizes dripping losses. Other organic 
solvents such as butanol require an extremely long evaporation process that leads to a very 
time-consuming extraction procedure. All of these methodologies have aimed to improve the 
efficiency of extraction with respect to the target matrix; these include biofluids such as 
serum, plasma, blood, and urine, as well as solid matrices such as microorganisms, tissue, 
cell lines, etc.
49,80,106–110
 In spite of its advantageous simplicity, the LLE methodology is 
riddled with disadvantages such as long extraction times, multi-step procedures, relatively 
high solvent consumption, long reconstitution periods, and poor reproducibility. As described 
above, lipid molecules containing unsaturated double bonds can be subjected to oxidation in 
the presence of oxygen.
111
 In this sense, the low sample throughput, time requirements, and 
high solvent-consumption associated to these classical approaches have been surpassed by 
other relatively new extraction techniques.  
1.5.2 Solid-phase extraction (SPE) 
As a common sample preparation technique, SPE utilizes a polymeric stationary phase as a 
sorbent that captures specific classes of compounds with similar properties. The sorbent is 
typically embedded in a cartridge format to remove analytes trough a differential analyte-
sorbent interaction. The analyte is subsequently removed from the sorbent using an organic 
or a mixture of organic/aqueous eluting solvents. For lipidomics and lipid analysis purposes, 
SPE is normally employed in conjunction with either LLE or protein precipitation to provide 
additional sample clean-up and enrich particular classes of target lipids from biological 
samples.
112
 Pre-packed SPE cartridges are readily accessible from commercial vendors, with 
numerous variations in sorbent chemistry. The SPE columns that are most commonly used 
for extraction of lipids include normal phase silica columns, reversed phase columns (C8 and 
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C18), and ion-exchange columns (packed with aminopropyl).
113
 Aminopropyl columns and 
silica-based columns are popular for separation and partial extraction of neutral or polar lipid 
(sub) classes, and can be optimized with proper selection of the eluting solvents.
37,114
 
Furthermore, several efforts have been made to apply C8 and C18 pre-packed cartridges for 
isolation and purification of PC, PE, lysoPC, ceramides, triglycerides, and fatty acids on 
several clinical samples, including blood plasma,
89
 serum,
115
 sputum,
116
 human eye,
117
 and 
skin.
118
 An extra pretreatment step, including either ultracentrifugation, chemical 
derivatization/pretreatment, or thin-layer chromatography, was required in all cases, while 
instrumental analysis was mainly carried out with the use of GC or direct infusion MS. In 
comparison to LLE approaches, SPE presents better sample clean-up and is more convenient. 
Also major goal of SPE for lipidomics applications involves the reduction of matrix effects, 
which are the most problematic issue in LLE approaches. Extension of column lifetime and 
improvements in overall method robustness remain as main challenges of SPE 
methodologies. Besides the demand of costly cartridges, the main disadvantage of this 
method lies in the selection of sorbent material to enhance the chemical selectivity of the 
preparation procedure, which can adversely reduce the lipid class coverage. Moreover, 
concerns about biosafety issues using eluting solvents have driven the demand for 
biocompatible and less or non-toxic solvents.  
1.5.3 Other emerging extraction techniques 
In addition to the described lipid extraction techniques, alternative methods with a focus on 
specific groups of lipids have been reported. These techniques include microwave-assisted 
extraction (MAE), supercritical fluid extraction (SFE), and ultrasound-assisted extraction 
(UAE), which are more commonly used for the extraction of lipids and metabolites from 
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other biological samples such as plants and foods. SFE is more established for the extraction 
of lipids from plants and food, and only recently has its application been expanded onto 
animal tissues,
119,120
 and dried human-plasma spot samples;
121
 mainly, it has been applied for 
the extraction of phospholipids such as PC, LysoPC, PE, and LysoPE. In general, the use of 
microwave energy during sample extraction, which is applied to increase temperature and 
pressure, helps in the enhancement of overall extraction efficiencies, with a reduction in the 
required amount of organic solvents and time of extraction. However, MAE is not commonly 
used for lipid extraction, as the generated heat could potentially cause the degradation of 
thermally labile lipids. This method has been mainly used for the extraction of fatty 
acids.
95,122–124
 Ultrasound-assisted extraction (UAE) utilizes the energy of ultrasonic pulses 
(frequencies ≥20 kHz) to facilitate mass transfer between immiscible phases.125 However, 
this method is normally used in combination with conventional LLE methods to improve the 
extraction efficiency of lipid species from biological samples.
126
 The application of this 
method has been recently reported for exhaustive lipid fingerprinting of human plasma with 
the use of methyl tert-butyl ether (MTBE) and ultrasound (US) energy.
127
 Despite the 
advantages of the proposed MTBE-US protocol for lipid extraction, it involves long 
extraction times and a tedious multi-step procedure. In other cases, the application of the 
ultrasound technique in lipid analysis of biological matrices has been merely restricted to the 
extraction of fatty acids.
128,129
 For all the above mentioned techniques, in order to achieve an 
efficient lipid recovery, the operating conditions have to be carefully optimized based on the 
targeted lipid class of interest; hence, these methods are not adequate for comprehensive 
coverage of all lipid categories from biological samples.
130
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1.6 Solid-phase microextraction 
Solid-phase microextraction (SPME) was first introduced by Pawliszyn and coworkers as a 
non-exhaustive, equilibrium-based sample preparation technique that provides rapid sample 
clean-up and pre-concentration in a single step. This method was initially designed for the 
extraction of volatile and semi-volatile organic compounds for subsequent separation by gas 
chromatography.
131–133
 However, over the past twenty years, the technique has evolved 
significantly due to enormous advancements in its geometry, configurations, sorbent 
specificity and coating biocompatibility. Consequently, SPME has become a powerful tool in 
the pharmaceutical, environmental, food, forensic, and clinical fields for the extraction of 
various classes of compounds.
134–143
 In terms of format, SPME has endured several 
transformations to fulfill the compatibility with LC-MS analysis, and thus improved SPME 
bio-applications.
138,144,145
 In this regard, features such as biocompatible thin-film coating and 
the use of 12-blade configuration have been introduced to enable automated high throughput 
extraction in a 96-well plate format.
136,146
 Figure  1-1 schematically illustrates the typical 
SPME workflow from a given biological sample to LC-MS. Here, the coating is exposed 
directly to the sample where the target analytes are extracted; subsequently, the coating is 
removed from the analytical sample and exposed to a desorption solvent for desorption of 
analytes from the coating and into a solvent solution. An adequate proportion of the obtained 
solution is eventually introduced to the analytical instrumentation (LC-MS here), and data 
are acquired and further processed. 
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Figure  1-1 Schematic representation of a typical SPME workflow from a given biological sample to LC-
MS. Small arrows indicate the direction of mass transfer. 
 
Depending on the type of sorbent, the analyte extraction occurs through either through 
absorption or adsorption of the analyte to the extraction phase.
147
 Therefore, careful selection 
of appropriate coatings and desorption solvents is required during method development, as 
different coatings functionalities establish different extraction mechanisms. The extraction of 
analytes can occur either through the direct immersion of the coating into the sample matrix 
for capturing semi volatile to non volatile compounds, or by exposing the sorbent to the 
headspace above the sample for extraction of volatile compounds. Subsequently, desorption 
of the analytes could be carried out either thermally by direct insertion of fibers into the GC 
injector, or with the use of an appropriate desorption solvent. The research presented in this 
thesis deals with the analysis of lipids as non-volatile, semi-polar, and non-polar species from 
biological fluids; consequently, direct immersion mode and solvent desorption were required 
throughout this work. 
Typically, the SPME device consists of a sorptive extraction coating immobilized on a solid 
support; the coating is directly exposed to the analytical sample for a sufficient period of time 
until equilibrium is reached between the sample and SPME coating. In principle, extraction is 
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performed based on the partitioning diffusion of the analyte from the sample matrix towards 
a boundary layer and to the sorbent coating. According to the principal theory of SPME, the 
amount of analyte extracted by SPME in equilibrium conditions is proportional to the volume 
of the extraction phase and the partition coefficient of analyte between coating and matrix, as 
calculated by Equation  1-1 
Equation  1-1 
   
         
        
   
where ne is the amount of analyte extracted at equilibrium; Vf and Vs are the volume of 
sample and coating, respectively; and C0 is the initial analyte concentration in the sample. Kfs 
is the partition coefficient between the extraction phase and sample matrix, and is dependent 
on the nature of the selected coating and the analyte properties. Kfs will also vary with 
temperature, pH, and ionic strength of the sample matrix; therefore, these parameters must be 
constant during extraction. Another interesting features of SPME is that when the volume of 
the sample is much larger than the partition coefficient (Vs ≥ KfsVf ), extraction is performed 
under the conditions of negligible depletion; as such , Depending on the type of sorbent, the 
mechanism of analyte extraction is enforced either through absorption or adsorption of the 
analyte to the extraction phase. Therefore, careful selection of appropriate coatings and 
desorption solvents is required during method development, as different coatings 
functionalities establish different extraction mechanisms. It is noteworthy to mention that no 
further extraction supposedly occurs at equilibrium, and thus, probability for local depletion 
of the analyte under study from the matrix is low. This important feature makes the SPME 
technique suitable for in vivo applications, since it does not interrupt the internal equilibrium 
of the living system.  
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In this regard, it can be concluded that at the optimum extraction time, the analyte is in 
equilibrium with the coating and other binding components of the sample matrix (such as 
proteins, for example), and consequently, the amount of extracted analyte is linearly 
proportional to the unbound concentration and the initial sample concentration. This 
distinction is considered an important advantage of SPME over traditional methods, as it 
determines the application of SPME for measurement of free (unbound) or total (bound + 
unbound) concentrations of analyte through the performance of appropriate calibration.
148–151
 
This is the most important differentiated advantage of SPME from other traditional methods 
such as SPE, as the SPME procedure is non-exhaustive in nature, and only a small portion of 
analyte in their unbound format being removed from the sample. In contrast, SPE utilizes 
large volumes of sorbents to ensure exhaustive removal of analytes from samples.
152
 The 
extraction of analytes can occur either through the direct immersion of the coating into the 
sample matrix for capturing semi volatile to non volatile compounds, or by exposing the 
sorbent to the headspace above the sample for extraction of volatile compounds. 
Subsequently, desorption of the analytes could be carried out either thermally by direct 
insertion of fibers into the GC injector, or with the use of an appropriate desorption solvent. 
The represented research in this thesis deals with lipids as non-volatile and non-polar 
endogenous species in biological fluids; thereby, direct immersion SPME mode was required 
throughout this work. 
Typically, the SPME device consists of a sorptive extraction coating immobilized on a solid 
support; the coating is directly exposed to the analytical sample for a well-defined period of 
time until equilibrium is reached between the sample and SPME coating. Principally, 
extraction is performed based on the partitioning diffusion of the analyte from the sample 
 24 
 
matrix towards a boundary layer and to the sorbent coating. According to the principal theory 
of SPME, the amount of analyte extracted by SPME in equilibrium conditions is proportional 
to the volume of the extraction phase and the partition coefficient of analyte between coating 
and matrix, as calculated Equation  1-1 can be simplified, and the amount of analyte extracted 
at equilibrium can be calculated by Equation  1-2 
Equation  1-2 
           
Due to the growing interest for integration of multi-step sampling and sample preparation, 
this equation is of great importance, as it determines the insignificant role of sample volume 
in quantitative analysis. In such cases, sampling can be performed directly on-site or in vivo 
within a tissue or in circulating blood of a living organism.
139,153,154,154,155
 From the 
perspective of sample preparation technology, the feasibility of in vivo sampling is 
considered a very significant competence that makes SPME an outstanding choice for 
metabolomic studies. 
1.6.1 Thin-film microextraction 
Rod fiber geometry as the original SPME configuration has to date been the most commonly 
used SPME format in various applications. However, changes in the configuration of the 
device by enlargement of the surface area of the coating have been shown to improve 
extraction recovery and result in higher amounts of analyte extraction. Accordingly, the 
traditional geometry has been recently transfigured to thin-film geometry by immobilization 
of the coating onto a blade-shaped stainless steel base.
156
 Although the fundamental theory of 
extraction and the requirements for method optimization remain the same regardless of 
coating configuration, the use of thin-film geometry offers other important advantages over 
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conventional fibers. First of all, it improves extraction efficiency by increasing the amount of 
analyte extraction, consequently enhancing the overall sensitivity of method. Secondly, the 
thinner coating design improves the overall convection and facilitates the mass transfer of 
analytes, which results in a faster equilibrium rate and ultimately, a higher sample 
throughput.
146
   
The demonstration of thin-film SPME and its related theoretical concept for the LC-MS 
application was reported by the Pawliszyn group, where a layer of octadecyl 
silica/polyacrylonitirile (C18-PAN) coating was sprayed and immobilized on a 2 cm tip of a 
flattened metal blade.
136
 The new geometry was represented in the state-of-the-art 96-blade 
SPME format, and ever since, various bio-applications of this configuration have been 
reported through direct immersion of the coating into complex sample matrices, without any 
need for sample pre-treatment. These applications involve high throughput sample 
preparation and extraction of drugs and metabolites from various biological samples such as 
whole blood, plasma, urine, cells, and tissue.
141,156–160
  
1.6.2 SPME for metabolomic studies 
Metabolomics and lipidomics are powerful approaches in the study of systems biology, 
aiming to elucidate the metabolic origins and pathways of small molecules such as sugars, 
amino acids, and lipids present in living systems. As a result, the development of reliable 
analytical methodologies has been gaining growing interest in these areas of research; in this 
context, the selection of appropriate sample preparation methods is an important 
consideration in the metabolomic workflow. In this regard, several SPME approaches have 
been introduced, using a variety of coatings and configurations. Various headspace (HS) 
SPME platforms in combination with GC-MS and GC × GC systems have been used for 
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extraction and enrichment of volatile metabolites in plant and food metabolomics.
161–168
 In 
addition, headspace SPME was also successfully applied for the determination of metabolic 
changes and potential biomarkers from the volatile emissions of breath, skin, cancer tissue, 
and cell line. However, due to the non-volatile and highly lipophilic nature of lipids, 
headspace SPME cannot be considered as an option when it comes to comprehensive 
lipidomic studies.
169–173
 
Biological fluids such as serum, plasma, blood, urine, and saliva consist of several 
endogenous and exogenous metabolites with a wide range of polarities that exist in abundant 
to trace concentrations. The selection of potential SPME coatings is therefore critical to 
guarantee metabolite coverage and metabolomics data quality. To this purpose, different 
coating chemistries were evaluated by Vuckovic in terms of metabolite coverage
174
 by 
inspecting a variety of SPE particles coated in the SPME platform for a broad range of 
metabolites polarities. The obtained results indicated that mix-mode (C8 or C18-
benzenesulfonic acid), polystyrene divinylbenzene (PS-DVB) and phenyl boronic acid (PBA) 
coatings provide the best coverage of hydrophilic and hydrophobic metabolites. 
Subsequently,  biocompatible SPME probes were represented by Mirnaghi et al., who 
included detailed information regarding coating preparation and their evaluation process for 
in vivo studies of biological fluids;
136
 today, some of these biocompatible SPME fibers are 
commercially available. Subsequent researches were also reported by the same authors, 
aiming to establish the optimum extraction phase for a Thin-Film 96-well plate format for 
high-throughput metabolomics.
140
 Additionally, another untargeted metabolomics study was 
reported for analysis of blood using the needle-based in vivo SPME device. In this research, 
metabolites with fast turn-over that had not to date been found by traditional methods such as 
 27 
 
ultrafiltration and protein precipitation were successfully captured directly from circulating 
blood.
174,175
 Moreover, a study was recently reported detailing the applicability of mixed-
mode SPME coatings for brain tissue bioanalysis, where multiple endogenous 
neurotransmitters such as glutamic acid, serotonin, and dopamine in the striatum of the rat 
brain were monitored and quantified.
142
 
1.7 Research objectives 
Over the last several years, our laboratory has developed different analytical methods for 
extraction of small molecules such as drugs and metabolites by making various fundamental 
modifications to different SPME techniques. However, attention has never been focused on 
the development of a unique SPME approach for comprehensive analysis of the large family 
of lipids, aiming to cover the entire spectrum of various lipid categories and sub-categories. 
The main research objective of this thesis is to demonstrate for the first time the adaptability 
of direct extraction SPME for lipidomics studies using LC-MS platforms.  
With this perspective, Chapter 2 focuses on the analysis of fatty acids, which are the major 
building block of other complex lipids. Biocompatible SPME fibers were utilized for 
development of a simple, robust and effective extraction protocol for determination of 
polyunsaturated fatty acids from pooled plasma. Analytical performance and characterization 
of the final optimized method were assessed for quantification of fatty acids in human and 
fish plasma individually. In addition, the method was successfully applied for monitoring 
PUFA changes during an operation procedure with the utilization of a set of plasma samples 
obtained from patients undergoing cardiac surgery with the use of cardiopulmonary bypass 
(CPB). Conventional sample preparation techniques for lipid analysis consist of a tedious 
multi-step sample handling which suffer from lack of efficiency in covering broad range of 
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endogenous lipids. In addition, failure in sample clean-up as a key issue in traditional 
methods leads to undesired ionization suppression/enhancement, and the proliferation of 
significant errors in quantitative data. In Chapter 3, the analytical approach is expanded to the 
whole lipid spectrum in order to address the requirement for comprehensive analysis of all 
lipid species from different classes and polarities, while enhancing the sensitivity and 
throughput by direct immersion of the thin-film 96-blade SPME system. This chapter details 
the successful application of the lipid quantification technique for measurement of target 
lipids from human blood plasma. Chapter 4 describes research undertaken on the effect of 
omega-3 polyunsaturated fatty acid as a treatment agent on the hepatocellular carcinoma 
HUH7 cell line. lipid profiling was performed on two groups of cells (control and treated 
cells) with the use of the optimized SPME technique; further, results were compared to 
concurrent findings obtained by use of the conventional Bligh & Dyer extraction technique 
as a preliminary proof-of-concept study. Up-regulation and down-regulation of lipids in 
treated cells were monitored, and important lipid species extracted by each technique are 
listed and compared. This comparison was useful to place SPME within the context of 
commonly employed LLE methods, and to investigate whether the offered SPME protocol 
was competitive in terms of analytical parameters such as sensitivity, precision, and lipid 
coverage. Finally, Chapter 5 summarizes the main research findings of the current work and 
proposes future directions and challenges for this type of studies. 
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Chapter 2 
Application of Solid Phase Microextraction for Quantitation of 
Polyunsaturated Fatty Acids in Biological Fluids 
 
2.1 Preamble and introduction 
2.1.1 Preamble 
This chapter has been published as a paper: Afsoon Pajand Birjandi, Fatemeh S. Mirnaghi, 
Barbara Bojko, Marcin Wąsowicz, and Janusz. Pawliszyn, “Application of solid phase   
microextraction for quantitation of polyunsaturated Fatty acids in biological fluids” Anal. 
Chem., vol. 86, no. 24, pp. 12022–9, Dec. 2014. The materials of the current chapter are 
reprinted from this publication with the permission of the American Chemical Society 
(Copyright American Chemical Society 2012). The contribution of co-author Fatemeh 
Mirnaghi, Barbara Bojko and Marcin Wasowicz to the work described within this chapter 
was technical and scientific advice. Provision of biological material, patient’s recruitment 
and obtaining REB approval for collection of plasma samples from patients undergoing heart 
surgery was performed at Toronto General Hospital. All of the experimental results and data 
reported within this chapter have been performed solely by the author. 
2.1.2 Introduction  
Fatty acids (FA) are essential components of living cells and important substrates that play a 
critical role in mammalian energy metabolism. They can either be saturated, 
monounsaturated or polyunsaturated depending on the number of double bonds. They differ 
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in length as well, majorly having a 4–28 carbons in their chain. Long-chain fatty acids 
(LCFA) are fatty acids with aliphatic tails of 16 or more carbons. Among the different fats, 
some fatty acids can be used as functional ingredients such as α-linolenic acid (ALA), 
arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), 
stearidonic acid (STA) among others. Fatty acids are combined as the building blocks of 
more complex lipids through ester or amide bonds and form glycerolipids or phospholipids. 
Esterified fatty acids serve as primary components of lipid bilayer membrane, lipoporoteins 
and liposomes; act as suppliers of chemically stored energy; or are involved in signal 
transducers pathways, thereby a small proportion of total fatty acids in the biological systems 
are present as nonesterified fatty acids (NEFA) also called free fatty acids (FFAs).
176
 They 
are continuously produced, integrated into lipids, and degraded in the β-oxidation pathway 
and citric acid cycle.
177
 Alterations in the metabolism of this portion is of specific interest 
since it is established to be associated with pathological conditions and observed with 
numerous disorders, such as obesity,
178
 insulin resistance,
179
 diabetes mellitus,
180
 or 
metabolic syndrome.
181
  
Accurate determination of the composition of free fatty acids (FFA) in different biological 
matrices is a predominant problem in total fat extraction. The most common procedures used 
to measure FFA concentration consist of multiple-step methods, including (a) an extraction 
procedure to isolate lipids from the sample bulk, (b) separation of FFA from the rest of the 
lipids using conventional methods such as thin-layer chromatography (TLC) and/or solid 
phase extraction (SPE),
182,23
 (c) derivatization of FFA to fatty acid methyl esters 
(FAMEs),
183,62
 and (d) a final chromatographic method for differentiation of individual fatty 
acid species.
33
 The chromatographic determination of FAMEs is by far mostly done using 
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capillary gas chromatography (GC,)
184–186
 and less frequently by high performance liquid 
chromatography (HPLC).
183,187,188
  
Lipid analysis deals with enormous sample complexity. In order to obtain satisfactory results, 
the extraction of lipids from complex biological matrices, which aims at removal and 
isolation from interfering agents such as proteins, saccharides, or other small molecules, is 
usually indispensable before the analysis. Therefore, a broad range of extraction techniques 
are currently used for this purpose.
189
 However, the most common extraction approaches 
have been mainly based on solvent extraction so far. The most popular extraction methods for 
lipids include the traditional Folch method,
91
 or a modified Folch method 
185
 that employs a 
solution of chloroform/methanol (2:1, v/v), or the commonly called Bligh and Dyer method, 
in which a chloroform/ methanol/water mixture is used to extract the lipids.
190
 Moreover, 
exhaustive Soxhlet extraction is probably the most commonly used technique for the 
extraction of fats and oils from food matrices.
191
 More modern methodologies take advantage 
of solid-phase extraction (SPE) for fatty acid extraction,
192
 typically by using amino-bonded 
phase and C18 bonded-phase columns.
129
 In comparison to liquid-liquid extraction (LLE) 
methods, these procedures minimize the volumes of organic solvents which lead to good 
recovery and higher reproducibility. However, most of the proposed SPE protocols offer the 
application of derivatization or solvent extraction followed by evaporation and reconstitution 
procedure.
193
 In addition, the limitations may include clogging of cartridges when handling 
complex matrixes such as plasma or tissue. Considering the exhaustive nature of SPE, the 
recovery is significantly increased when the volume of the sample is larger but when dealing 
with a large volume of samples, limitations of breakthrough volume and low peak capacity of 
SPE cartridges may affect the quantitative results.
149,194,195
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In contrast, among all extraction techniques, solid phase microextraction (SPME) is sampling 
and sample preparation technique characterized by simplicity, reproducibility and non-
exhaustive nature of the extraction process when very small sorbent volume is used. The 
benefits of SPME for highly complex matrices such as biological samples have been already 
discussed elswhere.
143,154,196–199
 Headspace SPME (HS-SPME) has been previously reported 
for determination of short chain volatile fatty acids, including the C2-C7 carbon chain or their 
ethyl esters from waste water.
200,201
 However, extraction of long chain fatty acids in 
biological and nutrition analysis is a very challenging goal due to their hydrophobicity, 
perceived abundance as plasticizers, ubiquity in the environment, great tendency to 
bioconcentrate, vast distribution in conjugated forms in cellular structure, very high affinity 
to biological proteins such as albumin, and a high risk of matrix effect encounters. The main 
goal of this study is to address the above mentioned challenges for unbiased high throughput 
quantification of “total” and "free” concentration of nonesterified fatty acids in the complex 
biological media via optimization and validation of a SPME assay followed by HPLC-ESI-
MS. The method involves a simple SPME protocol with no necessity of using halogenated 
solvents or chemical derivatization approaches that use highly reactive reagents. In the 
proposed method, entire procedure is simplified to immersion of SPME fiber into the 
biological fluids which allows for extraction of the NEFA without interrupting the 
lipoproteins or cell membrane lipids (Figure  2-1). This is in contrast to the commonly used 
liquid based methods which only provide estimation of total concentration of fatty acids due 
to the disruption of protein-bound fractions and complex lipid structures such as lipoproteins 
by organic solvents. Therefore, as the SPME extraction is non-exhaustive, the natural balance 
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in the investigated system is not disturbed and the obtained results provide information about 
the actual equilibrium in the sample.  
 The possibility of encountering matrix effect in HPLC-ESI-MS analysis of human and fish 
plasma was evaluated using different experimental approaches. The proposed method was 
fully validated according to the bioanalytical method validation guidelines. The final protocol 
was applied to monitor PUFA changes in plasma obtained from a group of patients during 
cardiac surgery with the use of cardiopulmonary bypass (CPB) and to quantify level of the 
PUFAs in fish plasma. 
 
Figure  2-1 schematic of the experimental model for the equilibrium extraction of free fatty acids from 
plasma using the SPME fiber. Figure reprinted from reference with the permission of the publisher.
59 
 
 
2.2 Experimental 
2.2.1 Chemical and Materials 
Methanol, acetonitrile, 2-propanol (all HPLC grade) were purchased from Caledon Labs 
(Georgetown, ON). LC-MS grade formic acid was obtained from Fisher Scientific (Ottawa, 
ON). Biocompatible SPME C18 probes (C18, 45 µm thickness, 15 mm coating length) were 
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provided by Supelco (Bellefonte, PA). Human serum Albumin, essentially fatty acid free was 
obtained from Fluka (Sigma-Aldrich Oakville, ON). Fatty acids were selected based on (i) 
their hydrocarbon chain length and (ii) number and position of double bonds. 
Docosahexaenoic acid (DHA), Docosapentaenoic acid (DPA), Adrenic acid, Docosatrienoic 
acid (DTA), Eicosapentaenoic acid (EPA), Arachidonic acid, Eicosatrienoic acid (ETA), 
Stearidonic and α-Linolenic acid were purchased from Cayman Chemical (Ann Arbor, MI) 
and stored at −20°C. Individual stock solutions containing 1 mg/mL of each standard were 
prepared by dissolving the analytes in HPLC-grade methanol. For instrument calibration, 
working standard solutions with known concentrations of standard fatty acids were prepared 
by mixing adequate volumes of diluted stock solutions and adding acetonitrile as needed. All 
stocks and working standards were stored at -20°C. A phosphate-buffered saline (PBS) 
solution was prepared by dissolving 8.0 g of sodium chloride, 0.2 g of potassium chloride, 
0.24 g of potassium phosphate monobasic, and 1.44 g of sodium phosphate dibasic in 1 L of 
purified water (pH = 7.4). Extraction standards also were prepared daily by dilution to 1 
μg/mL with PBS buffer solutions at pH 7.4 to mimic the physiological conditions, while 
keeping the organic solvent content of all extraction standards at ≤1% (v/v). PBS buffer 
solutions have been used for this study to mimic the physiological conditions for the initial 
SPME method optimization as a matrix-free environment. 
2.2.2 Plasma Sample Preparation 
Plasma samples were obtained from seven patients during cardiac surgery involving the use 
of cardiopulmonary bypass (CPB). Blood samples were taken on a sampling schedule order 
at 5, 10 and 15 minutes before initiation of the infusion; 5 minutes after chest opening and 5 
minutes before commencing CPB, following by frequent sampling every 30 minutes during 
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CPB; and 5, 60 and 120 minutes after chest closure.
135,158,202,203
 Perioperative care has been 
provided to all the patients as described previously. 
204
 The study approval was obtained from 
Toronto General Hospital/University Health Network and University of Waterloo Research 
Ethics Boards. All the patients signed the consent to participate in the study. Fish plasma 
samples were also collected from White Sucker (Catostomus commersoni) at Lake Superior 
(Provincial Park, ON) due to their widespread availability in the watershed. Blood was 
collected by caudal puncture with a heparin-coated needle and syringe (5cc) and centrifuged 
at 10000 rpm for 4 min to separate plasma. All plasma samples was transferred to a cryovial, 
snap-frozen in liquid nitrogen and stored at -80C until analysis. Animal care and all 
investigative procedures adhered to the guidelines of the Office of Research Ethics, 
University of Waterloo (AUPP:10-17) and the Canadian Council of Animal Care. 
2.2.3 Optimization of SPME Procedure 
C18 and mix-mode fibers (Supelco, Bellefonte PA) were compared during the preliminary 
stage of extraction phase selection. In order to determine the extraction efficiency and 
reproducibility of the SPME coatings, a phosphate buffered saline (PBS) at pH 7.4 was 
spiked with authentic standards of fatty acids for a concentration of 0.1 µg/ml. Prior to use, 
all fibers were preconditioned by 30 minutes agitation in a methanol: water solution (1:1, 
v/v) in order to activate the silanol groups of the stationary phase. The analytes spiked in 
plasma were pre-incubated in room temperature for 60 min prior extraction to allow 
establishment ofprotein binding, knowing that the binding rate of fatty acid to albumin is 
rapid. 
205
 The SPME experiment was performed by immersing the fibers into 1 mL of sample 
aliquots for 60 min extraction time with 800 rpm orbital shaking (model DVX-2500, VWR 
International, Mississauga, ON). Immediately after extraction, fibers were rinsed in purified 
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water for 10 s to remove any remains of biological material from the coating surface, 
followed by 60 minutes desorption in 1 ml acetonitrile with agitation (1000 rpm) . Extracts 
were further injected to HPLC–ESI-MS system for analysis. Percentage of extraction 
efficiency (or percent absolute recovery) was calculated as the ratio of the amount extracted 
versus total amount of fatty acid spiked × 100%.  
2.2.4 LC-ESI-MS Operating Conditions 
All samples were analyzed using an HPLC-ESI-MS system consisting of two Varian 212-LC 
pumps (Walnut Creek, CA), a Prostar 430 autosampler, and a 500-MS ion trap mass 
spectrometer (Varian, Palo Alto, CA). Data acquisition and processing were performed using 
Varian MS Workstation software (Version 6.6). Chromatographic separation was performed 
on an Ascentis® Express C18 RP-LC column (2.1 x 150 mm, 2.7 μm). The binary gradient 
run consisted of eluent A (90% water, 10% Methanol) and B (80% methanol, 20% 
acetonitrile) at room temperature with a flow rate of 0.3 mL/min and 10 µl injection volume. 
Optimal separation was achieved using the following solvent gradient elution: Mobile B 
starts with 60% holding for 1 min (min 0–1), increasing to 95% (min 1–2), increasing to 
100% (min 2–5), held for one minute (min 5–6), then ramped back to 60% over thirty 
seconds, followed by two more minutes of re-equilibration resulting in a total run time of 
eight minutes. All fatty acids were analyzed at negative ionization mode (forming [M-H]
-
) 
and were monitored in full scan mode. The optimum MS parameters were as follow: 
capillary voltage: 90–110 V, RF loading of 80-90, ion spray voltage -4500 V and drying gas 
temperature 400 °C. 
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2.2.5 Determination of Matrix Effect and Ionization Suppression 
Measurements of matrix effect were evaluated by using two different approaches including 
the “post-extraction spiked method” 206 and the “sample extract dilution” method in 
triplicates (n = 3). For the post-extraction spiked method, neat solvent of acetonitrile was 
used (because it was indicated as the optimized desorption solution) at two different 
concentration level (50 and 500 ng/mL). The extracts from plasma samples were spiked with 
fatty acid standards at the same concentration as the neat solvent, and samples were 
individually injected into the LC/MS/MS system for quantification. In addition, matrix effect 
was also evaluated using the “sample extract dilution”. In this technique, the final sample 
extract from spiked human plasma is diluted by different dilution factors (1:0, 1:1, 1:2, 1:4 
and 1:9). The evaluation of matrix effect using this method was studied for the final extract 
of SPME for spiked human plasma at a concentration of 2µg/ml of standard PUFAs; results 
were then compared with that of the absolute matrix effect method. 
2.2.6 Determination of Protein Affinity Constant  
(Ka) The extraction recovery of NEFAs was measured at different human serum albumin 
(HSA) concentrations to determine if variations in HSA level affect the free concentration 
and consequently the extraction recovery of studied fatty acids. Human serum albumin 
(essentially fatty acid and globulin free) was dissolved in PBS buffer solution (pH 7.4) to 
reach protein concentrations of 0, 5, 10, 20, 30, 40, 50, 60, 70 and 100 g/L, These solutions 
were then spiked with fatty acids standards to reach the concentration of 3 µg/mL in all 
solutions. The study was conducted in duplicate. 
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2.2.7 Determination of plasma protein binding: investigation of free and total 
concentrations   
The determination of plasma protein binding by SPME is based on the quantification of the 
free concentration of ligand in the presence of plasma proteins.
136,146,150,151,153,207,208
 In order 
to have a better understanding of plasma protein binding, the calibration curves were not only 
constructed in PBS and plasma, they were also constructed in standard human serum albumin 
solution (essentially fatty acid free) to mimic the plasma with only albumin as binding agent. 
Linearity was verified by analyzing spiked plasma samples at the concentrations of 0, 1, 2, 3, 
4, 5, and 7 µg/mL, with three replicates in each point. After incubation allowing for protein 
binding equilibrium (60 min), extractions from PBS, serum albumin and plasma samples 
were performed under the same conditions using SPME fibers. Batch-to-batch precision was 
determined according to Matuszewski et al.
209
 Five different sources of human plasma at all 
concentrations (n=3 for each point) were utilized for the construction of standard addition 
calibration curves.  
2.3 Results and Discussions 
2.3.1 HPLC-ESI-MS  
Electrospray ionization in negative mode was chosen because fatty acids form [M−H]─ 
quasimolecular ions due to their carboxylic acid moiety. Disregard of the applied collision 
energy level, the product ion spectrum of [M−H]− in MRM mode was also dominated by the 
unfragmented deprotonated molecular ions of a low sensitivity. The lack of production of 
detectable fragments in ESI-MS/MS has been already described for underivatized FAs.
32
 A 
series of experiments were performed to identify the optimal HPLC method for separation of 
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nine long chain polyunsaturated fatty acids. A set of different HPLC columns including C8 
and C18, as well as different mobile phase compositions were examined. Although, most of 
fatty acids of interest were different in only one number of double bond or two carbons in the 
hydrocarbon chain, the column and gradient method were carefully optimized to enable 
thorough fatty acid differentiation, so that less abundant fatty acids would not be interfered 
by other abundant species. For chromatographic separation of PUFAs a C18 column with 2.7 
m core–shell particles was chosen. As the main advantage of core–shell compared to 
UHPLC columns with the fused-core small diameter (<2 µm), is to have a major benefit of 
the small diffusion path (0.5 μm) compared to conventional fully porous particles and are 
able to achieve high speed and high efficiencies but at much lower backpressures.
80,210
 
Several HPLC additives were also tested with further adjusting pH in the eluent solution. 
Preparation of mobile phase using tributylamine (pH 9.2) provided less or equal resolution 
compared to ammonium acetate (pH 8.1) or formic acid (pH 3.2); not only all these additives 
provide no improvement in sufficient resolution they also established the relevant buffer-
induced ion suppression resulting in significant decrease in signal intensity for all fatty acids. 
Moreover, having data acquired in full scan mode, a background signal of m/z 255 and 283 
was always detected in blank which has been previously reported as the mass spectrometric 
ubiquities contaminations due to the abundant presence of palmitate and stearate as 
plasticizers in environment and on plasticware.
188,211
 To overcome this problem, replacement 
of the stainless steel tubing and injection loop by inert PEEK material for chromatographic 
connections and tubing was done. Additionally, fresh solutions were prepared daily and 
careful examination of the blanks for these compounds was performed in every experiment. 
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Based on the chromatographic method, a two-carbon increase in fatty acid chain length 
increases the retention time by ~1.8 min, whereas introduction of a double bond, decreases 
retention time by ~0.7 min. Peak widths of 4–6 s were found and chromatographic resolution 
could be achieved in a total run time of 8 min. A typical SPME-LC–MS/MS chromatographic 
data set for equilibrium extraction of fatty acids from human plasma is illustrated in Figure  2-2 
 
Figure  2-2 Examples of XIC chromatograms for SPME-LC-MS analysis of 2µg/mL of fatty acids from 
human plasma; DHA: 327.3, DPA: 329.3, ADR: 332.3, DTA: 333.3, EPA: 301.3, ARA: 303.3, EPA: 305.3, 
SDA: 275.2 and 10-ALA: 277.2 respectively) 
 
2.3.2 SPME method development   
The experimental standard procedure was followed based on previously published SPME 
protocol for method validation.
148
 The properties of the C18 biocompatible fibers was 
described in details elsewhere.
138,144
  
Extraction: The extraction time profile was obtained in both PBS and plasma. The initial 
stages of extraction time profile for all fatty acids under study were similar in both PBS and 
plasma meaning that the equilibrium was achieved in both media within first two hours. 
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However, after four hours of extraction in plasma, the extracted amount started to increase 
reaching second plateau after 10 hours and remaining constant for up to more than 18 hours 
extraction Figure  2-3. Checking the physical appearance of the fiber, a jelly-like attachment 
around the fiber was observed after 4 hours extraction with vortex agitation. The initiation of 
protein attachment was observed around the metal part of the rod fibre which is in contact 
with plasma during long time aggressive agitation. This effect could be explained as a result 
of protein attachment to the surface of metal. The coating biocompatibility was tested several 
times and has been reported previously; 
138,144
 hence it is anticipated that this effect is only 
visible for longer contact of fibre with aggressively agitated sample.  Therefore, extraction 
time must be long enough to meet sensitivity requirement, and short and gentle to avoid the 
initiation of protein aggregation around the fiber. Therefore, the use of 800 rpm orbital 
shaking, which is a less aggressive agitation approach compared to vortex agitation, prevent 
the protein aggregation occurrence. The required time to reach equilibrium extraction in 
plasma for all nine compounds was less than 120 minutes; therefore, 2 hours was chosen as 
the optimum extraction time for the entire study.  
 
Figure  2-3 Extraction time profile for extraction of (3000 ng/mL) fatty acids spiked in plasma, the second 
plateau is an unusual observation due to the initiation of protein aggregation around the fiber after 4 
hours extraction with aggressive vortex 
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Wash: Exposure of the coatings to complex biofluidic matrices provides the risk of 
attachment of particulates and macromolecules into the coating surface. Therefore, 
optimization of a fast washing step after extraction is crucial for efficient cleaning of the 
coating surface with minimum loss of analytes. This also helps to minimize the 
contamination of the final extract and avoid possible ion suppression/enhancement caused by 
interfering components in electrospray ionization source. Figure  2-4 illustrates the effect of 
different washing approaches on percentage recovery. The evaluation of the wash step in this 
study indicated that a 10 s immersion of fibers in nanopure water was found to be optimal for 
efficient cleaning of the coatings after extraction from plasma samples. Extending the 
washing step or application of any mechanical agitation in this study resulted in a loss of 
precision and reproducibility due to an inconsistent loss of analytes and observation of higher 
variation in the results.  
 
Figure  2-4 Evaluation of analyte loss using different washing strategies, extraction from spiked PBS 
(30ng/ml) 
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the best desorption solvent. The comparison of the absolute recovery of the five desorption 
solvents for equilibrium extraction is demonstrated in Figure  2-5. Results indicated that the 
100% acetonitrile solvent resulted in the best recovery and the lowest carryover. According 
to desorption time profile, the most efficient desorption of the analytes with the lowest 
carryover was found at a minimum 60 min desorption time at 1500 rpm agitation speed (1 
mm amplitude).  
 
Figure  2-5 Desorption solution composition containing acetonitrile, ACN/MOH/W (40:40:20) plain or 
with additives of NH4OH (pH 7.8), Formic acid (pH 3.2) or tributhylamin (pH 9.2), extraction from 
spiked PBS (30ng/ml) 
 
Carry over: Efficiency of desorption should also be determined by evaluation of possible 
carryover. However, considering that it is impossible to evaluate the potential carryover of all 
macromolecules and metabolites present in a typical biological sample, these biocompatible 
SPME devices are recommended for single use for both in vivo and in vitro applications. This 
is recommended in order to prevent accidental cross contamination of subsequent samples by 
any coeluting traces from previous extractions. The amount of carryover of analytes in the 
coating was evaluated through a second desorption of the same set of fibers used for 
evaluation of desorption time. Results concluded that a 90 min single step desorption was 
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not result in any detectable signals. A desorption efficiency greater than 95% is acceptable 
for quantitative analysis. Due to the desorption efficiency of the analytes, percentages of 
carryover were found negligible regardless of type of extraction biological matrix being 
sampled. 
2.3.3 Extraction efficiency of the SPME method in PBS  
The absolute recovery of FAs from a physiological buffer solution (pH 7.4) using 
biocompatible fibers was higher than 44% for all cases, which resulted in a significant 
depletion conditions during the binding study. Coatings with such high fiber constants are 
preferred for the study of FAs in order to ensure that the amount of ligand extracted by the 
coating is sufficiently high so that instrumental sensitivity is adequate to determine the 
extracted amount accurately. The results obtained in the PBS buffer solution as a matrix-free 
media are shown in Table  2-1. The precision of the proposed system was studied as inter- and 
intra-day relative standard deviations (RSD) for n = 6 coatings over four experiments. The 
assay showed good precision (5–12% intra- and 1–6% inter-day RSDs) for the analysis of all 
nine fatty acids. The matrix match calibration curve was also constructed in plasma in order 
to determine the linear regression equation and the correlation coefficient (r
2
) of the standard 
calibration line using the least squares method. The linearity of the standard calibration curve 
was confirmed by plotting the extracted amount (ng) versus spiked amount in plasma. Limit 
of quantification (LOQ) was determined by analyzing fatty acids in five replicates and 
verifying the RSD%, which should be smaller than 15%. Data are presented in Table  2-1. 
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Table  2-1 Evaluation of SPME method efficiency for extraction of FAs from physiological buffer solution 
(pH=7.4) 
FA 
Absolute 
Recovery 
(n=5) 
Inter-day 
RSD  
(4 trials) 
Intra- day 
RSD 
(n = 6) 
LOD 
ng/mL 
LOQ 
ng/mL 
R
2
 
Linearity 
ng/mL 
DHA 44±7 8 1 1.5  10  0.9986  10-1500  
DPA 76±1 7 1 1  7   0.9958  7-1000  
ADR 68±1 5 3 1  7  0.9997  7-1500  
DTA 90±6 11 2 1.5  2  0.9973  2-500  
EPA 61±10 9 4 3  10  0.9984  10-1500  
ARA 55±8 8 6 1.5  10   0.9931  10-1500  
ETA 74±3 7 2 1.5  7   0.9999  7-1000  
STD 81±8 12 3 5  5  0.9981  5-1000  
ALA 63±3 6 2 1  10  0.9970  10-1500  
 
2.3.4 Evaluation of matrix effect and ionization suppression  
Matrix effect can be considered as the Achilles heel of quantitative mass spectrometric 
analysis. Matrix effect occurs when matrix molecules coelute with the analyte of interest thus 
altering the ionization efficiency of the electrospray interface.
209
 Therefore, it is essential to 
employ appropriate strategies to minimize the ionization suppression or enhancement 
phenomenon associated with matrix effect. SPME, however, is a clean extraction method, 
where the biocompatibility of the polymer coating prevents extraction of macromolecules 
and other matrix components. Moreover, non-exhaustive extraction by SPME fiber applies 
not only to the analyte of interest, but also possible interfering compounds, thus eliminating 
or significantly minimizing competition in ionization process. In this study, the matrix effect 
was assessed using two different approaches including i) absolute matrix effect evaluation 
using the post-extraction spiked method described by Matuszewski et al.
206
 and ii) the sample 
extract dilution method.
212
 Calculation of absolute matrix effect involved relating the peak 
area obtained from a neat solvent spike with a known concentration (S2) to the peak area of 
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the blank extract, which is spiked with the same concentration of analyte standard after 
extraction (S1) 
Equation  2-1 
     
      
      
       
ME values larger than 120% and smaller than 80% represent significant ionization 
enhancement or suppression for a given analyte. For this study, matrix effect (ME) values are 
reported in Table  2-2. Utilizing the proposed SPME method, no absolute matrix effect was 
observed. Additional proof is provided by evaluation of matrix effect using the Sample 
Extract Dilution Method.  
2.3.5 Evaluation of matrix effect using Sample Extract Dilution Method 
The Sample Extract Dilution method was applied as an additional quantitative method in 
order to confirm the absence of an absolute matrix effect by proposed SPME method. 
Therefore, a plot was constructed for each analyte; the x axis reports the dilution factor, and 
the y axis represents the normalized peak area (peak area of the chromatographic peak 
multiplied by dilution factor). In the electrospray ionization (ESI) source, the total number of 
ions per time unit formed is approximately constant; at higher concentrations a competition 
occurs between all ions to escape from the final droplet surface. Once the compound 
concentration decreases as a result of sample dilution, this competition decreases 
concurrently. As a result, the matrix effect on analyte response originated by coeluting 
compounds can be reduced significantly. 
213
 When there is no absolute matrix effect, the y 
axis response remains constant for the entire applied dilution factors, within the experimental 
error Figure  2-6.The results of this evaluation indicated that in spite of the complexity of the 
plasma matrix, the final extract obtained from the SPME method required no dilution in all 
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cases. The SPME method resulted in clean final extracts of biological samples due to the 
isolation of analytes from any interfering matrices. In addition, the application of the 
biocompatible coatings and washing step aided to prevent transfer of macromolecules 
(including polysaccharide, proteins, and particulates) and in reducing the possibility of 
suppression/enhancement of analytes signals during ionization. 
 
 
Figure  2-6 Plasma sample dilution effect on normalized ion current intensity for fatty acids extracted 
from spiked plasma at a concentration of 2µg/ml of standard fatty acids 
 
2.3.6 Determination of albumin affinity constant by SPME 
In plasma, fatty acids are soluble in concentrations up to about 1 μM. Owing their low 
solubility in plasma, FAs require a transporter to increase their concentration in vascular and 
interstitial compartments. Human serum albumin (HSA) is the transport vehicle for free fatty 
acids and the main FA-binding protein in extracellular fluids
214
 which binds with 
approximately 0.1-2 mol per mole protein, under normal physiological condition.
215
 Further 
increase of NEFA concentration increases the bound NEFA proportion, accordingly.
205
 
Because SPME extraction occurs via free concentration, the study of plasma protein binding 
(PPB%) and the effect of albumin concentration on fatty acid recovery by SPME seemed 
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crucial for this study. To ensure accurate quantification of fatty acids independent of albumin 
concentration, the recovery profile of NEFAs was measured at different HSA concentrations. 
Amount of FAs extracted from spiked standard human albumin solutions were plotted against 
the protein concentrations (Cp), and the Ka was determined by fitting Equation  2-2 through 
the data points.
216
 
Equation  2-2 
      
  
         
  
 
Where, C0 is the amount extracted at a protein concentration of 0, and fup is the unoccupied 
fraction of protein. In this experiment, fup is approximately equal to 1 because the total 
protein concentration (5-100 g/L) was much higher than the spiked fatty acid concentration 
(3 µg/L). Figure  2-7 shows the absolute recovery calculated for each individual protein 
concentration. The reference range for albumin concentrations in human blood plasma is 34 
to 54 g/L. In the exaggerated range of HSA (<20 and >70 g/L), protein concentration affects 
the recovery of fatty acids by changing its free concentration equilibrating with the SPME 
coating. However, these extreme values are not expected in plasma samples except of hyper- 
or hypoalbuminemia and in this study they are only considered in order to evaluate fiber 
performance. As the results show in Figure  2-7, absolute recovery is constant within the 
physiological range of HSA concentration (30-60 g/L). Accordingly, the mean calculated 
Ka values from this experiment were in the range 9.2 × 10
4
 to 4.3×10
5
 M
-1
 Table  2-2. Affinity 
constant (Ka) was reported to be dependent on the fatty acids carbon chain length; it increases 
with an increase in length and decrease of the number of double bounds in studied fatty 
acids.
205
 The obtained results for the affinity constant using the SPME method follow the 
same pattern and correspond very well with literature values,
214,217
 which proves the validity 
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of the proposed SPME method for the study of free concentration and protein binding of 
nonesterified fatty acids in biological systems.  
 
Figure  2-7 Albumin concentration-dependent NEFA recovery; y-axis represents the extraction recovery 
percentage of fatty acids vs albumin concentrations after 2 hr of extraction. Figure reprinted from 
reference with the permission of the publisher. 
 
2.3.7 Plasma protein binding (PPB %)  
Binding equilibrium studies for long-chain fatty acids to serum albumin are complicated 
because of the low ligand solubility. The aim of this part of the study was to investigate 
binding equilibria of long-chain fatty acids in human blood plasma under varying conditions 
and to compare the results with observations on the affinity constant to serum albumin, 
which were discussed in the previous section. Plasma protein binding determination by 
SPME method has been reported based on the measurement of bioactive unbound 
concentrations of the ligand, which is often referred as the free concentration in presence of 
plasma protein.
218
  Briefly, the percentage of binding to plasma proteins (PPB) is calculated 
from the total and free concentrations of analyte using Equation  2-3 
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Equation  2-3 
      
            
     
      
 
Where Ctotal is the total concentration of ligand and Cfree is the free concentration of ligand in 
plasma. Considering that the total ligand concentration is directly proportional to the slope of 
the matrix-free calibration curve in PBS, and the free concentration is directly proportional to 
the slope of matrix match calibration;
218
 Equation  2-3 becomes: 
Equation  2-4 
         
                        
                     
       
 
In order to better understand the FA binding mechanism, the matrix match calibration curve 
was not only constructed in plasma, it was also constructed in HSA standard buffered 
solutions (35 g/L). Using the standard slopes obtained from these experiments, Equation  2-4 
was applied for determination of PPB values of nine PUFAs under study in both media; 
results are presented in Table  2-2. The present observations demonstrate that there are no 
significant variations in PPB values determined by SPME method using different approaches, 
and it correlates well with average literature values.
205,217,219
 
Table  2-2 Evaluation of albumin affinity constant and % plasma protein binding 
 DHA EPA ADR DTA EPA ARA ETA SDA ALA 
Matrix Effect (%) 103% 96% 88% 91% 116% 110% 93% 112% 116% 
Albumin affinity 
constant (M
-1
) 
9.2×10
4
 2.1×10
5
 2.2×10
5
 4.3×10
5
 1.2×10
5
 1.5×10
5
 2.9×10
5
 2.0×10
5
 2.2×10
5
 
Human serum 
albumin PPB (%)*  
97.9 98.6 99.1 99.4 98.0 98.6 99.2 99.5 99.6 
Plasma PPB (%)  98.3 99.3 99.5 99.7 98.7 98.8 99.6 99.5 99.6 
Intra-batch 
reproducibility (%) 
6 10 6 9 5 5 6 6 10 
Inter-batch 
reproducibility (%) 
9 14 8 9 11 8 7 7 12 
*PPB values are found with (± 0-0.2) standard deviation and the correlation coefficient (CV) lower than 15%. 
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2.3.8 Fatty acids quantification in plasma samples  
One of the most important elements of assay validation is the evaluation of the effect of 
matrix on the results of quantitative determination of metabolites in biological fluids.
220
  This 
goal could be achieved by comparison of the assay precision and accuracy of a typical 
validation experiments performed in a single lot of plasma versus the same validation 
experiment performed in five different plasma lots according to Matuszewski et. al.
209
 For 
this purpose, the standard addition method is used as the most suitable calibration method 
that recompenses any variation related to complexity of the matrix. For quantification of fatty 
acids of interest in this study, seven concentration points in three replicates were used to 
construct the standard addition calibration curves. In order to avoid disturbing the matrix and 
dilution of the sample, the volume of organic content of added standard solution was kept 
<1%. The concentration of investigated FAs was kept within the linear range. The limit of 
detection (LOD) and limit of quantification (LOQ) obtained in the range of 0.5−2 and 5−12 
ng/mL, respectively, with a linear dynamic range of 100 fold for each compound. The 
stability of standard fatty acids was investigated in the stock solutions, PBS and incubated 
plasma. Storage stability of FAs in human plasma and the influence of freeze-thaw cycles 
were also examined and convinced by processing a set of QC samples. On the other hands, 
due to the limited availability of plasma samples obtained from patients, it was essential to 
compare the reproducibility of standard addition calibration in different plasma lots under the 
same extraction and chromatographic conditions. Therefore, not only the five calibration 
curves were built separately in the same single plasma lot to compare the precision and 
accuracy, they were also built in five different plasma batches to evaluate the relative matrix 
effect due to the lot-to-lot variation.  
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The precision and accuracy values obtained in a single plasma lot using the proposed SPME 
method ranged from 5 to 10%, and 95 to 110%, respectively. The inter-lot and intra-lot 
reproducibility is reported in Table  2-2. Moreover, when the same validation was attempted 
in five different plasma lots, the precision values were persuasive (7-14%) under identical 
conditions; likewise the correlation variance (CV) of standard line slopes did not exceed 4–
5% for the method. The very small variability of slopes of calibration curves obtained from 
five different plasma sources is a direct indicator of assay reproducibility and serves as a 
good quantitative indicator of the absence of a relative matrix effect in the proposed SPME 
method. The unknown sample concentrations were calculated from the equation, y = mx + b, 
as determined by weighted (1/x) linear regression of the standard line. Eventually, for 
quantification, the mean calibration equation obtained from five different pooled plasma lots 
was employed to extrapolate and quantify the unknown amount of PUFAs under study in the 
patients undergone cardiac surgery. However, due to the limited availability of fish plasma, 
the standard addition method was performed in an individual lot of pooled fish plasma (three 
replicates for each concentration point). Data are summarized in Table  2-3.  
2.3.9 Comparison of NEFA composition in fish and human plasma  
In general, the mean of standard calibration line slopes determined in human control plasma 
and fish plasma are similar for all fatty acids, which serves as another excellent measure for 
the absence of a relative matrix effect not only within the same individual, but also between 
individuals. The observed differences of the Y-axis intercept of the calibration equations 
clearly indicate that the initial level of fatty acids is considerably higher in fish. Total plasma 
NEFA in the study of White Sucker species ranged 0.76-11.13 µg/mL, whereas for control 
human plasma only arachidonic acid was detectable in the quantification range. The amounts 
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of DHA and EPA were significantly higher in fish plasma with a p value of 0.002 and 0.007, 
respectively, though the concentration level of arachidonic acid was not statistically different 
between these two subjects with a nearly non-significant p value (0.78). These results are 
consistent with the erstwhile work done on the White Sucker fish, which indicated higher 
DHA and EPA, and lower AA.
221–223
 Our results confirm the well known fact that fish is an 
omega-3 rich food choice because of its primary source of essential fatty acids and 
demonstrate that presented analytical protocol can be used for assessing the nutritional value 
of fish products in simple and relatively fast manner. 
 
Table  2-3 Linear dynamic range of fatty acid concentration in human and fish plasma samples 
 Human plasma 
calibration(n=5)
1
  
Lot-to-lot CV 
(%)
2
 
Fish plasma calibration 
4
 
Human 
plasma 
conc.(µg)
3
 
 Fish plasma 
conc.(µg)
5
  
DHA y = 0.0041x + 0.67 5% y = 0.0044x + 26.9 LOD 11.1 ±0.2 
DPA y = 0.0037x + 10.5 4% y = 0.0039x + 16.6 ND 6.6 ± 0.1 
ADR y = 0.0019x + 1.6 5% y = 0.0019x - 0.5 ND LOD 
DTA y = 0.0018x + 3.3 3% y = 0.0022x + 4.3 ND 3.0 ± 0.1 
EPA y = 0.0041x +4.7 3% y = 0.0041x + 13.1 LOD 9.0 ± 0.1 
ARA y = 0.0036x + 1.7 3% y = 0.0027x + 1.04 2.9± 0.1 2.7 ± 0.1 
ETA y = 0.0026x + 0.8 4% y = 0.0025x + 0.4 1.2± 0.1 1.1 ± 0.01 
STD y = 0.0034x + 1.26 4% y = 0.0044x + 1.1 ND 0.76 ± 0.01 
ALA y = 0.0012x +1.5 5% y = 0.0011x + 5.2 2.8± 0.2 1.6 ± 0.1 
1
Mean of calibration equation of five different human plasma lots, three replicates each. 
2
Lot-to-lot variation of slope of calibration equations from five different sources of plasma  
3
Primary concentration of fatty acids in human plasma extraction, total µg 
4
Mean of calibration equation obtained from single human plasma lot, three replicates. 
5
Primary concentration of fatty acids in fish plasma extraction, total µg 
2.3.10 Clinical data analysis  
Using the validated SPME method, PUFA changes were monitored in seven patients. The 
scheme in Figure  2-8 shows the order of sample collection during the cardiac surgery 
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performed with the use of extracorporeal circulation (CPB). As the results indicate in Figure 
 2-9, the major changes in concentration of unsaturated fatty acids during the surgery refer to 
the period when the patient is placed on CPB and the most significant increase is related to 
the level of ALA (18:3). Pre-operative or intra-operative metabolic changes in cardiac 
surgical patients are widely discussed in the literature.
7,224,225
 From a metabolic point of view, 
the cardiovascular response to increased metabolic demands after cardiac surgery may lead to 
enhanced glucose and down regulated free fatty acid (FFA) metabolism; yet the heart can use 
several substrates, among which free fatty acids (FFAs) and glucose are the major sources.
224
 
Having known this fact, the reason behind fatty acid elevation right after commencing bypass 
could be clearly explained. Hence, the reason for specific amplification of ALA in all patients 
needs deeper clinical controversy, which is beyond the scope of this article. The alteration in 
metabolic profile of ALA and its metabolites was already reported and discussed in the 
studied group of patients and current targeted analysis confirms previous findings.
135
 
 
Figure  2-8 Scheme of cardiac surgery with the use of extracorporeal circulation (CPB) indicating the 
sample collection over the time of surgery. Figure reproduced from reference with the permission of the 
publisher
158
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Figure  2-9 Metabolic profile of FAs in patients undergoing cardiac surgery with the use of CPB; the most 
significant increase of FAs was observed for patient 7, in which the level of ALA reaches to 75±4 µg. 
Based on Table  2-3, concentration of ALA in the normal human plasma is only 2.8± 0.2 µg. Figure 
reprinted from reference with the permission of the publisher. 
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2.4 Conclusions and Future Directions  
This research aims to develop a simple unbiased analytical method based on SPME in 
combination with LC-MS method for the extraction of free fatty acids from human and fish 
plasma. It was shown that the use of biocompatible C18 SPME fibers could be successfully 
applied for quantification and qualitative profiling of this group of lipids. This method 
permits the avoidance of interferences from hydrolysis of esterified fatty acids from other 
lipid sub-classes. Moreover, the protein affinity constant of polyunsaturated fatty acids has 
been determined and compared to the literature values. Indeed, the obtained results indicate 
the selectivity of the proposed method for the determination of fatty acid species despite their 
slight structural differences in carbon chain length and double bond number and localization. 
The extensive validation of the method demonstrates the fulfillment of requirements for the 
bioanalytical assays. The results of calibration equations obtained from fish and human 
plasma suggested that this approach could be extended to the plasma samples of other 
biological species. The application of the protocol allowed for the successful monitoring of 
the elevation of fatty acids in plasma collected from a group of patients undergone cardiac 
surgery right after initiation of extracorporeal circulation. The promising outcomes of the 
study show the potential of the approach for profiling and quantification of fatty acids in vivo 
in low invasive way as it was already demonstrated for other fiber-based SPME 
applications.
154,199,226–229
 The presented method could be also adopted for high throughput in 
vitro analysis either in its fiber form or using thin-film geometry format using automated 96-
SPME device autosampler.
157
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Chapter 3 
 Methodological modifications on quantitative analysis of plasma 
lipids using high throughput solid phase microextraction 
3.1 Introduction 
Lipidomics is a relatively new branch of “omics” science and a quickly progressing 
discipline that aims to comprehensively determine the lipid composition in living cells and 
organisms, as well as to characterize their biochemical relations and interactions with other 
neighboring lipids and proteins. To this end, accurate quantification of individual lipid 
species, as a first step in lipidomics, remains a very  essential, yet challenging task.
230
 Lipid 
quantification generally falls into two categories: i) relative quantification that measures the 
pattern changes of lipids and ii) absolute quantification that calculates the exact amount of 
individual lipid species and subsequently, the mass level of particular subclasses and 
classes.
50
 A quantitative method should strive for the highest degree of accuracy and 
precision; accordingly, the error propagation in each step, from sampling to experimental 
analysis and data processing, must be carefully pre-estimated and controlled. 
 General analytical platforms of lipid analysis and lipidomic studies have been already 
introduced and discussed in section  1.4 and  1.5 followed by a detail description of the most 
important conventional sample preparation techniques involved in lipid analysis, represented 
in section  0 of  Chapter 1. To date, sample preparation followed by chromatographic 
approaches coupled to mass spectrometry remains as the chief technological approach used 
in lipidomics. This includes various cutting-edge tandem mass spectrometry 
strategies,
39,51,75,77,231,232
 specialized reagents and calibration standards,
4,233
 and 
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comprehensive searchable lipid databases,
2
 towards online data analysis.
3,234,235
 Within the 
whole workflow, the possibility of matrix effect encounters, chances of chemical cross-
contamination and co-elution, as well as isobaric interferences of naturally occurring lipids 
with the same nominal mass are the key analytical challenges of lipid quantification. To 
correct biased losses of lipid classes, spiking of samples with lipid standards is a necessary 
step that needs to be taken prior to extraction. As a critical step, appropriate calibration 
strategies should be employed by performing comparisons of analytes against either external 
or internal standards with similar molecular structures (e.g. stable isotopologue of analytes). 
For quantitative analyses of the lipid complex in a biological system, it is certainly 
impractical to use one isotope-labeled standard per each lipid species. Bearing in mind that 
the response factor of lipid species in ESI-MS depends primarily on the ionization properties 
and polarity of the head group of a given lipid, a single species per entire lipid sub-group can 
be employed as an external standard to allow quantification of individual lipid species within 
the same class.
52,236,237
  
In clinical and biological applications, sample extraction techniquess have not kept pace with 
the development of analytical technologies such as state-of-the-art mass spectrometry, and 
thus sample preparation techniques have become the weakest link in modern chemical 
analytical procedures. Although some of these methods are efficient, most of them are slow, 
labor/time intensive, and challenging to automate; in addition to requiring high consumption 
of organic solvents. Within the past years, driving forces such as the need for faster high 
throughput analyses have encouraged chemists to pursue automated modern sample 
extraction methods. Lipids are commonly extracted by traditional Bligh & Dyer or Folch 
protocols that use chloroform, methanol, and aqueous buffer. Nevertheless, the conventional 
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sample preparation methods relying on manual lipid extraction are labor intensive and prone 
to error, thereby difficult to fulfill the need for large scale lipidomics studies that require the 
throughput of numerous samples per day.
238,239
 In this context, automation of the sample 
preparation and extraction procedures is essential for improving the cost effectiveness of 
such projects, minimizing sample losses, and decreasing unexpected experimental artifacts. 
Over the past years, attempts have been made to use the robot-assisted sample preparation 
and lipid extraction procedure in the 96-well format.
56
 In this regard, a high throughput 
method termed Matyash
105
, which combines methyl-tert-butyl ether (MTBE) extraction with 
mechanical homogenization and a conventional micropipetting robot, was introduced for the 
extraction of lipids from human brain
240
 and blood plasma.
105
 In related work, dimethyl 
sulfoxide (DMSO) was reported for extraction of cellular lipids from microalgae samples 
using a 96-well plate in conjugation with the fluorescence spectrophotometer.
241
 Another 
solvent-based extraction method termed BUME, based on a butanol:methanol mixture, was 
used in conjunction with an automated 96-well robot for the performance of total lipid 
extractions from plasma or serum.
103
 However, besides the high toxicity of these 
methodologies, which are all riddled with a high solvent-to-sample ratio, conventional 
approaches are also challenging for automation in the 96-well format. To bypass these 
challenges, automated 96-well format solid-phase extraction (SPE) has been widely used for 
high-throughput determination of phospholipids in nutritional and epidemiological 
studies.
242–244
 Various sorbent chemistries, such as aminopropyl silica, mixed mode, C18, 
etc., were used to analyze lipids, but they either mainly focused on analysis of fatty 
acids,
62,210
 or were otherwise class-selective depending on the elution conditions 
used.
37,112,245,246
 The Waters Ostro 96-well Plate was originally intended as a sample clean-up 
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approach for the capture and removal of highly abundant phospholipids in the analysis of 
polar metabolites;
238,239
 but was later modified for target lipid extraction during routine 
bioanalysis.
247,248
 Although this approach promises significant advantages for analysis of 
large sample numbers in shorter times, it reportedly has several qualitative and quantitative 
limitations. Several attempts have been made to combine liquid–liquid extraction and solid 
phase extraction methods (LLE-SPE) for plasma and blood, primarily with the purpose of 
separating phospholipids from the rest of metabolites; in different studies, the use of this 
approach was reported to achieve better lipidome coverage.
238,249
 However, the method is 
tedious and labor intensive, yields unavoidable experimental artifacts, and due to the 
multiplexed sample preparative steps that need to be taken, impractical to wholly 
automate.
130
    
Thin-film microextraction (TFME), as a newly emerged format of the SPME technique, 
offers improvement of sensitivity without sacrificing time by increasing the available surface 
area and volume of coatings. Current thin film configurations are available on a fully 
automated 96-blades system compatible with standard 96-well plates, and different coating 
chemistries have been reported for various applications, including the analysis of drugs and 
metabolites from biofluids, tissue, cells, and food matrices.
137,141,146,159,204,250–253
 In spite of 
the promise of the method for extraction of hydrophilic and hydrophobic compounds, this 
technique has never been applied in lipidomics and lipid analysis studies. In the last chapter 
( Chapter 2) we presented the novel application of disposable rod fiber SPME for analysis of 
nonesterified fatty acids from biological matrices. The aim of this study was to develop a 
high throughput automatic 96-blade SPME protocol towards the production of a crude lipid 
extract for analysis on the LC-ESI-MS/MS system in order to obtain a highly reproducible 
 63 
 
methodology that could be used to quantify lipid classes in clinical studies. In this regards 
standard addition calibration was used based on the one-class/one-standard approach for the 
determination and quantification of unknown lipids from plasma samples.  
3.2 Experimental  
3.2.1 Reagents and materials 
LC-MS grade Methanol, acetonitrile, 2-propanol (all HPLC gradient grade) were purchased 
from Fisher Scientific (ON, Canada). LC-MS grade acetic acid and ammonium acetate were 
obtained from Fluka (Sigma-Aldrich Oakville, ON, Canada). Human Na citrate plasma was 
purchased from Lampire Biological Laboratories, Inc. (Pipersvile, PA, USA). Two groups of 
lipid standard with even-numbered carbon chains (endogenous lipids), as well as odd-carbon 
acyl chains (non-endogenous) from each lipid class and subclass species were purchased 
from Avanti Polar Lipids (Alabaster, AL) for method development:1-palmitoyl-2-hydroxy-
sn-glycero-3-phosphocholine, (LPC 16:0); 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine, 
(LPC 18:1); 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (PC 14:0/18:0); 1-stearoyl-
2-arachidonoyl-sn-glycero-3-phosphocholine, (PC 18:0/20:4); 1-palmitoyl-2-linoleoyl-sn-
glycero-3-phosphoethanolamine, (PE 16:0/18:2); N-oleoyl-D-erythro-
sphingosylphosphorylcholine, (SM d18:1/18:1); 1-(9Z-octadecenoyl)-rac-glycerol, (MG 
18:1(9Z)/0:0/0:0); 1,2,3-trihexadecanoyl-glycerol, (TG 16:0/16:0/16:0); 1,3-di-(9Z-
octadecenoyl)-2-hexadecanoyl-glycerol, (TG 18:1/16:0/18:1); 1,2-distearoyl-sn-glycero-3-
phospho-(1'-rac-glycerol), (PG 18:0/ 18:0); N-lauroyl-D-erythro-
sphingosylphosphorylcholine, (SM d18:1/16:0); N-heptadecanoyl-D-erythro-sphingosine, 
Ceramide (d17:1/17:0); 1-heptadecanoyl-rac-glycerol, (MG 17:0); 1,2-diheptadecanoyl-sn-
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glycero-3-phospho-(1'-rac-glycerol), PG(17:0/17:0); 1,2-diheptadecanoyl-sn-glycero-3-
phosphocholine, (PC 17:0/17:0); 1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolamine, 
(PE 17:0/17:0); 1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine, (LPC 17:0); 1,2,3-
triheptadecanoyl-glycerol, (TG 17:0/17:0/17:0). 
3.2.2 Preparation of standard solutions and plasma samples 
A standard mixture containing equal amounts of all authentic standard lipids was prepared in 
chloroform/methanol 1:1 (v/v) to reach a concentration of 0.5 mg/ml for each lipid, and 
stored at -30°C. Working standard mixtures were prepared freshly every day in 
IPA/methanol 1:1 (v/v) for immediate use. The working standard solutions at the calibration 
range were injected in the beginning and the end of sequence, for evaluation of instrumental 
performance throughout a long sample sequence. The phosphate-buffered saline (PBS) 
solution (pH 7.4) was prepared by dissolving sodium chloride (8.0 g), potassium chloride 
(0.2 g), potassium phosphate (0.2 g), and sodium phosphate (1.44 g) in 1 L of purified water. 
PBS and plasma samples were spiked with working standard solution while stirring at 500 
rpm to prepare the required concentrations for the method development experiments. In order 
to validate the optimized SPME method in plasma, calibration standards and validation 
samples were prepared by spiking an appropriate amount of each lipid standard in plasma to 
reach a final concentration range between 500-8000 ng/mL (keeping the organic solvent 
concentration at approximately 1% methanol). After spiking, plasma samples were incubated 
at room temperature for one hour to ensure binding equilibrium occurred prior to extraction. 
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3.2.3 Preparation of C18-PAN 96-Blade coatings  
For the high-throughput analysis of lipids, coated thin-film SPME blades were immersed into 
plasma samples using the manual Concept 96 unit (Professional Analytical System (PAS) 
Technology, Magdala, Germany). The TF-SPME blades were made in-house. For efficient 
immobilization of coating particles, the stainless steel surface was conditioned by sonication 
of blades in strong hydrochloric acid for approximately 60 min prior to the coating process. 
The blades were then rinsed thoroughly with nanopure water, dried in an oven for 30 min at 
150 °C, then left to cool until they reached room temperature. The slurry of C18-PAN 
mixture was sprayed to immobilize the C18 particles on the surface of the stainless steel 
blades, followed by immediate thermal curing at 180 °C for 2 min. The identical coating-
curing sequence was repeated 10 times in order to ensure uniform exposure and proper 
thickness of the C18-PAN coating on the surface of the blades. A comprehensive report of 
this procedure is discussed elsewhere.
136
 
3.2.4 Optimization of the SPME procedure 
Time is one of the key factors in SPME procedure; the amount of analyte extracted increases 
as time of extraction elapses, until equilibrium between analyte and SPME coating is 
established. Therefore, extractions from a 200 ng/mL mixture of lipids in PBS (pH=7.1) were 
carried out with the use of C18-blades for  5, 10, 20, 30, 45, 60, 75, 90, 120 and 160 minutes 
to ensure sufficient time coverage for extraction equilibrium under agitation conditions. For 
plasma samples, extraction times were extended up to 600 min in order to outline the 
equilibrium profile of lipid species in such a complex matrix. For each time point, two 
replicates were considered. After the extraction process, desorption time profiles were 
constructed for 5, 10, 20, 30, 45, 60, 75, 90, 120, and 160 minutes to ensure desorption 
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equilibrium. Since most of the studied lipid classes are highly hydrophobic, the same SPME 
blades were desorbed for a second time in 1 mL of desorption solvent in order to evaluate the 
amount of analyte residue on the coating after the first desorption. Likewise, extraction 
recoveries were also compared for different desorption solutions using various ratios of 
water/organic solvents. All SPME coatings were pre-conditioned for 30 min in a mixture of 
methanol/water (1/1, v/v) prior to use in order to activate the silanol groups of the stationary 
phase. SPME blades were immersed into 1 mL of sample aliquots for 90 min extraction with 
1000 rpm orbital shaking. Immediately after extraction, coatings were rinsed by dipping the 
blades in purified water for 10 s to remove any residuals of biological material from the 
coating surface.  Afterwards, the coatings were agitated for 60 minutes in 1 ml IPA/methanol 
for proper desorption of lipids, and the resulting extract solutions were injected to the HPLC–
ESI-MS/MS system for analysis.  
3.2.5 LC-ESI-MS Operating Conditions 
All samples were analyzed using a LC-MS/MS system consisting of a Shimadzu high-
pressure liquid chromatography system (Shimadzu, Kyoto, Japan) operated with dual pumps 
(Shimadzu LC10ADvp), a system controller (SCL10Avp), and SCIEX API 4000 hybrid 
triple-quadrupole mass spectrometer with a Turbospray liquid interface (Applied Biosystems, 
CA, U.S.). The chromatographic system was equipped with apolyether ether ketone (PEEK) 
connection tubing consisting of a non-metallic injector unit and a 10-µl PEEK sample loop; 
this was done to avoid systematic carryover due to the undesired interaction of lipids with 
metallic materials.  
Data acquisition and processing were performed with the use of Analyst software (version 
1.4.1). The instrument tuning was performed manually by infusion of individual lipid 
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solutions and scanning the ion mass of each lipid considering the ion adduct with highest 
intensities. The MS/MS analysis was performed in positive mode under multiple reaction 
monitoring (MRM) conditions; instrument settings are described in Table  3-1. MS conditions 
were optimized for curtain gas at 10, collision gas at 8 (arbitrary units), and 25 and 40 for ion 
source gases 1 and 2, respectively, with 5500V for ion spray voltage and 450°C temperature. 
A CTC PAL auto-injector from Leap Technologies (CTC Analytics, NC, U.S.) was used for 
injection of 10µl sample volumes into the LC–MS/MS system. Analytes were separated 
using an XBridge C18 3.5μm 2.1x150mm Column (Waters Corp, Milford, MA); mobile 
phase A consisted of water/acetonitrile (10:90) containing 0.1 % Acetic acid, while mobile 
phase B consisted of 100% isopropyl alcohol, with addition of 0.15 mM ammonium acetate 
for a flow rate of 300 µl/min. Optimal separation conditions were as follows: mobile B 
started at 10% and remained constant until minute 6, then increased to 60% until minute 8, 
followed by isocratic hold at 60% B until minute 18, then ramped back to 10% for one 
minute, followed by six further minutes of column re-equilibration, for a total run time of 25 
minutes.  
3.2.6 Data analysis and calculations 
After data acquisition, the Quantitation Wizard feature of the Analyst software (version 
1.4.1) was used for calibration of individual lipids using 1/x weighted linear regression. The 
instrument calibration curve was obtained daily from the standard working solution of lipids 
in desorption solution (single standard per concentration level, minimum of 6 levels to cover 
the entire linear range of the instrument). Weighted regression was found to perform better 
than simple linear regression by improving the accuracy of low concentration standards. 
Extraction efficiency (or absolute recovery) was calculated for each lipid standard by 
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percentage ratio calculation of the extracted amount (ng) to the total spiked amount of 
analyte (ng). The instrumental calibration curve was used to determine the extraction 
efficiency (or absolute recovery) of the SPME method. The experimentally determined 
concentration was divided by the nominal spiked concentration (ng/mL), and the obtained 
result was multiplied by 100% in order to calculate the relative recovery percentage 
(accuracy). The SPME calibration of lipids in plasma was performed for each standard in 
duplicate for a minimum of six concentration levels across the entire linear range. The 
unknown sample concentrations were calculated from the equation, y = mx + b, as 
determined by weighted (1/x) linear regression of the standard line.  
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3.3 Results and Discussion 
3.3.1 Chromatographic Method Validation 
Blood plasma is a complicated biological mixture containing a variety of lipids including 
phospholipids, sphingolipids, glycerolipids, etc., which vary in fatty acid composition and 
glycerol backbone occupation. In order to establish an SPME method for sample preparation 
and clean-up, an integrated LC-MS based analytical platform relying on gradient elution and 
MS/MS fragmentation in this study. 
 The LC/MS method was developed and assessed using lipid standards aiming to provide 
maximum coverage for lipid classes and sub-classes. In this study, the MRM approach 
allowed absolute quantification of endogenous molecular lipids; for this methodology, 
method quality assurance by spiking an appropriate representative of each lipid (sub) class is 
indispensable.
254
 Systematic studies of instrument response determined that ionization 
efficiency was predominantly dependent on the polar head group of each lipid category; 
whilst length and structure of fatty acid moieties played minor roles in ionization 
efficiency.
52,74
 In order to evaluate such a possibility, two sets of lipid standards, including 
one set of synthetic lipids with heptadecanoyl (17:0)n FA moieties and another set containing 
most common endogenous lipid species with even FA moieties, were simultaneously 
employed throughout the SPME method validation procedure. None of the odd-lipid (those 
that have odd number of carbon in FA chains) class selective standards were detectable in the 
total extract of plasma samples. It is also noteworthy that these standards are commercially 
available, and since they are not isotopically labeled, their precursor and fragment peaks 
produce natural isotopic profiles, identical to endogenous lipids. A detailed list of all lipid 
standards including odd and even groups is represented in the Table  3-1. The solutions of 
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both lipid sets in different concentrations were injected to the LC/MSMS system and the 
dynamic range of instrumental calibration was determined (data shown in Table  3-2).  
 
Table  3-1 Summary of LC-MS/MS parameters for analysis of lipids 
Lipid Q1 Q3 
Ion 
adduct 
DP 
(V) 
EP 
(V) 
CE 
(V) 
CXP 
(v) 
LOD 
(ng/ml) 
LOQ 
(ng/ml) 
LPC 17 510.2 184.1 
[M+H] 110 8 37 18 10 10 
LPC (16:0) 496.2 184.1 
PE (17:0/17:0) 720.6 579.5 
[M+H] 80 10 28 20 5 10 
PE (16:0/18:2) 716.6 575.6 
SM (d18:1/17:0) 647.4 184.1 
[M+H] 88 10 30 15 1 5 
SM (d18:1/16:0) 703.7 184.1 
MG (17:0) 362.4 327.2 [M+H] 
[M+NH4] 
100 9 15 10 15 25 
MG (18:1) 374.5 339.3 
TG(17:0/17:0/17:0) 862.4 579.5 
[M+NH4] 95 10 35 20 10 25 
TG(18:1/16:0/18:1) 876.7 577.6 
PC 17:0/17:0) 762.7 184.1 
[M+H] 90 10 40 18 5 10 
PC (14:0/18:1) 734.9 184.1 
PG (17:0/17:0) 773.5 194.9 
[M+H] 100 10 45 20 5 10 
PG (18:0/18:0) 801.7 194.9 
CE (d18:1/17:0) 552.6 264.1 
[M+H] 70 10 35 10 1 5 
CE (d18:1/18:0) 566.6 264.1 
*DP=Declustering potential, FP=Focusing potential, EP=Entrance potential, CE=Collision energy, and CXP=Collision cell exit potential 
 
Choosing an optimal mobile phase composition is one of the most crucial bottlenecks of LC-
MS method development for lipid analysis. The optimal elution system must contain proper 
buffer additives and ionic strength in order to facilitate efficient electrospray ionization, 
while also providing proper peak shape and retention. A desired scan spectrum presenting 
only simple adducts of lipids with high intensity was achieved through tuning of the ion 
source settings in the presence of mobile phase. However, the ionization of different lipid 
classes was observed to be contrarily dependent on the mobile phase buffer additives. For 
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example, certain lipid classes, such as glycerolipids, mainly form [M+NH4]
+
 adducts; in this 
sense, the mobile phase must supply sufficient ammonium ion to facilitate formation of this 
adduct..  
Conversely, it was observed that the presence of ammonium salt caused buffer-induced 
ionization suppression and peak deformation for some phospholipids. As phospholipids 
contain at least one acidic phosphate group, the mobile phase must be slightly acidic to force 
them into a protonated state, as this improves chromatographic peak shape; since they mainly 
form [M+H]
+
, the acidic mobile phase must also supply the ESI source with sufficient 
hydrogen ions. In contrast, the acidified solvent works oppositely for glycerolipids, causing 
peak tailing and mainly peak deformation for most glycerol lipids such as TGs and MGs. In 
general, PC, PE, and SM species are retained as broad peaks when the standard eluting 
system of acetonitrile/water (9:1) in the absence of acid (pH 6.7 by ammonia) is used, whilst 
TG shows a sharp Gaussian peak under such circumstances. On the other hand, when the 
solvent contained 0.2% formic acid (pH 4.8), the PC, PE and SM tailings were corrected 
although the peak related to TG was extensively broadened. This contrasting behavior is 
expected due to the positively charged head group of phospholipid compounds. Therefore, 
the acidic solvent reduces the undesired interaction between the mobile phase and the 
positively charged head group of PC, PE, and SM species. Figure  3-1 illustrates the effect of 
buffer additives on these two major lipid classes.  
In order to overcome such a conflict, adopting a proper gradient method and best balance of 
buffer additives would allow us to find the ionization behavior of lipid classes in formation 
of ion adducts with highest intensities and meanwhile to produce good resolution for all lipid 
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species of interest. Figure  3-2 indicates the optimum gradient method as well as the final 
obtained chromatogram. 
 
 
 
 
Figure  3-1 Extracted ion chromatograms (XIC) of PC and TG using acidic buffer in elution 
 
As part of this series of adjustments, various LC mobile phases were examined; an ideal 
elution was established when 10mM ammonium acetate was added to mobile phase A 
(water/acetonitrile) and 0.1% formic acid added to mobile phase B (IPA). Accordingly, the 
final gradient method was programmed in a way that mobile phase B reached 70% of total 
elution (maximum acid) in the region where phospholipids are retained, followed by a ramp 
back to only 10% (minimum acid) in the region where glycerol lipids such as TGs and MGs 
are retained.  
Triglyceride (TG) Phosphatidylcholine (PC) 
1 % acetic acid 
 (pH 4.8) 
 
No acid  
(pH 6.7) 
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Figure  3-2 Example of extracted ion chromatograms (XIC) for 3 mg/mL odd lipid standard in blood 
plasma; mobile phase A consist of ACN/ W (90:10) Containing 0.1 % Acetic acid and mobile phase B 
consist of  IPA 100% 0.15 mM amonium acetate 
 
Our final validated LC/MS method provides a complete separation of multiple categories of 
lipids within a single run and in less than 18 min, while the adduct preference accommodates 
a high signal intensity. Figure  3-2 represents the optimized MSMS chromatogram of lipid 
standards in positive ion mode. Table  3-2 represents the instrumental validation of lipid 
standards in positive ion mode 
 
Table  3-2 Automated LC-MS/MS method validation and instrumental robustness results 
Lipid  log p  water solubility  
(mg/mL)  
RT  
(min)  
LOD  
(ng/ml)  LOQ  Dynamic range  
Intra-day 
precision 
%  
Inter-day 
precision 
%  
LPC  2.38  2.75e-04  4.5  5 10  10-1000  1  7  
PE  8.97  8.97e-05  13.5  1 10  10-700  1  2  
SM  5.41  3.23e-05  10  1  5  5-500  1  12  
MG  5.32  1.51e-03  8.5  15  25  25-1000  7  11  
TG  10.74  7.70e-06  18  10  15  15-800  11  8  
PC  6.8  2.40e-05  11.5  5  10  10-500  4  3  
PG  8  1.090E-04  11  5  10  10-1000  3  5  
CE  9  2.120E-05  12.5  1 5 5-1000  4  5  
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3.3.2 Extraction phase: Comparison of C18 fiber and thin film 
For the validated extraction method of fatty acids represented in  Chapter 2, commercial rod 
fibers were selected that are suitable for in-vivo applications. However, in order to extend the 
analytical method for the whole lipid spectrum, evaluation of an appropriate extraction phase 
with relatively high affinity is preliminary in the method development procedure. Therefore, 
due to the hydrophobic nature of most lipid species, polymeric C18 particles were used as a 
primary extraction phase in two different geometries: the commercial rod fiber (Supelco, 
Bellefonte PA, USA) and the in-house thin film coated blades. In addition, previous research 
conducted in our group has indicated that the “hydrophilic lipophilic balanced” (HLB) 
particles are efficient for the extraction of hydrophobic compounds 
142,155,159,198,255,256
 
Accordingly, HLB particles (60 mm, average particle diameter) were similarly used to 
prepare the thin-film coated blades. Extraction of a lipid mixture in PBS (300ng) 
demonstrates the relative affinity of target compounds.  
 
Figure  3-3 Evaluation of different SPME coatings for the extraction of lipids from PBS; comparison of 
coatings (C18 vs. HLB) and geometries (rod fiber vs. Thin-Film) 
 
Based on the obtained results, although both HLB and C18 extraction phases have shown 
nearly comparable affinities for all lipids, C18 is a better candidate for some lipid categories 
such as TGs (logP 10.74) due to their more hydrophobic characteristics. With respect to the 
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configuration, all analytes were extracted more efficiently with thin film phases than with 
cylindrical fibers. The likely reason is the difference in surface area and volume, which is 
about 10 times greater with the films than with the fibers (Figure  3-3). Therefore, changing 
the geometry of the coatings and using C18 particles could achieve a significant 
improvement to the method sensitivity. In addition the new thin-film configuration could be 
applied in a 96-well plate to perform high throughput analysis of lipids from complex 
biological matrices.  
3.3.3 Optimization of extraction and desorption conditions 
Desorption: various solvents and solvent mixtures were evaluated in order to optimize 
desorption with minimum carryover, 1ml of lipid mixture solution in PBS buffer (n=3) was 
extracted for 90 min and desorbed into 1ml solution.  
 
Figure  3-4 Evaluation of desorption solvent for C18-PAN coatings for equilibrium extraction from PBS 
buffer solutions containing 200 ng/mL lipids 
 
Acetonitrile provided poor efficiency in desorbing of most lipids, while the solution 
containing water and ACN resulted in incomplete desorption of more hydrophobic lipids 
such as TG, PC, and PE from SPME coatings, resulting in higher carryover (4-6%) on the 
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fiber. A 50:50 ratio of MOH/IPA was selected as the desorption solvent, providing efficient 
desorption of analytes with negligible carryover (≤ 1%). Figure  3-4 summarizes the 
desorption recovery of individual lipids using various desorption solutions. Desorption time 
profiles were also prepared by desorbing the coatings into MOH/IPA for different time 
lengths. As the Figure  3-5 indicates, 60 min is the optimum time for highest desorption 
recovery with least carryover on the coatings. 
 
Figure  3-5 Evaluation of the optimized desorption time profile in 1ml MOH/IPA desorption solution 
 
Extraction: An extended extraction time would allow the analytes to reach the equilibrium 
stage improving of SPME potential sensitivity. Hence, optimization of extraction time is 
important in the primary stages of SPME method development. Equilibration times were 
determined by generating a time profile for extraction of each lipid species spiked in PBS 
and plasma individually. Compared with pre-equilibrium SPME, equilibrium sampling offers 
better sensitivity and reproducibility, and both free and total concentrations of analytes are 
easily determined simultaneously. Conversely, increases in sampling time and amount of 
extracted analytes may result in non-negligible depletion and disturbance to the system under 
study, particularly when thin film SPME is utilized.  
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For extraction from plasma, a very long extraction time frame was selected to ensure that 
equilibrium was achieved for all lipid species. The inset graph obtained from PBS indicates 
an optimum extraction time of 90 min. Similarly, in plasma, the required time for all analyte 
lipids to reach the initial equilibration was determined to be also 90 min, in which the 
extraction recovery remains constant up to 180 min, as shown in Figure  3-6. When the 
extraction times were extended more than 180 min, a second plateau was observed for all 
lipid species. Coating biocompatibility was tested several times, and has been reported 
previously elsewhere; 138,144 hence, it is anticipated that this effect is only visible for longer 
lengths of contact between the coating and sample in cases where the analyte is hydrophobic. 
The excessive extraction time was measured to investigate any possible effects of complexity 
of plasma matrix on the diffusion of analytes to the fiber. The aforementioned phenomenon 
can be likely explained by possible changes in lipoprotein composition of plasma as a result 
of degradation in room temperature, which hypothetically results in constant leakage of lipids 
to the plasma matrix. However, no study was performed to further investigate the nature of 
changes, because such a long time span would not be relevant in practice. 
 
Figure  3-6 Extraction time profile obtained for lipid standards using Thin-Film C18 coating. Extraction 
conditions: (3500ng/ml) standards of odd lipids spiked in human plasma 
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It is important to note that at equilibrium, no further extraction of the analyte is expected and 
thus the initial plateau may reflect the presence of intact plasma proteins, and the delayed 
extraction increase some uncharacterized degradation process. As a result, 90 min was 
selected as the optimum extraction time.  
3.3.4 Mass balance and distribution; Investigation of suitability of PBS buffer for free 
concentration determination 
Physiological buffer (PBS) is commonly used as a protein-free environment that can provide 
information about extraction performance. However, for hydrophobic species, PBS might not 
be desirable due to the lack of solubility and the possibility of nonspecific bindings of these 
compounds. In order to verify if a single SPME extraction step is sufficient to determine lipid 
concentration, and to investigate if PBS can serve as an adequate surrogate matrix for such 
applications, a mass balance experiment was performed. Mass balances were established for 
the first and second SPME measurements from PBS solution, as well as the residual fractions 
adsorbed to pipette tips and test vessels due to secondary interactions of lipids with 
plasticwares.  
For less volatile compounds including lipids, the effect of headspace partitioning was shown 
to be insignificant, since their vapor pressures are typically very low; 
257
 accordingly, the 
headspace portion was not considered in further mass balance evaluations. A mixture 
solution of standard lipids in PBS was prepared to make a 100 ng/ml mixture. Using plastic 
pipette tips, 1 ml of this solution was placed individually in each 96-well (n=4 replicates) and 
submitted to the first SPME procedure for 90 min. The used pipette tip was also rinsed using 
1ml desorption solution for 5 push-pull cycles. Subsequently, the same extracted PBS 
solutions were re-extracted with a new set of preconditioned SPME coatings for another 90 
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min and desorbed in 1ml fresh desorption solution. Finally, the PBS were carefully 
discarded, and the used wells were rinsed by agitating 1ml fresh desorption solution for 30 
min. All the obtained solutions were injected to the LC-MS/MS system individually, and 
amounts calculated for each fraction. The mass balance recovered percentages are 
summarized Table  3-3 
Partitioning of lipids in PBS solution indicates a total mass balance of 66–82%. The mass 
balance is obtained when the sum total of analyte amounts distributed in the individual 
phases is equal to the initial amount of the analyte in the system. When the total extraction 
recovery is less than 80%, it can be assumed that the mass balance for those lipids is not 
obtained and thereby the amount of analyte loss is significant enough to potentially affect 
quantification results.
153,257–261
  
 
Table  3-3 Evaluation of Mass balance and total absolute recovery (%) from PBS solution containing 
200ng lipid mixture using SPME extraction under optimized conditions; the total extraction recovery is 
compared to the recovery percentage reported in the literature 
 
1st Ex 2nd Ex 
96-
well 
pipette Total 
Folch  
262
 
Folch 
103
 
BUME 
103
 
Matyash 
262
 
SPE-
Ostro 
FT 
262
 
SPE-
Ostro E 
262
 
SM 62±3 8±2 12±3 ND 82 ± 8 101±5 101±5 97±3 - - - 
CE 63±6 3±1 10±3 ND 76 ±10 91±3 91±3 92±4 98±2 - - 
PG 59±4 4±1 11±3 ND 74 ±8 74±4 84±1 94±6 101±6 82 ± 3 2 ± 4 
PE 54±6 4±1 12±3 ND 70 ± 10 134 ± 14 102±4 97±2 91±5 105 ± 3 11 ±1 
PC 57±5 6±2 10±3 ND 68 ± 10 76±4 92±3 97±3 92±2 0 105 ± 10 
LPC 51±8 7±1 14±3 ND 66 ± 11 85±3 - 88±3 92±2 2 ± 0.4 102±12 
MG 53±6 7±2 12±2 ND 72±10 - - - - - - 
TG 54±10 9±3 14±2 ND 67 ± 10 103±8 - - 86 ±7 47 ± 8 25 ± 6 
 
It is also presumed that due to the initial “overspiking”, the standard lipids may aggregate 
upon addition to PBS and rapidly form vesicular structures of concentric lamella that 
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sediment to the plasticware.
263
 In the PBS solution, aggregation happens due to the absence 
of biologic micellar components such as liposomes and lipoproteins that assist the lipid 
dispersion throughout the bulk of fluid. Therefore, a secondary interaction may lead to 
nonspecific binding and adsorption losses of lipids through their attachment onto the surface 
of plastic wells. This will consequently reduce the available proportion of lipids for SPME 
and cause lower extraction recoveries from PBS. To prevent the undesirable effect of 
adsorption loss in our quantitative evaluation process, further calculations and measurements 
were performed directly from spiked plasma.  
Based on the principles of SPME theory, the amount extracted from a matrix-free 
environment is equal to the total amount due to the absence of binding components. In this 
regard, the reported extraction recoveries of standard lipids from PBS and plasma by various 
extraction techniques are collected from the literature and compared against the results of 
total recoveries by SPME (Table  3-3). All the presented classical techniques including LLE 
and SPE have been already described in sections  1.5.1 and  1.5.2 and their fundamental 
differences are discussed in detail. The percent recovery of SPE using the commercial Ostro 
Flow Through cartridges was reported for zero recovery of PC, while the Ostro Eluate Plate 
has been shown to work well for this compound. A comparison of extraction recovery values 
for the Folch method reveals lower percentage recoveries and significant variations in 
experimental data for some cases. Generally, extraction recoveries for SPME have been 
found to be lower than those of other techniques because SPME is non-exhaustive by nature, 
while all others are exhaustive methods. It is noteworthy to mention that in conventional 
methods, such as LLE, regardless of the secondary interaction, all analytes, including the 
proportion attached to the labware as well as the bound/free portion, are washed out during 
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the adsorption step; thus, secondary interaction of analytes with used equipments do not 
affect the quantitative results. Conversely, in addition to the use of large volumes of toxic 
organic solvents in these laborious processes, none of the classical techniques provide 
fundamental information about analyte distribution and bound/free fractions. As an 
alternative, the SPME approach is sensitive to all changes and points of analyte loss in a 
sample matrix. But when the method is properly optimized and the experimental conditions 
are well controlled this shortcoming could be dispelled. In addition, SPME provides detailed 
information on free and total concentrations of analytes in complex and dynamic systems; in 
classical approaches, this achievement is not an option. 
3.3.5 Matrix free calibration 
Experimentally, matrix-free calibration is performed in a physiological buffer because it 
mimics the ionic strength and pH of the biological fluid, while allowing free analyte 
concentrations to be determined due to free and total concentrations being equal in the 
absence of binding components. In order to determine if adsorption loss influences the 
measurement of lipids in PBS, a matrix-free calibration was performed by extracting the 
lipids at different concentrations from PBS solutions and the obtained linear regression (R
2
) 
and fiber constant (KfsVf) inspected. This procedure is necessary to determine the product of 
KfsVf   as the slope of the linear regression line by performing equilibrium extractions from a 
set of standard solutions with known analyte concentrations prepared in an appropriate 
matrix.  
Multiple point matrix-free calibration was obtained by analyzing PBS solutions at both low 
and high concentration ranges (10-100 and 100-500 ng/mL; n= 3 replicates in each point) 
with the use of the optimized 96-blades SPME system. For the calibration curves in both low 
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and high concentration ranges, the linearity was verified by achieving regressions R
2 0.98. 
This indicates that although nonspecific binding occurs upon addition of lipids to PBS, the 
amount of adsorption loss is proportional to the analyte concentration.  
 
 
Figure  3-7 Example of matrix-free calibration curves obtained in PBS in a) low and b) high concentration 
ranges; the slope of calibration as well as linearity regression of each lipid are displayed beside the plots  
 
This result, in turn, determines that adsorption to the plastic wells plays a minor role in our 
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and aqueous phase. Regardless, the use of correction factor was considered in the 
calculations when constructing the matrix free calibration plot and acceptable linearity was 
achieved. However, the adsorption loss of lipids was noted to occur when extractions were 
performed in unsupported aqueous media such as PBS which does not contain proteins. This 
phenomenon however is not expected where lipids can be immersed and transported by large 
biologic assemblies such as liposomes and lipoproteins of plasma and cells. In these 
biological environments, the availability and interaction of lipids to the bulk fluid and plastic 
surface will be restricted when the matrix is subjected to extraction. 
263,264
 In conclusion, 
matrix-free calibrations (performed in PBS) were corrected according to the mass balance 
percentage recovery, and further analytical assessments as well as matrix-matched 
calibrations were performed directly in plasma to prevent any potential pitfalls and errors. 
Examples of calibration curves of lipids in low and high concentrations extracted from PBS 
buffer are shown in Figure  3-7 
3.3.6 Evaluation of matrix effects  
The quantification of lipids from complex biological environments is challenging due to the 
possibility of matrix effect encounter, especially for the direct infusion approaches. However, 
this concept may mislead scientists if the importance of selecting appropriate sample 
preparation and extraction techniques is overlooked. Therefore, if proper conditions that 
provide clean extract solution for direct infusion to ESI source are employed, the ionization 
suppression/enhancement could be minimized or completely avoided. In lipid analysis, 
matrix effects may be particularly serious, because species (or classes) with minor abundance 
could be easily masked in the presence of more abundant species (or classes). Conversely, 
application of appropriate chromatographic approaches may mitigate matrix effects by 
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providing efficient separation of discrete lipid categories, since they retain in different time 
domains due to their structural difference. However, chromatography still fails to resolve the 
lipid species of the same sub-categories when their co-elution causes saturation of ion source. 
This is particularly significant for phospholipids that belong to discrete sub-categories. For 
instance, ubiquitous PCs or PEs may co-elute with less abundant isobaric PGs, with 
competition for ionization causing signal suppression for PGs.
107,230,239,265,266
 Previous 
research showed that SPME can address such critical concerns in LC–MS approaches for the 
analysis of drugs and metabolites from biological matrices.
146,149,158,174,198,203,255,267–270
 The 
detailed procedure for calculation of absolute matrix effect is already discussed in section 
 2.3.4 and  2.3.5. In this study, blank plasma extracts were spiked with low and high 
concentrations (50 and 500 ng/mL) and peak areas were compared to those of pure standards 
at the same concentration. Table  3-4 summarizes the observed absolute matrix effect for both 
concentration levels for all nine compounds. As the results indicate, no significant matrix 
effects were determined with the use of C18 coatings for all lipids, both in low and high 
concentration ranges. This indicates the effectiveness of a selective extraction mechanism 
and the superiority of the SPME extraction technique in avoiding matrix effects. 
A “sample extract dilution” experiment was also performed following the same detail 
procedure described in section  2.2.5 in order to ensure the absence of matrix effect. Briefly, 
plots of normalized peak areas (peak area multiplied by dilution factor) were constructed 
against the corresponding dilution factor for each analyte under study. If no matrix effect 
were present, the normalized response was similar for all dilution factors (within the 
experimental error). Figure  3-8 illustrates a comparison of maximum dilutions of sample 
extracts obtained from SPME; as can be seen, no matrix effect could be observed. This could 
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be explained firstly as a result of the biocompatibility of the coating, which prevents fouling 
of the coating with proteins and other macromolecules, consequently decreasing the chance 
of ion suppression/enhancement of the analytes by matrix interferences. Secondly, due to the 
non-exhaustive nature of extraction, only a small proportion of whole lipid quantity is 
extracted by SPME and as such, unlike exhaustive extraction approaches such as LLE and 
SPE, no extreme concentration is introduced to the ESI source. Lastly, the washing step after 
extraction is another efficient factor in successful cleaning of interfering compounds from 
coatings, preventing their transfer to the final extracts.  
 
 
Figure  3-8 Matrix effect of SPME method using the sample extract dilution method; for some lipids 
signal was not detected in higher dilution levels. No dilution was required for SPME extracts for any of 
the studied lipids. 
  
In addition, as for all analytical methods, optimizations for effective chromatographic 
separation as well as performance of standard addition calibration are two auxiliary 
approaches that can be applied to compensate for any possible matrix effects. No ion 
suppression/enhancement was observed when extracting lipids by the optimized SPME-LC 
system. A comparison of the results obtained for the two independent matrix effect 
experiments confirms the reliability of the obtained quantitative results for all cases. 
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Table ‎3-4 Evaluation of matrix effect and ionization suppression in two different concentration 
levels 
  MG SM CE PG PE PC LPC TG 
ME % low conc (50ng/ml) 102% 85% 86% 89% 87% 98% 94% 112% 
 High conc (50ng/ml) 94% 104% 100% 91% 107% 101% 104% 88% 
IS % low conc (50ng/ml) -2% 15% 14% 11% 13% 2% 6% -12% 
 High conc (50ng/ml) 6% -4% 0% 9% -7% -1% -4% 12% 
  
3.3.7 Evaluation of non-depletive extraction recovery by sequential SPME extractions  
In order to investigate the non-depletive extraction condition with thin-film, and to determine 
whether a single extraction is suitable to quantify the amount of lipids in biological systems, 
further investigations were required. Therefore, successive SPME extraction was performed 
in human plasma to inspect depletion and identify the extraction response in a real sample 
environment, where all the binding components and complex molecular assemblies exist.  
A series of sequential extractions were performed from the same spiked plasma using fresh 
preconditioned SPME coatings in each step. Spiked plasma samples were prepared at a low 
quality control (QC) concentration. A row of preconditioned C18 blades were immersed in 
1ml spiked plasma (n=5 replicates), and extractions performed for 90 min. After extraction, 
the blades were transferred to a dry and clean 96-plate containing IPA:MOH (1:1), and 
desorption was performed for 60 min. A new row of preconditioned C18 blades were then 
placed in the same plasma and agitated for another 90 min, followed by desorption in a fresh 
set of solutions for 60 min. This sequence was repeated 6 times (6×90min extraction from the 
same 1 ml plasma). This way, the measured amounts of lipids in each step must remain 
constant if the extraction is non-depletive; if extraction concentrations drop, this would 
reflect a situation in the bio-assay where plasma is depleting the analytes. 
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For this purpose, extracted amounts in each step were calculated for the spiked lipids as well 
as natural non-spiked lipids. For instance, for measurements of phosphatidylcholine, an odd 
non-endogenous lipid, standard PC (17:0, 17:0) was spiked to plasma, and extracted amounts 
were monitored in each step for 6 time sequential extractions. Meanwhile, PC (14:0/18:0) 
and PC (18:0/18:0), abundant phospholipids existing naturally in plasma, were 
simultaneously monitored at each extraction step. This approach was similarly employed for 
at least one representative of each lipid class and sub-class based on their standard 
availability. The results are shown in Figure  3-9. 
 
 
 
Figure  3-9 Measured concentrations (n = 3) of consecutive SPME measurements for a) spiked odd lipid 
standards and b) natural non-spiked lipids. The extraction uptake was monitored for the 1
st
, 2
nd
, 3
rd
, 4
th
, 
5
th
 and 6
th
 successive extractions. 
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Considering the vast distribution of lipids in biological macro-structures, a valid analytical 
method must provide accurate quantitative measurement of both, total and free concentration 
of the analytes through a non-depletive extraction condition where the system equilibrium is 
not disturbed, while the integrity of lipoproteins and liposomes remains intact. The suggested 
SPME method provides a maximum percentage recovery of 1% for all lipid species from 
plasma, which is sufficient for sensitive detection while satisfying the non-depletive 
condition. Based on the obtained graphs (Figure  3-9), depletion of both natural and odd lipids 
for a single SPME measurement is below 1%, which is considered negligible.  
Depletion was only observed after 4 successive extractions for both lipid groups, bearing in 
mind that each extraction step was performed for 90 minutes. Spiked odd lipids (17:0) 
demonstrated constant recovery for the first four SPME measurements, followed by a sudden 
significant drop after the 5
th
 extraction; in the 6
th
 measurement, the extracted amount reached 
below method sensitivity. It is important to note, that failure to comply with the non-
depletive condition after 4 subsequent extractions for natural non-spiked lipids is observed 
after an increase in measured concentrations. The extraction of lipids by the thin film C18 
coating in a single step extraction is too small to cause depletion; accordingly, the conditions 
of negligible depletion SPME (nd-SPME) are ensured.
271,272
 Therefore, equilibrium SPME 
coupled to external calibration was chosen for the quantitative analysis of free and total lipid 
concentrations in plasma. Previous reports prove that multiple extractions from one sample 
vial may result in statistically significant analyte depletion.
145
 However, total extraction 
recovery less than 1% in a single step implicates that analyte-sorbent partition coefficient is 
very small and therefore the extraction condition can be considered negligible.  
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Figure  3-10 Extraction recovery after 6 sequential extractions from spiked plasma (3000ng) 
 
Figure  3-10 illustrates the maximum extraction recovery achieved after six successive 
extractions from plasma samples, with extraction duration of 90 min at each step. In the 
highest case, for TG, the extraction recovery reaches no more than 7% after multiple 
extractions. These results are in line with the results obtained for extraction time profiles in 
section  3.3.3 where the recovery of lipids from plasma illustrates the appearance of a second 
plateau after 3 hours of constant extractions from the same plasma and with the use of the 
same coating. In this experiment, an increase in extraction recovery is observed after 4 
extractions of the same plasma (4×90 min), using fresh coatings in each step. Therefore, it 
seems possible that the increased recovery in repeated extraction steps is again related to 
certain changes occurring in plasma as a result of exposure to more than three hours 
experimental conditions (agitation, open vial, prolonged contact with air, etc.).  
3.3.8 High throughput 96-blade SPME system for Plasma Protein Binding (PPB %) 
Due to the hydrophobic nature and poor water solubility of lipids, transportation of these 
compounds is severely restricted in aquatic environments. However, lipid transfer proteins 
(LTP), so-called “lipid chaperones”, are effective transport vehicles that mediate lipid 
0% 
1% 
2% 
3% 
4% 
5% 
6% 
7% 
CE 17 PG 17 LPC 17 TG 17 SM 17 PE 17 PC 17 
Ex
tr
ac
ti
o
n
 r
e
co
ve
ry
 (
%
) 
6th ex 
5th ex 
4th ex 
3rd ex 
2nd ex 
1st ex 
 90 
 
translocation through their connection to the lipoproteins.
273–275
 Lipid transfer proteins (LTP) 
operate both intra- and extracellularly. They deliver lipids to plasma lipoproteins since they 
are able to reversibly and non-covalently interact with lipids, enhance their solubility, 
transport them in the blood stream and facilitate their trafficking through membrane. 
Conversely, apoproteins are distributed among various lipid-protein complex structures and 
form plasma lipoproteins of different density classes.
13,17,21,274
 The interaction and 
transportation sufficiency of apoproteins is directly related to the structure of the individual 
apoprotein and the specific nature of the lipid. As a result of this dynamic exchange and the 
net transfer of lipids between lipid transfer proteins and apolipoproteins, the content of 
plasma lipoproteins is continuously modified during their intravascular metabolism. 
Therefore, availability of lipids is distinctly regulated by the significance of protein affinity 
in a temporal and spatial manner, and can be varied in the presence of other competing 
ligands. The dynamic equilibrium of lipids between various binding compartments of blood 
plasma such as albumin or multiple apoprotein constituents of lipoproteins generates a series 
of lipid fluxes within the blood stream that can be analyzed by advanced separation 
techniques. 
SPME has been reported as an extraction technique that can precisely determine the 
percentage of ligand-protein binding by measuring the total and free concentrations of the 
molecules. The detailed principles and equations of SPME for calculations of free, total, and 
percent ligand-protein binding for variety of drugs and exogenous compounds are already 
reported in the literature.
138,146,151,218,276
 Moreover calculation of FA-protein binding has been 
extensively discussed in section  2.3.6 and  2.3.7 of this thesis. In this section, SPME is 
assessed for the study of lipids in their natural state, and was applied for evaluation of protein 
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binding of lipids under negligible depletion conditions of a 96-blade SPME system. For this 
reason, calibration curves were constructed in spiked PBS at two different concentration 
levels (5-100 and 100-500 ng/mL), as well as in spiked plasma (0.5-8.0 µg/mL) based on 
optimized SPME conditions. The detailed description of calculation of protein binding by 
SPME using the Equation  2-3 and Equation  2-4 is already discussed in section  2.2.7. Briefly, 
the percentage of lipid binding to plasma proteins (PPB) is calculated from the total and free 
concentration of lipids. Lipids in plasma are solubilized and dispersed through their 
association with specific groups of proteins. Most free fatty acids and related structures with 
carboxyl functional groups associate with albumin, whereas the transport and distribution of 
more complex lipids are accomplished by means of plasma lipoproteins. Equation  2-4 was 
applied for the determination of lipid plasma protein binding for the test lipids and results are 
summarized in the Table  3-5 for each lipid category. However, based on these data the 
distribution and affinity of each lipid class to individual carrier proteins and apolipoprotein 
particles of the bloodstream cannot be provided and only total plasma binding is considered. 
Here, total protein binding is equal to the lipid distribution between HSA, LTPs, and various 
apoproteins involved in lipoprotein structure, and can be written as:   
Equation  3-1 
                                          
 
Considering the variety of apoproteins involved in the structure of different lipoproteins, the 
PPB% related to apoproteins can be written as:  
Equation  3-2 
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Figure  3-11 Schematic of different lipid-binding proteins in interaction with lipids in plasma. Binding is a 
complex function of the affinity of proteins to different lipids. 
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Binding is the complex interplay of protein affinity to various lipids. Therefore, percentage 
data were converted into an equivalent logarithm of the apparent affinity constant log K by 
application of formulation derived from the law of mass.
277,278
  
Equation  3-3 
            
    
        
    
 
KA denotes an average of binding affinity to all available lipid transfer proteins under the 
assumption that binding is not exclusively limited to HSA. Log KA is then a binding constant 
that estimates the net complementary properties of the binding adhesions established between 
all available proteins to a given lipid. This approach is also based on the hydrophobic 
subtraction model of binding, since the lipophilicity and logP of lipids play a major role in 
providing binding affinity to proteins, whilst other factors such as electrostatic, charge, and 
hydrogen bond may add their contributions to binding. Thus, the binding affinity (KA) of 
every lipid species is distinct to specific apoproteins associated in the structure of HDL, 
LDL, or VLDL. On the other hands, the association of lipids with lipoprotein particles may 
not follow the law of mass action kinetics since lipids do not occupy well-defined individual 
binding sites on proteins but they merge into protein-coated lipid droplets. The model 
described by Equation  3-3 can be served to develop an original approach for comparison of 
protein selectivity in correlation with lipid attribute. Theoretically, this value could be also 
determined for each protein involved in lipid transportation when SPME is applied to that 
specific protein instead of whole plasma. By far, no concrete guideline is reported to generate 
quantitative information in regards to lipid distribution patterns for specific transfer 
lipoproteins based on binding affinity. Consequently, if the suggested SPME protocol be 
applied to isolated and characterized lipoprotein fractions, this method may be applicable as 
 94 
 
an optional approach for obtaining such information. Further, the proposed protocol could be 
a subject of future studies. 
 
3.3.9 Summary of method performance 
Reliable quantitative analysis necessitates accurate measurement methods for which either 
external or internal calibration techniques are mostly employed. Relative extraction 
recoveries may be significantly influenced by the presence of biological matrix components, 
which may consequently distort SPME quantitative measurements. Therefore, it is important 
to understand the relation between deviations in calibration curve linearity associated with 
measurement errors, and to address them accordingly. Due to the high level of protein 
binding for all lipids, the use of both matrix-free and matrix-matched calibration curves 
provide an advantage for determination of both free and total concentrations using a single 
analytical method. The approaches for calculation of free (unbound) concentrations using 
matrix-free calibration in PBS, as well as mass balance assessment and its related 
corrections, have been discussed earlier in this chapter (section  3.3.4). However, when an 
appropriate blank matrix is unavailable (due to the abundant presence of lipids in plasma), 
the standard addition calibration is acknowledged as the best applicable quantitative method 
that can compensate for variation of measurements in such complex matrices. Therefore, the 
amount of analyte extracted by SPME was individually plotted against known concentrations 
Table  3-5 different plasma lots by solid phase microextraction (SPME) 
Lipids 
SM 
(17:0) 
CE 
(17:0) 
PG 
(17:0) 
LPC 
(17:0) 
PE 
(17:0) 
PC 
(17:0) 
MG 
(17:0) 
TG 
(17:0) 
%PPB 98.0 97.1 98.3 96.6 97.1 96.0 93.6 89.6 
Log K 1.68 1.52 1.75 1.46 1.52 1.38 1.17 0.93 
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of spiked standards in plasma to determine the total and unknown concentrations of lipids. 
Calibrations were performed for both odd (as nonexistent lipids) and even (naturally existent 
lipids) lipids in plasma so as to compare the correlation between the data set obtained from 
each group. The least square linear regression method was used to construct calibration 
curves. For the even lipids, the calibration curves were extrapolated to quantify the unknown 
amounts of each lipid analyte in the pure plasma sample (0 added), whilst the calibration 
curves were forced through the origin for odd lipid standards, since they are not 
endogenously present in plasma. The linear dynamic range was calculated using a non-
weighted linear least square regression fit for both calibrations. As shown in Figure  3-12 a 
good linear relationship was obtained for seven-point calibration (n =3 each point) for all 
lipids. In the present study, the thin-film constant (KfsVf obtained from SPME main 
equasion
147
) as the slope of matrix-free and matrix-matched plots was calculated for PBS and 
plasma individually. These values were used for determination of free and total 
concentrations of lipids in plasma. Moreover, the linear regression coefficient (R
2
), 
sensitivity (curve slope), reproducibility, LOD, LOQ, and dynamic range of the SPME-LC–
MS/MS method were studied as described in section  2.3.8. For each lipid class/subclass, 
comparisons were carried out between extracted amounts of spiked odd standards and those 
of spiked standards with even carbon numbers. For instance, the calibration curves of two 
different molecular phosphatidylcholines, PC (17:0/17:0) and PC (14:0/18:1), were 
monitored at equimolar concentrations with the use of SPME-LC–MS/MS. The linear 
regression and correlation coefficient (R
2
) were subsequently obtained by plotting spiked 
versus extracted amounts at each concentration level, the results of which can be found in 
Table  3-6.  
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Linearity was evaluated by constructing three independent calibration curves in three 
different plasma batches, using independent sets of blades to investigate if the acquired 
calibration equation was reproducible for quantitative analysis of lipids. The results showed 
excellent agreement. For instance, the average slope of three calibration curves in three 
different plasma lots of blood plasma was found to be 0.022833 for PC (14:0/18:1), and 
0.0234 for PC (17:0/17:0), while the linear regression coefficients (r
2
) ranged from 0.987-
0.999, as shown in Figure  3-12. Using this approach, a comparison could be carried out 
between the measured amounts of extracted odd versus even lipid standards of the same 
category. In a similar fashion, for other lipid standards, measurements of odd and even 
species showed a correlation higher than 0.8 (R
2
 ≥0.8) for lipids of the same class/subclass. 
The good agreement between odd and even lipid quantification (in the range of experimental 
error) demonstrates that fatty acid chain length and degree of saturation within the same lipid 
subclass do not create variations in calibration measurements. Accordingly, one universal 
calibration equation per each lipid subclass could be applied for calculation of all lipids of 
the same sub-category, regardless of the differences in their fatty acyl moieties. This is 
illustrated in the example calibration curve obtained for PC from three different plasma lots. 
The linearity data further confirms good overall performance of the SPME method to 
compensate properly for inter- and intra-lot variations by elimination matrix effect issues. 
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Figure  3-12 Human plasma samples (n = 3 lots) were analyzed by SPME-LC-MS/MS; a) example 
calibration curve of class-specific lipid standards for PC (17:0/17:0) and PC (14:0/18:1) at equimolar 
concentration range (500-5000 ng/mL; n=3 each point). Linear regression and correlation coefficient (R
2
) 
are compared; b) Correlation between data obtained for measurement of PCs of different aliphatic 
chains.   
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Table  3-6 Summary of linearity results obtained for C18 coatings in 3 different pooled plasma lots. Each 
point of each calibration set was obtained using different sets of coatings (n=3 determination for each 
concentration level). 
Lipids  Unweighted linear 
regression equation  
Lot-to-lot CV %  Correlation 
coefficient, R2  
LOQ 
(ng/ml) 
linearity 
range (ng/ml)  
LPC (16:0) y=0.3026 (±0.0090)x 5 % 0.9862 (±0.0068) 
0.5 10-500 
LPC (17:0) y=0.0193 (±0.0002)x 1 % 0.9934 (±0.0027) 
    
 
 
MG (18:1) y=0.0369 (±0.0014)x 4% 0.9951 (±0.0010) 
2 20-1000 
MG (17:0) y=0.0377 (±0.0003)x 1% 0.9900 (±0.0080) 
    
 
 
CE (d18:1/18:0) y=0.0226 (±0.0004)x 3 % 0.9797 (±0.0042) 
0.3 5-800 
CE (d18:1/17:0) y=0.0200 (±0.0009)x 5 % 0.9945 (±0.0034) 
    
 
 
SM (d18:1/16:0) y=0.0137 (±0.0007)x 5 % 0.9881 (±0.0020) 
0.5 5-1000 
SM (d18:1/17:0) y=0.0131 (±0.0006)x 5 % 0.9881 (±0.0020) 
    
 
 
PE (16:0/18:2) y=0.0143 (±0.0005)x 1 % 0.9916 (±0.0034) 
0.5 7-1000 
PE (17:0/17:0) y=0.0192 (±0.0001)x 1 % 0.9956 (±0.0015) 
    
 
 
PC (14:0/18:1) y=0.0228 (±0.0005)x 2 % 0.9877(±0.0063) 
1.5 10-1000 
PC (17:0/17:0) y=0.0235 (±0.0003)x 1 % 0.9910(±0.0008) 
    
 
 
PG (18:0/18:0) y=0.0151 (±0.0001)x 1 % 0.9908 (±0.0033) 
1 8-1000 
PG (17:0/17:0)) y=0.0113 (±0.0002)x 2% 0.9884 (±0.0034) 
    
 
 
TG(18:1/16:0/18:1) y=0.3105 (±0.011)x 4 % 0.9955 (±0.0011) 
0.8 12-1500 
TG(17:0/17:0/17:0) y=0.1451 (±0.0026)x 2 % 0.9925 (±0.0022) 
 
The method was linear in the range of 500-8000 ng/mL obtained by extraction of lipids from 
plasma, making it amenable for quantitative monitoring of these lipids. Summary of obtained 
data and calculations are represented in Table  3-6. It should be noted that the upper bound of 
the linear dynamic range reported here is due to limitations of MS detection (detector 
saturation or ESI droplet surface saturation) and not by the SPME procedure itself. This 
means that samples exceeding the upper limit can still be successfully analyzed after 
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appropriate dilution. In addition, the reproducibility of the assay was studied through an 
evaluation of inter- and intra-day RSD, and excellent reproducibility was found for all lots 
with all RSD values ranging from 2-7% for all analytes tested. Meanwhile, the inter- and 
intra-day method precision ranged from 1-12% RSD, both of which meet acceptance criteria 
for quantitative bioanalysis. The obtained results for all compounds (n = 5 coatings) indicate 
proper sensitivity and reproducibility of the SPME-LC–MS/MS method for determination of 
lipids from the complex matrix under study.  
3.3.10 Conclusions and future directions  
In this study, the SPME-LC-MS/MS method was developed for simultaneous quantification 
of the most abundant lipid classes present in plasma and whole blood. The quantitative 
procedure relied upon the use of a set of seven diheptadecanoyl (17:0/17:0) synthetic 
standards based on one-class/one-standard approach for common phospholipids, 
sphingolipids, and glycerolipids classes and their subclasses. Another important approach 
was the use of additives in the aqueous chromatographic elution to improve phospholipid and 
triglyceride peak shapes and retention time stabilities. The SPME methodology produced a 
comprehensive and quantitative description of the complex ensemble of lipid species by the 
direct analysis of total lipid extracts of human plasma. In addition, the developed method 
provided a good degree of recovery, reproducibility, and quantitation for the analysis of the 
compounds under study. The performance of the proposed SPME-LC-MS/MS method was 
found satisfactory for the analysis of lipids in human blood plasma, meeting all regulatory 
requirements codified by the ICH
279
 and IUPAC
280
 guidelines. The obtained results show that 
the LOQ (5 ng/mL) achieved in the current work is satisfactory, while the achieved sample 
throughput is considerably improved due to the parallel nature of extraction In principle, the 
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fact that SPME extracts via free concentration makes it on one hand a limitation because of 
the low recoveries which can lead to sensitivity issues, while it is compensated in cases of 
compounds with high concentrations and high affinities to the extraction phase. Considering 
the high natural concentration of all lipids as one of the most abundant metabolites of plasma, 
this approach is still suitable to meet minimum quantitative requirements. Meanwhile, the 
lower extraction recoveries could be considered as an advantage when considering the results 
of the matrix effect evaluation, which indicates the suitability of this technique for analysis of 
lipids, keeping in mind that lipids have a bad reputation for ion suppression/enhancement in 
ESI approaches. By optimizing the geometry of coatings, the disadvantages of low extraction 
recoveries could be successfully overcome for the SPME approach, which requires no 
evaporation/reconstitution step, unlike other conventional techniques employed for lipid 
analysis. Furthermore, the absence of matrix interferences indicates that the proposed 
biocompatible SPME system can be used for quantitative analysis of lipids in other types of 
biological matrices such as cell lines and tissue through direct immersion extraction without 
the need for any additional pre-treatment of the sample. The method developed here should 
be useful in both research applications and diagnostic routine, taking to account that lipids 
are implicated in multiple biological and pathophysiological processes. 
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Chapter 4 
Discovery Lipidomic of Hepatic Cancer Cells in Response to 
Treatment by a Polyunsaturated Fatty Acid: Eicosapentaenoic Acid  
 
4.1 Introduction 
Hepatocellular carcinoma (HCC) is one of the common types of human cancer with high 
morbidity and mortality; the threat of HCC is expected to continue to grow in the coming 
years. One of the major causative factors in the development of hepatocellular carcinoma is 
the persistent infection of liver with the hepatitis C virus (HCV).
281,282
 Chronic liver 
infections subsequently lead to the accumulation of intracellular lipids (mostly TGs) in the 
liver known as steatosis. The abnormal retention of lipids can lead to more advanced and 
serve disease state call hepatic cirrhosis, which can potentially designate the progression of 
liver carcinogenesis. Thus, developing effective and efficient care for patients with end-stage 
liver disease and HCC must become a significant focus. Changes in lipid constituents alter 
the functionality of cell membrane by changing its fluidity and polarization which leads to 
alteration of their metabolic activity and cell signaling.
283
 For the past few years, lipids, and 
in particular omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), have received 
considerable attention in human health. Epidemiological studies are trying to find evidences 
for possible correlation between PUFA-rich diets and a reduced incidence of cancer. There 
are numerous experimental findings that indicate the effect of ω-3 PUFAs such as 
docosahexaenoic acid (DHA) and eicosapentaenic acid (EPA) in preventing cancer.
284–287
 
These findings could be further examined and validated through “discovery lipidomics”. This 
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new subdivision of lipidomic studies aims to reveal the lipid treasury of a biological system 
in an untargeted fashion Additionally, it aims to investigate the statistically significant 
variations between control and test group data sets, and finally, to explore disease-related 
molecular markers by determining their chemical structure and biosynthesis pathways.
288,289
 
In order to obtain reliable and meaningful answers in lipid discovery experiments, not only 
specialized mass spectrometric techniques are required to facilitate lipid characterization and 
identification, sample preparation strategies are also needed before implementation of the 
instrumental procedure.   
In the previous chapter ( Chapter 3) we described the development and validation of 
quantitative analytical method by employing the Thin Film Microextraction in the 96-well 
plate format for the extraction of lipids. The present study was designed to investigate the 
effect of ω-3 PUFAs on the lipidome profile of HCC cell lines by performing a “discovery 
lipidomics” experiment. Within this project, we aimed to evaluate the strengths and 
weaknesses of our validated SPME protocol in providing a comprehensive profile of 
lipidome changes by comparing the obtained results to that of classical liquid-liquid 
extraction based on Bligh & Dyer approach.  
 
4.2 Experimental  
4.2.1 Cell culture 
Human HCC cell line Huh7 was seeded in six 75cm
2
 flasks (n=3) in DMEM supplemented 
with 10% fetal bovine serum, 2 mM L-glutamine, and penicillin/streptomycin, then incubated 
at 37°C in a humidified CO2 incubator. Twenty four hours after seeding, media was changed 
to serum-free medium for 6hrs; three flasks containing HUH7 cells were then treated with 
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eicosapentanoic acid (EPA) at 0.4mM for 4hrs, while the control set (n=3) was kept 
untreated. Cells were then washed with 1ml of cold phosphate-buffered saline (PBS) twice, 
and scraped off the surface of the flask using a cell scraper in PBS. The cell suspension was 
then spun at 5000×g for 20 min, the supernatant discarded, and the cell pellet flash-frozen in 
liquid nitrogen. The pellets were stored at -80 °C until use. Each cell pellet of biological 
replicates (n=3 control and n=3 treated) contained approximately 8.4 x10
6
 HUH7 cells. Upon 
analysis, samples were thawed at room temperature, and 6ml of cold PBS were added to each 
sample tube, which were gently swirled until complete suspension was achieved. The content 
of each tube was divided into six aliquots of 1ml, from which 2×1ml portions were subjected 
to the lipid extraction based on Bligh & Dyer procedure, and 4×1ml portions were subjected 
to SPME analysis.  
4.2.2 Lipid extraction by Bligh & Dyer protocol 
This study employs two different extraction methods for lipid analysis on HCC cell lines, 
aiming to assess the potential impact of different extractions on current cancer lipid research. 
The standard procedure of lipid extraction was performed according to the Bligh & Dyer 
method, and results were compared against the data obtained from the optimized TF-SPME 
method. For each method, preparation and extraction of cell samples were carried out 
separately. In order to avoid bias, sample preparation was carried in a randomized order for 
biological replicates. For the Bligh & Dyer method, the total lipid fraction was extracted 
from 1ml cell suspension (1.70x10
6
 cells/ml) with the addition of 3.75 ml chloroform/MeOH 
mixture (2:1, v/v), followed by  vigorous shaking. Then, 1.25 ml extra chloroform was added 
to the mixture solution, which was subsequently vortexed for 20 s, followed by addition of 
1.25 ml nanopure water, and swirling for another 1min to form a two-phase system. The 
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lower organic phase contained almost all of the lipids, while the upper aqueous phase 
contained many of the non-lipid compounds as well as polar lipid species. The mixture then 
was settled at room temperature for 10 min to reach equilibration, and centrifuged at 2000 
RPM and 5 °C for 5 min. The organic bottom phase was recovered and transferred to a new 
tube. Subsequently, the chloroform was evaporated under N2 gas to dryness and the sample 
re-suspended in 1 ml IPA/methanol (1:1) for injection to LCMS.  
4.2.3 Preparation of C18-PAN 96-Blade coatings  
For the high-throughput analysis of lipids, coated thin-film SPME blades were exposed to the 
plasma with the use of the manual Concept 96 (Professional Analytical System (PAS) 
Technology, Magdala, Germany). The thin-film SPME blades were prepared in house 
following the same procedure as discussed in section  3.2.3 and a comprehensive description 
of this method is given elsewhere.
136
 In this study, the commercial mixed-mode SPME fibers 
were enclosed beside each pin in the 12 thin-film blade set. This assembly was designed to 
capture other polar metabolites from the same sample on the mixed-mode coatings, while 
lipids are captured by the C18 thin-film coatings. As the mix-mode coating has been 
previously reported as the most effective sorbent for the extraction of a range of highly polar 
to semi-nonpolar metabolites in metabolomic studies,
154,174,290
 this enables any potential 
biomarkers to be tracked and related to probable metabolic pathways, if particular 
biomarkers were to be found. Figure  4-1 shows the arrangement of the 12-thin film set and 
mixed-mode fibers. 
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Figure  4-1 Thin-film C18 blade set/ MixMode SPME fiber assembly for simultaneous extraction of lipids 
and polar metabolites of HuH7 cell sample placed in the same well 
 
4.2.4 SPME procedure  
All SPME coatings were pre-conditioned for 30 min in a mixture of methanol/water (1/1, 
v/v) prior to use in order to activate the silanol groups of the stationary phase. For the SPME 
approach, cells were homogenized by vigorous agitation using the VWR DVX-2500 digital 
vortex (Mississauga, ON, Canada) and incubated for 30 min at 37°C prior to analysis with 
SPME. The SPME experiment was performed by immersing the fiber-blade assembly 
directly into 1 mL sample aliquots, which were then randomly placed in each well of the 96-
well plate and agitated with 2400 rpm vortex agitation for a total extraction time of 90 min. 
Immediately after extraction, coatings were rinsed by dipping the set in purified water for 10 
s to remove any residuals of biological material from the coating surface. Afterwards, blades 
and fibers were disassembled, and rod fibers were placed in individually labelled glass vials 
and preserved in a -80 °C freezer for further investigations if necessary. Subsequently, thin-
film coatings were agitated for 60 minutes in 1 ml IPA/methanol (1:1 v/v) for proper 
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desorption of lipids, and the resulting final extract solutions injected to the HPLC–ESI-
MS/MS system for analysis. The total workflow from sampling to sample preparation is 
presented in Figure  4-2 Schematic of sampling order for SPME and B&D procedure for the 
cell suspension of HuH7; Each replicate tube contained approximately 8.4x106 cells. 
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Figure  4-2 Schematic of sampling order for SPME and B&D procedure for the cell suspension of HuH7; 
Each replicate tube contained approximately 8.4x10
6
 cells 
6 ml PBS 
added to 
each  
 
4×1 ml  
SPME 
Extractions 
2×1 ml 
B&D 
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4.2.5 LC-ESI-MS operating conditions 
Analyses of cell extractions were performed on a LC–MS system consisting of the Accela 
autosampler with a cooled system tray, Accela LC Pumps, and the Exactive Orbitrap mass 
spectrometer (Thermo, San Jose, CA, USA) equipped with a heated electrospray ionization 
(HESI) probe. Sheath gas and auxiliary gas (arbitrary units), spray voltage (V), capillary 
temperature (°C), capillary voltage (V), tube lens voltage (V) and skimmer voltage (V) were 
set to 30, 10, 4000, 350, 50, 100, and 25 for positive ion mode and 55, 30, 3500, 275, -67, -
85 and -24 for negative ion mode, respectively. To maintain a mass accuracy better than 5 
ppm, the Exactive Benchtop Orbitrap was calibrated every 24 hr with a Thermo Scientific 
ESI Calibration Solution consisting of Caffeine (20µg/mL), MRFA (1µg/mL), and Ultramark 
1621 (0.001%) for positive ion mode and a sodium dodecyl sulfate (2.9µg/mL), sodium 
taurocholate (5.4µg/mL), and Ultramark 1621 (0.001%) solution for negative ion mode. 
Samples were analyzed with the use of an XBridge BEH C18, 2.5 μm, 150 mm × 2.1 mm 
column XP (Waters Corp, Milford, MA). A binary solvent system was used for gradient 
elution that consisted of water/acetonitrile (10:90), with 0.1 % acetic acid as mobile phase A 
and isopropyl alcohol as mobile phase B, and 0.15 mM ammonium acetate, for a flow rate of 
200 µl/min. Optimal separation was achieved using the following solvent gradient elution: 
Mobile B starts at 10%, remaining constant until minute 6, then increasing to 60% until 
minute 8, followed by a gradual increase to 70% B until minute 18, then ramping back to 
10% for one minute, followed by four further minutes of column re-equilibration, for a total 
run time of 22 minutes. Quality control (QC) samples were prepared by pooling 10 μL 
aliquots of all sample extracts. Initially, 5 injections of blank and 10 injections of pooled QC 
were run for “system conditioning”. The cell lipidome was profiled by injecting each sample 
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once, in a well-considered randomized order, with periodic injection of blanks, QC, and 
standard lipid mixture throughout the sequence to evaluate system performance. This sample 
sequence yielded a total of 67 injections, each of which was run separately in positive and 
negative modes.  
4.2.6 Data processing 
The msConvertGUI.exe program from ProteoWizard was used to convert raw data output to 
the open .mzXML format.
291
 Data were then further processed with the open source XCMS 
R-package (Scripps Center for Metabolomics, CA, USA) for automated retention time 
correction, peak alignment, and peak integration. Following data processing, ion annotation 
was conducted with the use of the CAMERA R-package (Bioconductor Version 2.10) to 
identify adducts and isotopes through application of optimal parameter settings suggested by 
Patti et al.
292
 After data processing, an exported csv file was generated and converted to a 
Microsoft Excel spreadsheet containing accurate mass and retention time, m/z, and signal 
intensity for each generated molecular feature.  
4.2.7 Data analysis 
The produced datasheet was submitted into the SIMCA-P software 11.0 (Umetrics, Umea, 
Sweden), where statistical data analysis and data visualization were carried out. 
Unsupervised principal component analysis (PCA) was employed to demonstrate general 
clusters and trends among the observations. For validated models, Orthogonal Partial Least 
Squares-Discriminant analysis (OPLS-DA) was performed to establish which variables drive 
the separation. Prior to analysis, Pareto scaling was used on the acquired datasets and 
accurate masses were used as variables. Score plots derived from OPLS-DA and discriminant 
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compounds with absolute VIP (Variable Importance in Projection) values higher than 1.0 
were selected for identification. Feature identification was obtained through a mass-based 
search against three databases: Human Metabolome Database (HMDB), METLIN, and 
LIPID MAPS, with a mass tolerance window of 5 ppm. In order to avoid the possibility of 
false identification, the retention time of the related peak was compared with the partition 
coefficient (log P) of the matching features. 
4.2.8 Data Quality Assurance 
The stability of the chromatographic system throughout the data acquisition phase was first 
examined through the PCA of datasets (biological and QC samples) and confirmed by 
overlapping batches; clear spatial separation was found among different sample classes, 
regardless of the batch injection order and randomization. No instrument failure, indicating a 
decline in sensitivity, RT shifts, or changes in mass accuracy, was observed. The mass 
accuracy was assured by tracking the MS standard calibration every 24 hours.  
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4.3 Results and discussion 
4.3.1 LC-MS method assessment  
Lipids are found in a broad range of physical and chemical diversity, which create variation 
in their physical and chemical characterizations such as logP, charge, and functional group 
structure complexity. This diversity is a result of head group polarity between lipid 
categories, acyl side chain lengths, as well as degree of unsaturation within sub-categories. 
Due to the diverse nature of cell lipidome, both positive and negative ionization modes must 
be employed in the LC/MS profiling methods to achieve comprehensive coverage. Although 
some phospholipid species are ionized in both polarities, they all exhibit a significantly 
higher sensitivity in positive ion mode. In contrast, PI and PS are the only phospholipids that 
solely ionize in negative ion mode. This matter was considered as one of the determinant 
criteria during feature identification when searching the obtained mz ions against online 
databases. The LC/MS method was assessed on the Orbitrap system using lipid standards 
following the same procedure described in section  2.3.1. Our final validated LC/MS method 
is capable of analysing multiple categories of lipids in a single run with improved signal 
intensity and peak shape, while known ionization polarities and adduct preferences 
accommodate to confine the multiple hints for each identified ion. 
Figure  4-3 represents the XIC chromatogram of lipid standards in positive and negative ion 
modes. The same set of odd lipid standards were employed for evaluation of retention time 
and mass intensity. As could be observed, lipids involved in the same sub-category could 
show different retention times due to differences in their fatty acyl chains. Lipid standard 
solution and QC samples were frequently injected during the 24 hour sequence for each ion 
polarity. By placing these QC samples at regular intervals throughout the analytical run, LC-
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MS stability could be assessed, and any variation monitored in terms of relevant analytical 
parameters such as retention time, peak shape, peak intensity, and mass accuracy. 
Meanwhile, randomization of different biological replicates alternated with QCs allowed for 
the detection of systematic variability throughout the LC-MS measurement. 
 
Table  4-1 A breakdown of the lipid classes surveyed in the BIOSTD using the LC-MS system developed 
on orbitrap mass spectrometr 
 
Lipid class 
Ionization polarity 
Positive                       Negative 
Retention time 
region (min) 
Lysophospholipids (Lyso-) [M+H]+ - 2-4 
Phosphoethanolamine (PE) [M+H]+ - 10-12 
phosphocholine (PC) [M+H]+ - 11-13 
phosphoglycerol (PG) [M+H]+ [M-H]
-
 9-11 
Ceramide (CE) [M+H]+ - 12-14 
Sphingomyelin (SM) [M+H]+ - 9-12 
Monoacylglycerol (MG) [M+NH4]+ - 7-9 
Diacylglycerol (DG) [M+NH4]+ - 9-12 
Triacylglycerol (TG) [M+NH4]+ - 13-18 
Cardiolipin (CL) [M+NH4]+ - 15-20 
phosphoserine (PS) - [M-H]
-
 11-13 
phosphoinositol (PI) - [M-H]
-
 9-11 
Fatty acyls (FA) - [M-H]
-
 5-8 
Upon analysis of standards of each lipid class and subclass, the “major adduct preference” with 
higher ionization intensity was determined and represented.  
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 A) Standard Lipids in POSITIVE ion mode 
 
 
 B) Standard Lipids in NEGATIVE ion mode 
 
Figure  4-3 XIC chromatogram of lipid standards in A) positive and B) negative ion mode. Variations in 
retention time are expected for lipids of the same class and sub-class dependent on their structural 
orientation and acyl chain length 
Figure  4-4 shows the total ion chromatograms (TICs) obtained from control samples using 
BD and SPME methods individually in positive and negative ion modes. Evaluation of total 
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ion chromatograms (TICs) highlighted the dramatic changes in the overall chromatogram 
signal intensity when comparing BD versus SPME extraction methods. The TIC intensity for 
Bligh & Dyer (panel B and D) was 2.99× 10
8 
and 2.31× 10
8
 in positive and negative ion 
modes respectively; whereas the TIC intensity for SPME (panel A and C) was nearly one 
order of magnitude lower at 7.88× 10
7
 and 6.81× 10
7
 in positive and negative ion modes. In 
this regard, for XIC specimens, the signal to noise ratio was 30-50 times higher for Bligh & 
Dyer. For instance, the calculated S/N of PE (35:0) with mz ratio of 720.59000 is 1682:1 for 
SPME, while this value for Bligh & Dyer is 58180:1. The observed discrepancy in signal 
intensity is related to the different nature of the two extraction methods. Bligh & Dyer is a 
Liquid-Liquid extraction method that exhaustively extracts all lipid components of cells, 
including bound and free lipid species, whilst SPME is a non-exhaustive extraction method 
that purely extracts lipids in their free (unbound) format. Therefore, as opposed to the Bligh 
& Dyer technique, lipids involved in complex cell structures which are bound to proteins or 
particles of cell membrane remain intact in SPME.  On the other hand, higher extraction 
recoveries in Bligh & Dyer when dealing with biological samples for analysis of lipids is not 
necessarily an advantage, as high concentrations of abundant phospholipids may saturate the 
ESI source and cause ionization suppression or enhancement (this is thoroughly discussed 
later in this report in the matrix effect section). It should be noted that higher signal 
intensities are indeed necessary and considered an advantage when the instrumental 
performance is average. However, the higher signal intensity in Bligh & Dyer is attributed to 
higher concentrations of extracted lipids that may saturate the ESI source and reduce the 
chance of ionization for less competitive species. In the LCMS method used for this research, 
all phospholipids were noted to elute between min 8-13, with retention times of various 
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phospholipid subclasses varying based on their acyl moieties; in such cases, the possibility of 
co-elution, and consequently, saturation of ESI source is still significant. 
All detected lipid species for both SPME and Bligh & Dyer methods demonstrate an S/N 
ratio of at least 26 or greater, well above the assigned limit of detection (LOD) at S/N=3. The 
relative LOD range for extraction of different lipid classes using the proposed SPME method 
was 0.5-1 ng/ml (5-17% RSD, n=5), while for Bligh & Dyer, LOD values were found to be 
between 0.05-0.1 ng/ml. It is important to note that although SPME extracts smaller 
proportions of lipids, it does not substantially compromise the signal-to-noise and dynamic 
range for the detection of low-abundance lipid species. However, application of this method 
may potentially limit the identification of lipids present at trace levels due to its lower 
extraction recovery in comparison to Bligh & Dyer. During analysis, lipid standards showed 
RT coefficients of variance (CV) of less than 0.03% when compared within single ionization 
mode. The integration of XIC peak areas had CVs of less than 2.1% in either ionization 
modes.   
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Figure  4-4 Total ion count (TIC) chromatograms from control HUH7 cell lines obtained by: panels A and 
C) SPME and panels B and D) Bligh & Dyer extraction methods in positive and negative ion modes 
respectively  
A: SPME-Positive 
B: B&D-Positive 
C: SPME-Negative 
D: B&D-Negative 
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4.3.2 Comparison of sample preparation methods for known identified lipids  
Extracted Ion Chromatogram (XIC) of cell samples were compared to the XIC of injected 
authentic lipid standards and both accurate mass and retention time were used to assign the 
identity of these species in unspiked cell samples. Method precision for each sample 
preparation procedure was determined on the basis of five independent extractions of the 
same pooled cell samples. Example results are shown in Figure  4-5. The overall variability of 
SPME was below 18%, which is considered satisfactory for analytical method validation 
criteria. Contrarily, the results obtained for Bligh & Dyer demonstrate poor precision for SM, 
MG and LPCs.  For Bligh & Dyer, an interesting trend was observed, where less 
hydrophobic lipid species with lower LogP values, such as LPC, MG, and SM, not only 
presented higher %RSDs, but were also detected in low signal intensities compared to those 
for SPME. This trend is unexpected, since in general, signal intensities for Bligh & Dyer are 
expected to be much higher than those of SPME due to the exhaustive nature of this method. 
Therefore, not only does the obtained higher deviation demonstrate slightly poor precision of 
the traditional technique for extraction of such compounds, the lower signal intensity could 
be related to the possibility of ionization suppression associated with this technique. This 
issue was investigated further under matrix effect studies. This issue is further examined in 
section  4.3.10. 
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Figure  4-5 Comparison of method precision (expressed as % RSD for n=5 replicates) obtained for Bligh 
& Dyer with methanol/ chloroform and the validated SPME technique using C18 coatings 
 
 
4.3.3 Lipidomics - SPME results versus conventional Bligh & Dyer 
After data processing, analysis of two data sets from the results obtained for SPME indicated 
the presence of a total of 1922 ions in positive mode and 655 ions in negative ion mode, 
while for the Bligh & Dyer method, 1430 ions were detected in positive ion mode and 451 
ion in negative ion mode on average in HCC cell samples for a mass range of 100 to 1200 D. 
It is noteworthy to mention that in an ESI source, a single lipid can give rise to more than one 
ion adduct. These ions may include proton, sodium, potassium, and ammonium adducts; 
considering the multiple-charged ions of each, and also the isotope peaks.
48,293
 Therefore, 
identification and selection of lipids was based on searches for the most probable ion adduct 
for each lipid category, and for the precise identification assurance of at least two adducts at 
the same retention time. This approach was followed for feature identification in section 
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 4.3.6. Ion maps and histograms of the distribution of method precision for all unknown 
features with intensities higher than LOD levels are considered. For this purpose, six 
independent extraction replicates were used for each method to compare the data acquired by 
SPME to those of Bligh & Dyer for evaluation of method performance; the results are shown 
in Figure  4-6 and Figure  4-7. This type of representation is indicative of overall data quality 
for each method. In the perspective of data interpretation, high metabolite coverage is not 
useful when the method precision is poor, as in such cases, biological variability cannot be 
clearly distinguished from analytical variability.  
For the evaluation of method performance, the absence of analytical variability must be 
assured; since acceptable RSD values are 15% for targeted analysis, and 20% for quantitative 
analysis, an RSD value of 30% or less should be of acceptable precision in LC-MS 
lipidomics. 
220
 As observed in the Figure  4-6 and Figure  4-7, the distribution of % RSD for all 
features shows that both extraction methods represent RSDs bellow 30% in positive ion 
mode; in the case of SPME, this value was found to be below 5% for the majority of peaks. 
Moreover, in both cases, most features presented RSD values less than 30% in negative ESI 
mode, with only a small number of features exceeding 30% RSD. These data signify that 
SPME can match and in some cases exceed the accuracy of the data produced by the 
conventional method.   
Analysis of samples using negative ESI mode resulted in a total of 655 and 451 peaks 
observed for SPME and Bligh & Dyer, respectively. The ion maps of both methods 
demonstrate relatively identical coverage of features, yet in general, the metabolite coverage 
in negative ion mode is poor in comparison to coverage obtained for positive ion mode. This 
is attributed to the better ionization efficiency of lipids in positive ESI mode, since most lipid 
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classes and subclasses show a great tendency for ionization in positive ESI polarities, while 
some classes such as glycerolipids solely generate ions in positive ESI mode. In fact, among 
all the lipid classes under study, only PI, PS, and fatty acids were ionized in negative ion 
mode. This is in line with the trends reported for LC/MS method development for lipid 
analysis in section  2.3.1,  3.3.1and  4.3.1. 
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Figure  4-6 (a) Ion map (m/z versus retention time) for HUH7 cell samples extracted by Bligh&Dyer and 
SPME and analyzed using positive ESI-LC-MS method. (b) Number of peaks with given % RSD 
obtained for the two independent data sets. 
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Figure  4-7 (a) Ion map (m/z versus retention time) for HUH7 cell samples extracted by Bligh&Dyer and 
SPME and analyzed using negative ESI-LC-MS method. (b) Number of peaks with given % RSD 
obtained for the two independent data sets.  
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4.3.4 Quality control (QC) Monitoring- assessment of instrumental response robustness 
Quality control samples were prepared by combining aliquots of all samples, and injected 
frequently within the sample set. The results for this QC were used to ensure that no 
systematic drift occurred throughout the entire run time. Plots of signal intensity versus QC 
run order for known identified lipids for which authentic standards were available are shown 
in Figure  4-8. Lipids were selected so as to cover a wide range of signal intensities and the 
entire chromatographic retention times. QC1, QC2, QC3 and QC4 were considered part of 
the preconditioning procedure, and were included to show that the system was adequately 
pre-conditioned. Figure  4-8 shows a linear trend line for all QC injections for known lipids 
observed in the cell samples. The results indicate good performance of the entire LC-MS 
system.  
In addition to targeted monitoring of instrument response during a 24 hour run sequence for 
the selected lipids, QC samples were also used to assess the quality of lipidomics data. This 
was performed by subjecting these QC samples to SIMCA processing into a PCA plot 
together with the entire treated and control cell samples extracted by both Bligh & Dyer and 
SPME. The results of PCA analysis for the current study, including QC samples, are shown 
in Figure  4-9. As can be seen, all QC injections (shown in yellow) cluster tightly together, 
with no evident outliers, which is a good indication of the quality of the data set. This verifies 
that the instrument response was robust throughout the entire sequence and further 
processing and interpretation of the dataset is reliable.  
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Figure  4-8 Instrumental response variability for several QC injections randomized within the run 
sequence for selected compounds (a) CE, MG, and TG (b) SM and PE (c) PC and LPC; compounds with 
different signal intensity ranges are represented in separate charts.  
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4.3.5 Statistical analysis 
In this study, only lipid species whose levels were found to differ significantly between 
treated and control samples were reported. However, there were plenty of lipid features 
extracted by both B&D and SPME methods for which concentration levels were not 
significantly distinguished between groups; as such, these features were not included in the 
OPLS-DA model list. Principal Component Analysis was conducted on data obtained from 
HUH7-cell culture analysis, including control and treated cells extracted by both Bligh & 
Dyer and SPME methods in positive and negative ionization polarities. The purpose of this 
analysis was to evaluate the ability of the detected features to discriminate changes occurring 
between individual samples, and to compare differences between extraction methods. The 
PCA score plots displayed clear separation between different groups of samples. First, three 
components described 75.9% of the obtained variance, with apparent differentiation found 
between Bligh & Dyer and SPME, as shown in Figure  4-9.  
Moreover, Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) models were 
also obtained considering the score plots of the first and second components. Based on the 
OPLS-DA models and statistical analysis, samples were compared between control and 
treated cells. Data were modeled to visualize discrimination between control and treated cells 
using SPME and BD methods separately. The OPLS-DA score plot shows good separation 
between Bligh & Dyer versus SPME as different extraction methods; it also shows clear 
separation between control and treated cells using each method. A list was compiled of all 
the ions that failed to obtain a higher than VIP score of 1 on the score plots, as these ions 
were found to be driving the difference between groups in the OPLS-DA model. Numerous 
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tentatively identified ions were present as multiple adducts. Examples of PCA and OPLS-DA 
plots are illustrated in Figure  4-9 and Figure  4-10, respectively. 
Based on the results obtained from both extraction methods, features that were significantly 
higher in the treated cells led to the identification of a group of linked phosphatidylcholine 
(PC) and phosphatidylethanolamine (PE) with a higher degree of unsaturation in their fatty 
acyl moieties. Moreover, group separation in the OPLS-DA model between the two 
extraction methods revealed different strengths and weakness of each method in analysis of 
lipids, which will be discussed further in this chapter.  
 
Figure  4-9 Score plots of PCA performed on samples of control and treated cells extracted by SPME (red 
and violet dots); and samples of control and treated cells extracted by Bligh & Dyer (blue and green 
dots), QCs (yellow dots) and standard lipids (tiffany blue). Clustering of the QC samples demonstrates 
the repeatability of the analytical system used. X-axis and Y-axis represent the score of the first and 
second principal component, respectively. This plot is run for the pool of ion features unselectively.  
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Figure  4-10 Example OPLS-Da models (right) and representative S-plots (left) in positive mode 
comparing control and treated cell samples by using: 1) SPME (top) and 2) Bligh & Dyer (bottom) 
extraction methods. Green and blue markers in the OPLS-DA models (right panels) represent the 
significant difference between profile of control and treated groups, respectively using both methods; 
each green dot on the S-plots (left panels) represents an ion feature that was detected. The green dots 
inside red boxes were the ions that drive group separation and screened for further identification  
 
 
 
 
 
 
 
 
 
 
 
 
1) SPME 
2) B&D 
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4.3.6 Feature Identification 
A simple search of the Metlin and HMDB MS databases normally suggests multiple isobaric 
lipids for a single specific m/z ratio. A key criterion for narrowing down the selection is 
chromatographic retention time. As an example for the feature identification procedure, one 
of the recognized ion features which were significantly different in the OPLS-DA model 
between groups are illustrated with their XIC chromatograms (Figure  4-11) and the logistics 
for limiting the search is explained for this feature. For instance, a search through Metlin and 
HMDB presented numerous choices for different isobaric species for the ion feature with 
m/z=780.55338. However, this feature retained at 11.40 min, a retention time that falls into 
the region where the majority of the phospholipid species are found.  
Notably, lipids originally elute based on their hydrophobicity (LogP) and related acyl chain 
groups. Within the same lipid sub-group, retention time increases with acyl chain length and 
degree of saturation. Therefore, the retention time obtained for an mz value of 780.55338 that 
elute at min 11.40 could not possibly be a triglyceride, since all TG species elute after 13 
min. However, the suggested adduct ions should still be taken into consideration. Some of 
the feature hints identify PC and PE species for [M+ACN+H] or [M+NH4]. Based on our 
developed LCMS method, phospholipids solely produce [M+H]
+
 ions in high intensities. 
This property eliminates the majority of the remaining alternatives and further refines the list. 
Since the accuracy of the mass spectrometry was strictly monitored, and the instrument 
frequently calibrated, a maximum ion tolerance on 5ppm could be confidently selected, 
which helped to remove plenty of hint results. For example, when searching for structures 
that corresponded to the unknown ion mass of 780.55338 obtained in positive ion mode, 
features within 0-5 ppm accuracy of the exact mass determined isobaric phospholipids that 
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included 25 isomeric PC (36:5) species and 6 isomeric PE (39:5) species. The presence of 
isobaric species that are ions with the same mass and have different acyl compositions but 
the same nominal mass of 780.55338 (i.e 20:5/16:0 PC and 20:5/19:0 PE), will give us the 
likelihood of both PE and PC phospholipid species. Meanwhile, the presence of isomeric 
species that have the same chemical formula and belong to the same phospholipid sub-
category, but still have different FA localizations; create multiple hits in feature 
identification; (i.e. 20:5/16:0 PC and 20:4/16:1 PC). Owing to the fact that EPA (20:5) was 
used as the treating agent, it is expected that the up-regulated phospholipids, glycerolipids 
and sphinomilynes are more likely to form isomeric species with at least one FA moiety of 
EPA.  For instance, among the possible isomeric moieties associated to ion mz of 780.55338, 
the PC (20:5/16:0) is more likely than the PC (20:4/16:1) or PC (18:3/18:2) and such. To be 
clear, the aim here is to distinguish between lipid classes (PC, PE, and TG) based on 
retention times, and to narrow down the choices within each class based on mass. However, 
multiple isomers within each class cannot be discriminated; such further differentiation 
would require either MS/MS or MS
n
 instruments. In addition, for reassurance, the related 
peaks were inspected in the XIC chromatograms. One of the significant discriminative 
metabolites between control and treated HUH7 cell samples was found to be the peak with an 
mz ion of 962.72301, detected by both SPME and BD methods in positive ion mode. The 
XIC of this ion is specified in the Figure  4-11 for the individual samples using both Bligh & 
Dyer and SPME methods. 
  
Mz Rt Metabolite hint Δppm # of hints Lipid class 
962.72301 13.32 TG (60:15) 0 2 Glycerolipid 
 
 
 
Figure  4-11 Example XIC chromatograms illustrates the ion 962.72301 in control vs. treated groups using SPME and 
B&D. The chromatograms clearly confirm the changes of this species which were not detectable in the control HUH7 
cells cultured in normal condition. However, when the same cells were cultured while supplemented with EPA, this 
metabolite increased greatly and created a significant discrimination between cell groups in statistical analysis. 
SPME-Cont 
SPME-Treat 
BD-Cont 
BD-Treat 
Blank 
  
4.3.7 Comparison of extraction efficiency of two methods for the group coverage 
The performance of the Bligh & Dyer method versus SPME methods for extraction of various 
lipid groups was compared, and the results of these studies are summarized in Figure  4-12. 
Several trends are easily apparent. Bligh & Dyer exhibit weak performance for the extraction 
of low abundant phospholipids such as LysoPCs and PGs which may be related to ESI 
saturation. The results of the matrix effect evaluation for the two methods supported the 
current findings by evaluation of ionization suppression/enhancement for LysoPCs and PGs, 
which can be found in section  4.3.10. In addition, the recognition of subspecies of the 
Sphingolipid class wich contains ceramides and sphingomyelins suggest the superiority of the 
SPME technique in the extraction of these lipids. On the other hand, the Bligh & Dyer method 
had a distinct advantage for covering a larger number and diversity of high-abundant 
membrane phospholipids such as PC and PE. The amount of extracted total lipids is highly 
dependent on the solvent mixture used in solvent-based extraction methods. Given the high 
efficiency of chloroform and methanol as extracting solvents in B&D, it is not surprising that 
more coverage of membrane phospholipids was observed. This is due to the function of 
methanol in releasing lipids from their protein-lipid complexes, followed by their complete 
dissolution in chloroform.
39,107,294
 In SPME technique, the sample matrix remains undisturbed 
and it could be considered as a shortcoming for the extraction of membrane lipids. Both 
methods performed similarly in the extraction of triglycerides, although SPME worked better 
the extraction of less abundant glycerolipids, including Monoacylglycerols and 
Diacylglycerols.   
Figure  4-12 shows in more detail the performance of the selected methods for coverage of 
various lipids. The results implicate that SPME could be a better choice for lipidomics in 
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regards to better coverage between groups of various lipid categories. Conversely, Bligh & 
Dyer was shown to be highly efficient in the lipidomic study within class-specific lipids of the 
same (sub) category such as PC or PEs. By and large, a comparison of the obtained results 
makes it clear that most lipids identified by Bligh & Dyer were also confirmed by the 
suggested SPME approach. 
 
 
Figure  4-12 Comparison of extraction efficiency of a) Bligh & Dyer and b) SPME in covering a broad 
range of class-specific lipids. 
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group of treated cells, the Bligh & Dyer method yielded a final list of 31 features in positive 
ion mode and 16 features in negative ion mode, while for the SPME method 39 features were 
identified in positive ion mode, and 24 features in negative ion mode. Relative quantification 
was performed by reporting fold changes between control and treated cells for each feature 
with significant up/down-regulation. For the given lipids, the obtained P-values were 
calculated using an unpaired t-test comparison of group means for each ion that yielded P-
values between 8.90×10
-3
 to 1.06×10
-25
. Table  4-2 and Table  4-3 summarizes the tentative 
identification of top lipids found in positive and negative ESI modes, respectively, using both 
SPME and Bligh & Dyer methods. Features that contributed to the differentiation of samples 
are listed according to their significant up-regulation as a result of cell treatment with EPA. 
The similarity of the obtained list of lipid ions by Bligh & Dyer and that of SPME indicates 
that these two extraction methods are closely comparable. Although the most dominant 
species were the same in both lists obtained by Bligh & Dyer and SPME, clear differences 
were apparent in the less abundant components. Through application of the SPME method, a 
distinct pattern of diversity between lipid categories and sub-categories could be observed. 
For instance, less abundant phospholipid species such as LysoPC, LysoPE, PS, PG, DG, and 
CE were detected by SPME, while these features were apparently overlooked with the use of 
the Bligh & Dyer method. On the other hand, the Bligh & Dyer was shown to be more 
efficient for the detection of triglycerides and membrane phospholipids. Furthermore, 
according to our results, application of either method allowed for identification of lipids that 
emerged as significantly different between the control and treated groups, competently 
representing sharp distinction of unsaturation and elongation in their fatty acyls chains.  
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Theoretically, phosphoglycerides, together with sterols and sphingolipids, represent the major 
structural components of biological membranes. Based on the current results, diversity of TGs 
with higher degree of unsaturation was clearly detected in the treated cells using both 
extraction methods. This observation could also be explained by the fact that triacylglycerides 
provide a reservoir of fatty acids that can be mobilized for energy generation through the 
action of a series of lipases.
295
 In this regard, it is possible that enhanced storage of 
triacylglycerides could be beneficial for cancer cells, as they may be used as a readily 
available fuel source after re-oxygenation. It has been previously reported that the cells 
supplemented with omega-3 fatty acids significantly accumulate PUFAs in triglyceride form 
in their cytoplasm, which can be seen as lipid droplets.
284,296
 Enhanced lipid peroxidation, in 
turn, results in accumulation of toxic lipid peroxide products in cells that eventually cause cell 
death. However, in spite of evidence revealing the tumoricidal action of various PUFAs, their 
exact mechanism(s) of action is still not clearly understood.
108,286,296–298
 To this extent, our 
findings, taken together with other works, support the necessity of more profound 
investigations on the potential pathophysiological roles of this class of lipids on cancer cell 
metabolism. The identified lipids that were located away from the S-plot centre were the most 
discriminant features involved in differentiation of analyzed samples, and are identified and 
listed in Table  4-2. Relative quantification was performed by reporting fold changes between 
control and treated cells for each feature with significant up/down-regulation. Figure  4-13 
illustrates the level of difference between controls and treated groups using each extraction 
method. 
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Table  4-2 List of upregulated lipids with use of SPME and Bligh & dyer methods - positive mode; the 
input mz is the extracted mz ions by R program and the exact mass is the mass of lipid feature reported in 
Lipid Map Database and Metlin Database  
 Up-regulated- Positive 
  Fold Change 
 
Input mz Exact mz 
RT 
(min) 
Metabolite 
# of 
hits 
Class 
SPME B&D 
1 780.55338 780.5538 11.41 PC (36:5) or PE (39:5) 33 Phospholipid 56 23 
2 806.56897 806.5694 11.36 PC (38:6) or PE (41:6) 37 Phospholipid 41 8 
3 990.75424 990.7545 13.80 TG (62:15) 6 Glycerolipid 2566 291 
4 268.99826 - 1.88 Unidentified - - 5 ND 
5 146.01881 - 1.86 Unidentified - - 2 ND 
6 522.35518 522.3554 3.59 LPC(18:1) 20 Phospholipid 10 ND 
7 949.72522 949.7280 16.08 TG (60:13) 14 Glycerolipid 3383 119 
8 807.57242 807.5647 11.36 PE (40:7)  22 Phospholipid 43 8 
9 854.56918 854.5694 10.71 PC (42:10) 9 Phospholipid 4653 64 
10 834.60018 834.6007 11.72 PC (40:6) or PE (43:6) 30 Phospholipid 9 5 
11 337.10448 337.1070 2.17 Isopsoralidin 1 Polyketide 6 ND 
12 962.72301 962.7232 13.32 TG (60:15) 2 Glycerolipid 3763 353 
13 802.53533 802.5381 11.41 PC (38:8) 8 Phospholipid 56 28 
14 778.53784 778.5381 10.87 PC (36:6) or PE (39:6) 28 Phospholipid 44 18 
15 1018.78551 1018.7858 14.33 TG (64:15) 6 Glycerolipid 2822 299 
16 808.58482 808.5851 11.79 PC (38:5) or PE (41:5) 36 Phospholipid 2 8 
17 703.57479 703.5749 12.36 PE-Cer(37:1) or SM(34:1) 6 Sphingolipid 11 ND 
18 766.57443 766.5745 11.79 PC (36:4) 18 Phospholipid 40 30 
19 752.52239 752.5225 10.88 PE (37:5) PC(34:5) 23 Phospholipid 2 103 
20 856.58486 856.5851 11.07 PC (42:9) 14 Phospholipid 116 67 
21 942.75437 942.7545 15.26 TG (58:11) 28 Glycerolipid 3398 251 
22 916.73863 916.7389 15.41 TG (56:10) 26 Glycerolipid 3939 220 
23 764.55849 764.5589 11.64 PC (36:5)  6 Phospholipid 96 26 
24 921.69405 921.6967 15.41 TG (58:13) 8 Glycerolipid 2989 111 
25 764.52227 764.5225 11.46 PE (38:6) or PC (35:6) 31 Phospholipid 21 10 
26 970.78556 970.7858 15.91 TG (60:11) 30 Glycerolipid 2165 175 
27 944.76997 994.7702 16.08 TG (58:10) 38 Glycerolipid 786 188 
28 882.60059 882.6007 11.05 PC (44:10) 6 Phospholipid 1799 214 
29 804.55328 804.5538 10.92 PC (36:4) PE (39:4) 21 Phospholipid 112 4 
30 768.55314 768.5538 12:59 PE (38:4) or PC (35:4) 51 Phospholipid 2 1 
31 738.50655 738.5068 11.51 PE (36:5) or PC (33:5) 24 Phospholipid 29 21 
32 832.58469 832.5851 11:25 PC (40:7)  23 Phospholipid 17 4 
33 792.58985 792.5902 11.71 PC (38:5) 19 Phospholipid 59 19 
34 922.69748 922.7045 15.41 TG (58:10) 1 Glycerolipid 59 19 
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35 794.56952 794.5694 12.48 PE (40:5) or PC (37:5) 40 Phospholipid 4 3 
36 750.54250 750.5432 12.16 PE (38:5) 15 Phospholipid 5 3 
37 828.55350 828.5538 10.73 PC (40:9) 12 Phospholipid 295 96 
38 480.30832 480.3085 3.83 Lyso PE (18:1) 3 Phospholipid 5 ND 
39 721.50641 721.5014 13.39 PG (32:1) 14 Phospholipid 5 ND 
 
 
 
Table  4-3 List of upregulated lipids obtained with use of SPME and Bligh & dyer methods- negative mode 
Up-regulated-Negative  
 
Input mz Exact mz 
RT 
(min)  
Metabolite 
# of 
hits 
Class SPME B&D 
1 301.21768 301.2173 3.23 EPA (20:5) 13 Fatty acid 356 219 
2 283.26453 283.2643 9.34 Stearic Acid (18:0) 25 Fatty acid 4 1 
3 255.23317 255.2330 5.85 Palmitic acid (14:0) 32 Fatty acid 6 1 
4 329.24916 329.2486 4.15 DPA (22:5) 8 Fatty acid 28 28 
5 331.26493 331.2643 5.41 Adrenic acid (22:4) 12 Fatty acid 13 1 
6 281.24898 281.2486 6.19 Oleic acid, FA (18:1 69 Fatty acid 11 1 
7 303.23346 303.2330 4.02 Arachidonic acid (20:4) 67 Fatty acid 4 1 
8 311.29630 311.2956 10.86 Fatty ester (20:0) 26 Fatty acid 5 1 
9 279.23341 279.2330 4.48 Lineolic acid (18:2) 168 Fatty acid 4 1 
10 253.21765 253.2173 4.21 palmitoleic acid (14:1) 65 Fatty acid 5 ND 
11 818.59427 818.5917 12.72 PS (38:1) 7 Phospholipid 4 1 
12 883.53685 883.5342 10.97 PI (38:5) 28 Phospholipid 3 3 
13 885.55254 885.5499 11.35 PI (38:4) 24 Phospholipid 8 ND 
14 892.61004 892.6073 11.72 PS (44:5) 2 Phospholipid 9 7 
15 866.59438 866.5917 11.79 PS (42:4) 8 Phospholipid 5 ND 
16 894.62626 894.6230 12.37 PS (44:4) 3 Phospholipid 3 ND 
17 749.53427 794.5338 12.16 PG (34:0) 11 Phospholipid 6 ND 
18 875.58528 875.5808 12.82 PG (44:7) 2 Phospholipid 9 ND 
19 838.56301 838.5604 11.41 PS (40:4) 14 Phospholipid 48 36 
20 804.61491 804.6124 13.28 PS (38:0) 3 Phospholipid 5 5 
21 793.56064 793.5753 12.49 PA (43:4) 2 Phospholipid 8 ND 
22 761.58353 761.5702 12.37 PG (36:0) 6 Phospholipid 10 ND 
23 844.60968 844.6073 12.61 PS (40:1) 8 Phospholipid 7 1 
24 886.55604 886.5604 11.35 PS (44:8) 3 Phospholipid 6 2 
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Figure  4-13 Comparison between control and treated cells which illustrate the significant increase in the 
level of the above listed lipid species with application of a) Bligh & Dyer and b) SPME extraction 
technique
  
4.3.9 Control vs. Treated Cells - Down-regulated lipids 
By considering the lipid species, which were statistically down-regulated in the treated cells, 
both methods presented a list of 19 features in positive ion mode. These features were mostly 
groups of phospholipids with saturated and short hydrocarbon chains that were significantly 
higher in the control group and down-regulated in the treated cells as a result of treatment 
with the polyunsaturated fatty acid (EPA). Table  4-4 summarizes the tentative identification of 
important down-regulated lipids found in positive ESI modes using both SPME and Bligh & 
Dyer methods. Features that contributed to the differentiation of samples are listed according 
to their degree of down-regulation as a result of cell treatment. Based on the list, it could be 
clearly observed that all down-regulated lipid species were more saturated in control cells vs. 
treated cells. It also clearly shows that the control cancer cells produced phospholipids and 
glycerolipids with shorter fatty acyl moieties. In negative ion mode, although ions could be 
observed on the S-plot, none of these ions were achieving higher than VIP 1 on the score plots 
to drive the difference between groups in the OPLS-DA model.  
 
Table  4-4  List of down-regulated lipids obtained with use of SPME and Bligh & dyer - positive mode 
 Down-regulated - Positive 
 
Input mz Exact mz RT (min) Metabolite 
# of 
hits 
Class SPME B&D 
1 786.60055 786.6007 12.60 PC (36:2) or PE (39:2) 82 Phospholipid 2 10 
2 760.58459 760.5861 12.71 PE (37:1) or PC (34:1) 47 Phospholipid ND 5 
3 788.61603 788.6164 13.46 PC (36:1) or PE (39:1) 55 Phospholipid ND 3 
4 782.56924 782.5694 11.85 PC (36:4) or PE (39:4) 60 Phospholipid ND 8 
5 678.50661 678.5068 11.48 PC (28:0) or PE (31:0) 32 Phospholipid ND 4 
6 758.56889 758.5694 12.07 PE (37:1) or PC (34:1) 68 Phospholipid ND 6 
7 732.55333 732.5538 12.06 PE (35:1) or PC (32:1) 40 Phospholipid 5 5 
8 794.72296 794.7232 18.98 TG (46:1) 28 Glycerolipid 4 3 
9 822.75435 822.7545 20.23 TG (48:1) 60 Glycerolipid 3 2 
10 617.51151 617.5140 13.87 DG (34:1)  14 Glycerolipid 5 ND 
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11 468.30841 468.3085 2.83 LysoPC (14:0) 1 Phospholipid 3 ND 
12 627.53450 627.4983 11.34 DG (37:6) 4 Glycerolipid 3 3 
13 730.53777 730.5381 11:49 PE (35:2) or PC (32:2) 32 Phospholipid 3 9 
14 761.58805 761.5691 12.71 PG (20:3) 5 Phospholipid 5 ND 
15 772.58445 772.5851 12.27 PC (35:2) 56 Phospholipid 2 9 
16 704.52201 704.5225 11.44 PE (33:1) or PC (30:1) 29 Phospholipid 3 3 
17 1279.35114  17.47 Unidentified - - 3 ND 
18 1205.33235  16.69 Unidentified - - 3 ND 
19 687.19942  12.58 Unidentified - - 21 3 
 
 
 
Figure  4-14 The two graphs illustrate the significant decrease of the above listed lipids in the treated cells 
extracted by top) Bligh & Dyer and bottom) SPME method.
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Figure  4-15 Score plots of PCA performed on the lipid features of most significant difference listed in 
Table  4-2, Table  4-3 and Table  4-4. Plot illustrates a clear separation between BD-control and SPME-
control, BD-Treat and SPME-Treat. The x-axes and y-axes represent the score of the first and second 
principal component contributing 72.6% and 20.3% variances, respectively. 
 
 
Figure  4-14 illustrates the level of difference between control and treated groups using each 
extraction method. The PCA score plots displayed clear separation between different groups 
of samples. 
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Figure  4-16 Example Box-whisker plots representing four potential lipid candidates with lowest p values 
between the control and treated cell groups: m/z 780.55338 for PC (20:5/16:0) or PE (20:5/19:0); mz 
916.738626 for TG (20:5/20:5/16:0), m/z 838.56301 for PS (22:4/18:0) and m/z 329.24916 for 
docosapentaenoic acid (22:5). 
 
Representative box-whisker plots for some of the ion features are shown in Figure  4-16 and 
indicate the individual discrimination power between controls and treated cells using each 
method. 
In cancer biology, massive amounts of lipids are required as building blocks of cell 
membranes in order to promote the high proliferation of tumor cells. To achieve this, special 
modifications occur in the lipid composition of cancer cells that distort the cellular adhesion 
properties and cause resistance to apoptosis. The importance of membrane synthesis in cancer 
cells has been highlighted by the excessive expression and activity of some enzymes that are 
involved in the synthesis of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
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(the major phospholipids of cellular membranes).
299,300
 As mammalian cells are inefficient in 
synthesizing polyunsaturated fatty acids because of Δ3-desaturase enzyme deficiency, a high 
rate of de novo lipid synthesis in tumors elevates the relative amount of saturated and 
monounsaturated fatty acids. To support this hypothesis, the same group of lipids (containing 
short chain saturated fatty acyls) were detected more abundantly in the control cells and were 
diminished as a result of treatment with a highly unsaturated long chain fatty acid. This may 
lead to production of lipid species with longer aliphatic chains and multiple double bonds in 
their structure. Relying solely on the obtained data, a conclusion cannot be made that 
increased levels of polyunsaturated lipids (including those phosphatidylcholines and 
phosphatidylethanolamines) in treated cells could directly cause lipotoxicity and cell 
apoptosis. However, recently published research suggests that plasma membranes containing 
abundant quantities of polyunsaturated phospholipids are more prone to deformation and 
fission.
301
 Accordingly, in addition to suggesting that these lipids may induce modification in 
cell metabolism and morphology, our data also supports the necessity of further 
chemotaxonomical investigations in this arena. 
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4.3.10 Matrix effect evaluation 
Among all analytical methods employed for lipid analysis, LC-MS is the most commonly 
used technique for sensitive detection of a variety of lipids in biological matrices. However, 
phospholipids among all lipid categories may cause ionization suppression due to their high 
biological abundance, which results in suboptimal ionization of low-abundant lipid species. 
A matrix effect occurs when matrix molecules co-elute with the analyte of interest, 
competing for available charges, and consequently diminishing the ionization efficiency of 
the ESI interface. Absolute matrix effect was assessed using the post extraction spike method 
described by Matuszewski.
209
 As described in Equation  2-1, a calculation of matrix effect can 
be performed by relating the peak area of lipid standards in neat solvent to the peak area of 
the same lipid standards spiked in a matrix extract sample.  
 
 
Figure  4-17 Evaluation of ionization suppression involved in the extraction of cell samples 
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IS mvalues larger than 120% and smaller than 80% represent significant ionization 
enhancement or suppression for a given analyte. In the Bligh & Dyer samples, signal 
suppression was observed for PG, CE, and LysoPC, while PE and PC indicated significant 
ionization enhancement. However, In SPME samples, neither of the lipid species 
demonstrated a notable matrix effect (Figure 10). This confirms the overall quality of the 
SPME method in regards to the reliability of the collected data. 
4.4 Conclusion 
Previous research has indicated that when tumor cells are supplemented with PUFAs, a 
modification in their phospholipid fraction occurs.
286,302
 This modification alters the lipid 
metabolism pattern, consequently interrupting the lipid bilayer membrane, changing the cell 
morphology, and suppressing cell growth. The current study considered these findings to 
investigate lipidome alterations in treated cells while comparing the proposed SPME method 
to conventional LLE methodology based on the Bligh & Dyer protocol. The use of SPME 
yielded a list of 77 lipid species that were found to fifer significantly between control and 
treated cells, from which 63 lipids were up-regulated in treated cells. This list is nearly 
identical to the peer list obtained by the BD method. However, more diversity of lipid classes 
and subclasses such as LPC, ceramides, and prenol lipids were observed using SPME. 
Furthermore, in a comparison between control and treated cells, no single lipid was found to 
be significantly up-regulated or down-regulated to be determined as a potential biomarker; 
rather, a pattern of modifications emerged in the HCC cell lipidome profile, which clearly 
distinguished the control group from the cells supplemented with eicosapentaenoic acid 
(EPA).  
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Treated cell samples showed significant changes in the structure of lipids, primarily 
membrane lipids, including elongated triglycerides and sphingomyelins, both of whose fatty 
acyl moieties acquired a higher degree of unsaturation. Neither of the previously published 
studies investigated the modification of the whole lipidome profile of cancer cells when 
exposed to polyunsaturated fatty acids, mainly focusing on the effect of PUFAs on cell 
proliferation and metabolism pathways. 
286,303,304
 In other work, it has been reported that 
cancer cells supplemented by EPA demonstrate morphological features of cell death 
characterized by cell shrinkage and detachment. This phenomenon could be explained 
according to the results of the present study, in that the significantly increased number of 
polyunsaturated phospholipids prevents orderly collocation and tight packing of these 
molecules into a neat lipid bilayer assembly, thus facilitating membrane deformation. 
301
 
Moreover, a comparison of the SPME method with the Bligh and Dyer solvent extraction 
technique indicated the absence of a matrix effect (ionization enhancement/suppression) for 
all lipid classes for SPME applications. This constitutes an advantage of SPME method not 
only for isolation of lipid analytes from intrusive macromolecules, but also on prevention of 
the suppressive effect of highly abundant lipids in the ESI source on lipid species with lower 
abundance. The observed lipidome differences in our study were relatively considerable 
between the two groups of control and treated cells, yet the differences between the two 
applied techniques can be considered trivial for effective extraction of lipid components  
The data presented within this paper supports the use of SPME in lipidomic studies of cell 
line. In comparison to Bligh & Dyer, SPME provided more comprehensive simultaneous 
coverage of less hydrophobic lipid species with lower abundance, while Bligh & Dyer 
performed well for the coverage of PC and PE as membrane phospholipids species with 
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diversity in their aliphatic chain. The strength of our study is in the use of the validated 
SPME method coupled with the LC–MS platform; the proposed protocol is simple, does not 
require any sample pre-treatment, provides excellent clean-up, and prevents matrix effects, 
which is one of the main drawbacks of standard procedures. Therefore, this method could be 
successfully used as an alternative approach for sample preparation and sample clean-up in 
lipidomic studies. The presented study was a first approach to establish improved alteration 
in lipidomics studies of cell lines, which may now be followed-up in an extensive cohort of 
HCC tumors or any other tumor tissue.  
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Chapter 5 
Summary and future directions 
 
5.1 Summary  
Recent advancements in modern MS-based analytical technologies have allowed for the 
creation of a wealth of information in metabolomics and lipidomics studies. The created 
information should meet requirements of reliability, consistency, and authenticity, all of 
which are challenging to achieve due to the complexity of the “omic” workflow across 
multiple platforms. Also, the presence of high indulgence metabolite, peptide, and protein 
backgrounds makes target discrimination difficult.  
It has been long established that the extended process of sample preparation with multiple 
steps involved can increase the risk of errors and pitfalls in the obtained results, since each 
step is susceptible to experimental artifacts. In this process, selectivity and sample clean-up 
can be challenged during sample handling, and consequently influence the diversity and 
integrity of the captured lipidome. Nonetheless, in spite of the growing rate of universal 
interest in clinical studies and biomarker discovery, none of the currently available sample 
preparation methods have been truly modified and developed to acquire the desired 
competency for in vivo, ex vivo, and in vitro lipidomics with no demand of additional steps. 
This thesis covers a collection of analytical method developments for in vivo and in vitro 
lipid analysis using multipurpose SPME approaches in complex biological matrices; from 
sampling and sample preparation, use of fiber and thin film coatings, to separation with RP-
LC and detection by ESI/MS or tandem MS/MS. The presented work shows that modern 
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sample preparation approaches based on SPME can provide new insights in lipid analysis 
from complex biological samples. 
In this context, SPME has been fulfilling remarkable transformations in availability, 
throughput, configuration, application flexibility, as well as compatibility with 
groundbreaking advancements in analytical instrumentation. This technique was initially 
developed for GC applications, but to-date it is routinely employed in combination with other 
analytical platforms such as LC, electrophoresis, NMR, and mass spectrometry. The most 
dramatic advancement of SPME is in particular the feasibility of this technique for in vivo 
clinical studies; by extracting directly from living organisms for in vivo analysis, the 
necessity of a quenching step is completely excluded from the total workflow, while the 
captured lipids are the exact snapshot of the metabolic state at the time of sampling. In 
addition, various headspace SPME platforms in combination with GC-MS and GC × GC 
systems were used for the extraction and enrichment of volatile compounds in plant and food 
metabolomics.
161–168
 Insofar, headspace SPME has been successfully applied for the 
determination of metabolic changes and potential biomarkers from the volatile emissions of 
breath, skin, cancer tissue, and cell line. 
169–173
 However, due to the non-volatile and highly 
hydrophobic nature of lipids, headspace SPME cannot be considered as an option for 
comprehensive lipidomics. Here, we described a high throughput molecular lipidomics that 
benefits from the two available configurations of SPME, including the commercial SPME 
fibers suitable for in vivo studies, and the thin film geometry on a 96-blade device to 
potentiate high throughput ex vivo and in vitro lipid analyses. In this thesis, both approaches 
are comprehensively validated for absolute quantification targeted lipid analysis, as well as 
untargeted lipidomic profiling of several hundreds of molecular lipid species in diverse and 
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complex biological systems from biological fluids to cell culture. As a starting point, free 
fatty acids were selected as a class-specific lipid group. Commercial rod-fiber C18 SPME 
fibers were tentatively used in vitro to validate the extraction procedure from human and fish 
plasma, followed by use of LCMS using an ion-trap simple platform for accurate 
measurement and monitoring of polyunsaturated fatty acids in plasma samples of several 
patients during cardiac surgery. Afterwards, the 96-well robot-assisted SPME with the use of 
thin film geometry was employed for whole lipid analysis based on bioanalytical method 
validation guidelines. This was an attempt to minimize and automate the sample handling 
procedure while covering sensitive extraction of all lipid categories. Lipid extracts were next 
analyzed on a triple quadruple MS/MS for exact quantification of target lipids in human 
plasma, since it is likely that circulating plasma lipids can be used as predictive and 
diagnostic hallmarks in several disease states. Finally, in the last effort, the validity of the 
proposed thin film protocol was further examined on a group of cultured human 
hepatocellular cells for lipid profiling and “discovery lipidomics” assay. In this part, the list 
of extracted lipids was successfully compared with that obtained by use of traditional liquid-
liquid extraction based on the Bligh & Dyer protocol. The validation and key features of 
SPME methodology were discussed in comparison with Bligh & Dyer, emphasizing practical 
issues associated with operating the platform, and differences in the obtained results. By 
implementing lipid class extraction and separation prior to MS analysis, quantitative 
lipidomics of a wide range of cells and tissues can be achieved. The research presented 
herein highlights the efficacy of both fiber and thin film geometries by discussing their 
application for both low-throughput in vivo and high-throughput ex vivo/in vitro lipidomics 
studies. Just like any other counterpart methodologies, the presented SPME protocols come 
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along with several shortcomings, leaving room for improvement in the future studies. For 
instance, owing to its non-exhaustive nature, SPME renders lower extraction amounts that 
interpret into lower instrumental intensity and inferior overall sensitivity when comparing to 
other conventional sample preparation methods. Regardless of this shortcoming, SPME still 
suggests an identical precision in the quantitative and qualitative evaluations, indicating that 
smaller amounts of extracted lipids are still sufficient for trustworthy and consistent 
measurements. Looking at the glass half-full, non-exhaustive sampling with lower extracted 
amounts is somehow beneficial. The top-level advantages of this feature were clearly 
reflected in the results of matrix effect studies throughout the entire thesis, starting from fatty 
acids, whole lipid quantitative MS/MS, to lipidomics profiling. This is further beneficial not 
only from an ESI ionization efficiency point of view, but also concentration wise; abundant 
lipids with higher concentrations cannot conceal the peak of lipids existing in lower 
concentrations with lower signal intensities. One may suggest performing final extract 
dilutions for counterpart exhaustive methods to prevent this phenomenon; on one hand, 
dilution reduces the concentration of low abundant analytes to below-detection limits, while 
on the other hand, it is one additional step added to the sample preparation procedure, which 
increases the chance of contamination and artifact encounters.  
Despite the success of SPME in efficient extraction of lipid species from various biological 
matrices, for ex-vivo and in vitro sampling, there are inherent challenges particularly if the 
method is anticipated for the extraction of unstable lipids fast turn-over lipid metabolites. The 
current sampling time of 90 min may not be appropriate for monitoring rapid changes in 
extracellular lipids. Moreover, the long extraction time may result in deterioration and 
decomposition of lipoproteins and other bonded lipids. This seemingly problem will require 
further studies in order to improve the extraction time. A possible approach may be exploration 
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of the extraction under pre-equilibrium or kinetic calibration condition which will allow for 
improved time resolution. The other SPME coating may also need to be evaluated for increasing 
the efficiency and coverage of lipid metabolites. Optimization of coating composition will lead 
to better extraction of more polar lipid components as it has been previously demonstrated 
for metabolomics studies.
305
 For instance, the new mixed-mode coatings include less 
hydrophobic lipids such as lyso phospholipids. Lastly, the non-exhaustive SPME is of benefit 
to in vivo sampling methodologies, since it minimizes the system disturbance and provides 
the opportunity of using small probe dimensions inserted directly into living system organs. 
In this thesis, several methodological improvements were achieved throughout the new 
SPME protocols for usefulness and practicability of lipidomics sample preparation. First and 
foremost, the extraction procedure was simplified; second, a broader range of lipids with 
diversity in their classes and subclasses was achieved; third, direct extraction from biological 
samples was attainable without the need of multi-step sample pre-treatment and sampling; 
fourth, a better sample clean-up was achieved, and fifth, an improved, fully automated 
method for measurement of all lipid categories over a broad range was introduced. 
Last but not least, standard addition calibration using SPME provided accurate measurement 
of total and free lipid concentrations in biological samples. Meanwhile, a valuable insight 
into the lipid-protein interaction mechanisms is conceivable, and study of different binding 
affinities in complex biofluids is no longer a challenge. Finally, the SPME method offers 
important information on bioavailable concentrations of the analytes in plasma samples. 
5.2 Future directions 
The future of lipidomics holds massive deliverable output, which is essential to delineate 
disease mechanisms for the scientific community across the biological, clinical, and 
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biomedical research fields. As a consequence, it is critical for the 96-well format SPME to 
automatically handle intensive tasks and also be expanded to larger formats so as to speed up 
the extraction pipelines, and as a result, increase the throughput of the system.  
One of the future directions of the currently presented thesis could be the development of 
more efficient SPME coatings with improved selectivity and sensitivity for the extraction of 
individual groups of specific lipids. For instance, several phospholipids among all other lipid 
categories are of special interest in biomarker discovery lipidomics studies. These 
phospholipids contain a hydrophilic positively-charged ammonium head group (choline) 
which is connected to one or two hydrophobic tail(s). Accordingly, hydrophilic-lipophilic 
balanced (HLB) particles can be used as a potential sorbent coating in both thin-film and 
fiber geometries to facilitate more selective and effective extraction of this group of lipids. 
Several effective coatings were provided and reported in our lab for the extraction of 
quaternary ammonium compounds (QACs), which are structurally similar to some 
phospholipids;
306
 they also can be the potential choice for specified lipid extractions in the 
near future. However, newly emerging components of the SPME workflow will have to 
undergo systematic validation before routine adoption for complex matrices.  
Moreover, the presented lipid extraction protocol can also be expanded to the in vivo SPME 
platform, using the available needle-supported SPME fiber for extraction of lipids from 
tissue or organ of live and freely-moving animals for disease discovery research. It is 
noteworthy to mention that even though the presented SPME protocol herein is validated 
based on equilibrium extraction, kinetic calibration could be also considered for in vivo and 
in vitro applications so as to minimize the disturbance of the system under study by reducing 
the time of extraction.
160,174,197,228,307
 In addition, the validated method should not be 
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restricted to clinical analysis of lipids; it can be also employed towards the analysis of lipid 
content of food or plant for nutrition lipidomics purposes.  
In conclusion, the present study was a first approach to establish promising alterations in the 
clinical lipidomics workflow, which may now be followed-up in an extensive cohort of 
various biological matrices. 
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